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RESUME 
The chemistry of heterocycles have always been the major area of 
research for organic chemists owing to their wide spectrum of biological 
and pharmacological activities shown by them. Steroids too belong to 
the same category and thus became a matter of paramount interest in 
recent past. Our laboratory concerned mainly with the syntheses of 
steroidal compounds and their identification by chemical and spectral 
studies, a number of papers dealing with the preparation of 
heterosteroids have been appeared from our laboratory. The work 
embodied in this thesis described the syntheses of heterosteroids which 
are expected to be medicinally important. 
CHAPTER ONE 
Synthesis of Steroidal Selendiazoles : 
The fusion of any heterocyclic ring system to steroid or to 
introduce any heteroatoms such as sulfur, oxygen, nitrogen or halogen 
found to augment the biological and industrial range of them. 
Widespread applications of thiadiazoles in the areas of pharmaceuticals, 
agricultural, industrial and polymer chemistry prompted us to undertake 
the syntheses of steroidal selenadiazoles a metal carrier steroid which 
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may prove to be a potent pharmaceutically active compound, from easily 
available semicarbazones. 3P-Chloro-5a-cholestan-6-one semicarbazone 
(I) and its analogues 3P-acetoxy-5a-cholestan-6-one semicarbazone (II) 
and 5a-cholestan-6-one semicarbazone (III) on treatment with selenium 
dioxide in acetic acid gave 3P-chloro-5a-cholest-6-eno [6,7-d] 
selenadiazole (IV), 3{3-acetoxy-5a-cholest-6-eno [6, 7-d] selenadiazole 
(V) and 5a-cholest-6-eno [6, 7-d] selenadiazole (VI). 
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The mechanism for the formation of selenadiazoles (IV) - (VI) is 
outlined below. 
Ill 
R 
HaSeOa 
O 
H II II 
N-NH-C-NH2 
H \ / S e 
N ^ + 
I 
C = 0 
I 
NH2 
c=o 
c :NH2 
N^ / 
Se-^OH 
N 
I 
C = 0 
NH2 
CgHii 
R = CI, OAc, H 
IV 
CHAPTER - TWO 
Synthesis of N - Hydroxy Alkyl Lactams: 
Lactams are particularly important molecules owing to their 
versatility as synthetic intermediates and widespread occurrence in 
biologically important compounds. During last decade a number of 
azasteroids have been synthesized as 5a-reductase inhibitors. Guama 
et al. very recently reported the synthesis and biological evolution of a 
novel class of potent azasteroidal inhibitors (19-nor-lO-azasteroids) 
having bridgehead nitrogen atom at position 10 of the steroidal skeleton. 
Keeping in view the utility of these compound, here we have reported 
the synthesis of N - hydroxy alkyl lactams utilizing the slightly modified 
version of Schmidt reaction as described recently by Aube and 
CO - workers where hydrazoic acid had been replaced by hydroxy alkyl 
azide. 
3(3-Acetoxy-5a-cholestan-6-one (VII) and its analogues 3P-
chloro-5a-cholestan-6-one (VIII) and 5a-cholestan-6-one (IX) on 
reaction with 2-azidoethanol in presence of BFs-OEta gave S^-acetoxy-
N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (X), 3|3-ch loro-
N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (XI) and N-2'-
hyedroxyethyl-6-aza-B-homo-5a-cholestan-7-one (XII). Similarly 
cholest-5-en-3-one (XIII) gave N-2'-hydroxyethyl-3-aza-6P (2-azido-
ethoxy)-A-homochoIest-4a-en-4-one (XIV), 5a, 6p-dibromocholestan-3-
one (XV) gave N-2'-hydroxyethyl-3-aza-6P-bromo-A-homocholest-4a-
en-4-one (XVI) and cholest-4-ene-3, 6-dione (XVII) gave N, N-bis (2-
hydroxyethyl) 3, 6-diaza-A, B-bishomocholest-4a-ene-4, 7-dione 
(XVIII). 
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Following mechanism has been suggested, various steps involved 
are written as follows. 
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CHAPTER - THREE 
Synthesis of Steroidal s-Triazole and its Schiff bases 
Owing to the versatility of substituted s-triazoles as magnificient 
substrate especially 4-amino-5-mercapto-l,2,4-triazole for the synthesis 
of various heterocycles of medicinal importance, we have undertaken the 
synthesis of 4-amino-5-mercapto s-triazole attached to steroidal nucleus 
and their Schiff bases which may prove to be potent pharmaceutically 
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active compounds. Earlier we had planed our synthesis following 
method given by Hindel et al. in late 70's but did'nt succeed 
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Failure of this scheme prompted us to search out an alternate 
method which led us to the idea of direct reaction of ester with 
thiocarbohydrazide. 
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3 (3 (4'-Amino-5'-mercapto-1 ',2',4'-triazole-3'-methoxy) cholest-5-
ene on reaction with aromatic aldehyde such as benzaldehyde, p-toluene 
benzaldehyde, p-methoxy benzaldehyde and p-nitrobenzaldehyde in 
presence of catalytic amount of p-toluene sulfonic acid provides schiff 
bases, 3(3 [(4'-iminobenzylidine) 5'-mercapto-r,2',4'-triazole-3'-meth-
oxy) cholest-5-ene (XXIV), 3|3 [(4'-imino-p-toluedyl) 5'-mercapto-r,2', 
4'-triazole-3'-methoxy) cholest-5-ene (XXV), 3(3 [(4'-imino-p-methoxy-
benzylidine) 5'-mercapto-1 ',2',4'-triazole-3'-methoxy) cholest-5-ene 
(XXVI) and SP [(4'-imino-p-nitrobenzyIidine) 5'-mercapto-r,2',4' 
triazole-3'-methoxy] cholest-5-ene (XXVII). 
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CHAPTER - FOUR 
Application of X-Ray study in the Structural Elucidation of 
steroidal compounds 
X-Ray crystallography has grown ii<to a very precise, widely 
C«H 8"!? 
applicable and definitive tool, ever since the first discovery of the 
XI 
diffraction of X-rays by crystals. Identification of molecular structure 
and thereby the isomeric relationship between molecules, may be 
established by using a number of advanced techniques in perticular X-
ray crystallography, which determines the precise three dimensional 
arrangement of atoms, is the most powerful method available -X-Ray 
crystallography and its ability to measure accurate bond lengths within 
the molecules is the only tool available to determine bond stretch 
isomerism where molecules differs only in the length of one or more 
bonds. Thus widespread utility of this technique prompted us to 
undertake the crystallographic studies of steroidal compounds such as 
5a-cholestan-6-one (XXVIII), 6-nitrocholest-5-ene (XXIX), 3p-chloro-
5-nitrocholest-5-ene (XXX), 3P-acetoxycholest-5-en-7-one (XXXI) and 
cholest-3,5-diene-7-one (XXXII). 
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SUMMARY 
The chemistry of heterocycles have always been the major area of 
research for organic chemists owing to their wide spectrum of biological 
and pharmacological activities shown by them. Steroids too belong to 
the same category and thus became a matter of paramount interest in 
recent past. Our laboratory concerned mainly with the syntheses of 
steroidal compounds and their identification by chemical and spectral 
studies, a number of papers dealing with the preparation of 
heterosteroids have been appeared from our laboratory. The work 
embodied in this thesis described the syntheses of heterosteroids which 
are expected to be medicinally important. 
CHAPTER ONE 
Synthesis of Steroidal Selendiazoles : 
The fusion of any heterocyclic ring system to steroid or to 
introduce any heteroatoms such as sulfur, oxygen, nitrogen or halogen 
found to augment the biological and industrial range of them. 
Widespread applications of thiadiazoles in the areas of pharmaceuticals, 
agricultural, industrial and polymer chemistry prompted us to undertake 
the syntheses of steroidal selenadiazoles a metal carrier steroid which 
11 
may prove to be a potent pharmaceutically active compound, from easily 
available semicarbazones. 3P-Chloro-5a-cholestan-6-one semicarbazone 
(I) and its analogues 3P-acetoxy-5a-cholestan-6-one semicarbazone (II) 
and 5a-cholestan-6-one semicarbazone (III) on treatment with selenium 
dioxide in acetic acid gave 3|3-chloro-5a-cholest-6-eno [6,7-d] 
selenadiazole (IV), 3P-acetoxy-5a-cholest-6-eno [6, 7-d] selenadiazole 
(V) and 5a-choIest-6-eno [6, 7-d] selenadiazole (VI). 
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CRH 8^17 
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CI (I) 
OAc (II) 
H (III) 
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CI av) 
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The mechanism for the formation of selenadiazoles (IV) - (VI) is 
outUned below. 
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CHAPTER - TWO 
Synthesis of N - Hydroxy Alkyl Lactams: 
Lactams are particularly important molecules owing to their 
versatility as synthetic intermediates and widespread occurrence in 
biologically important compounds. During last decade a number of 
azasteroids have been synthesized as 5a-reductase inhibitors. Guarna 
et al. very recently reported the synthesis and biological evolution of a 
novel class of potent azasteroidal inhibitors (19-nor-lO-azasteroids) 
having bridgehead nitrogen atom at position 10 of the steroidal skeleton. 
Keeping in view the utility of these compound, here we have reported 
the synthesis of N - hydroxy alkyl lactams utilizing the slightly modified 
version of Schmidt reaction as described recently by Aube and 
CO - workers where hydrazoic acid had been replaced by hydroxy alkyl 
azide. 
3P-Acetoxy-5a-cholestan-6-one (VII) and its analogues 3(3-
chloro-5a-cholestan-6-one (VIII) and 5a-cholestan-6-one (IX) on 
reaction with 2-azidoethanol in presence of BF3-OEt2 gave 3|3-acetoxy-
N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (X), 3P-ch loro-
N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (XI) and N-2'-
hyedroxyethyl-6-aza-B-homo-5a-cholestan-7-one (XII). Similarly 
cholest-5-en-3-one (XIII) gave N-2'-hydroxyethyl-3-aza-6(3 (2-azido-
ethoxy)-A-homocholest-4a-en-4-one (XIV), 5a, 6(3-dibromocholestan-3-
one (XV) gave N-2'-hydroxyethyl-3-aza-6p-bromo-A-homocholest-4a-
en-4-one (XVI) and cholest-4-ene-3, 6-dione (XVII) gave N, N-bis (2-
hydroxyethyl) 3, 6-diaza-A, B-bishomocholest-4a-ene-4, 7-dione 
(XVIII). 
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Following mechanism has been suggested, various steps involved 
are written as follows. 
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CHAPTER - THREE 
Synthesis of Steroidal s-Triazole and its Schiff bases 
Owing to the versatility of substituted s-triazoles as magnificient 
substrate especially 4-amino-5-mercapto-l,2,4-triazole for the synthesis 
of various heterocycles of medicinal importance, we have undertaken the 
synthesis of 4-amino-5-mercapto s-triazole attached to steroidal nucleus 
and their Schiff bases which may prove to be potent pharmaceutically 
V l l l 
active compounds. Earlier we had planed our synthesis following 
method given by Hindel et al. in late 70's but did'nt succeed 
CRH 
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CH2 —CONHNH2 
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CgHn 
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Failure of this scheme prompted us to search out an alternate 
method which led us to the idea of direct reaction of ester with 
thiocarbohydrazide. 
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3(3 (4'-Amino-5'-mercapto-r,2',4'-triazole-3'-methoxy) cholest-5-
ene on reaction with aromatic aldehyde such as benzaldehyde, p-toluene 
benzaldehyde, p-methoxy benzaldehyde and p-nitrobenzaldehyde in 
presence of catalytic amount of p-toluene sulfonic acid provides schiff 
bases, SP [(4'-iminobenzylidine) 5'-mercapto-r,2',4'-triazole-3'-meth-
oxy) cholest-5-ene (XXIV), 3p [(4'-imino-p-toluedyl) 5'-mercapto-r,2', 
4'-triazole-3'-methoxy) cholest-5-ene (XXV), 3(3 [(4'-imino-p-methoxy-
benzylidine) 5'-mercapto-1 ',2',4'-triazole-3'-methoxy) cholest-5-ene 
(XXVI) and 3[3 [(4'-imino-p-nitrobenzylidine) 5'-mercapto-r,2',4'-
triazole-3'-methoxy] cholest-5-ene (XXVII). 
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CHAPTER - FOUR 
CsH, 
Application of X-Rav study in the Structural Elucidation of 
steroidal compounds 
X-Ray crystallography has grown into a very precise, widely 
applicable and definitive tool, ever since the first discovery of the 
XI 
diffraction of X-rays by crystals. Identification of molecular structure 
and thereby the isomeric relationship between molecules, may be 
established by using a number of advanced techniques in perticular X-
ray crystallography, which determines the precise three dimensional 
arrangement of atoms, is the most powerful method available -X-Ray 
crystallography and its ability to measure accurate bond lengths within 
the molecules is the only tool available to determine bond stretch 
isomerism where molecules differs only in the length of one or more 
bonds. Thus widespread utility of this technique prompted us to 
undertake the crystallographic studies of steroidal compounds such as 
5a-cholestan-6-one (XXVIII), 6-nitrocholest-5-ene (XXIX), 3P-chloro-
5-nitrocholest-5-ene (XXX), 3|3-acetoxycholest-5-en-7-one (XXXI) and 
cholest-3,5-diene-7-one (XXXII). 
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The explosive growth of natural and synthetic chemistry in the 
field of steroids during the last century had been the result of concerted 
efforts of all the leading organic chemists. The problem of isolation of 
the steroid entities from natural sources, their great value in modern 
medicine and interesting pharmacological properties have brought about 
an increasing interest. The synthetic modification of naturally occuring 
steroids, with the hope of improving pharmacological essentialities, has 
resulted in preparation and discovery of a number of diverse 
pharmacologically active, potent, highly specific commercially 
important therapeutic agents. The physiological activity of steroidal 
hormones depends on a number of factors. Among those of primary 
importance are stereochemistry and over all shape of the molecule. Thus, 
any really fundamental change (introduction of double bond, hydroxyl 
group, acetate group and ring enlargement and contraction etc.) in the 
steroid nucleus should alter the stereochemistry as little as possible. 
Since these have involved the modification of the basic carbon skeleton 
of the steroid nucleus itself, it provided an opportunity to deal with many 
problems of fundamental organic chemistry such as mechanistic and 
stereochemical aspects of transformations. 
Moreover, the deep involvement of modern spectroscopic tools 
(uv, l.r, n.m.r and mass spectrometry) in the structural elucidation of 
steroidal compounds envisaged. 
During the last decade the major efforts of the chemists were 
directed towards modification in the structure of steroids in order to 
enhance their non - hormonal activity and to increase the selectivity of 
certain biologically active compounds. The broad spectrum of biological 
activities found in these compounds and the multiplicity of action 
displayed by certain individual members make them one of the most 
intriguing class of compounds. 
Our laboratory, concerned mainly with the synthesis of steroidal 
compounds and their identification by chemical and spectral studies, has 
reported the preparation of a number of heterosteroids. In the present 
work an attempt has been made to synthesize some modified steroids of 
biological importance in order to have tinniest contribution towards the 
use of chemistry for mankind. 
Chapter One 
Synthesis of Steroidal 
Selenadiazoles 

The heat and light sensitivity and high chemical reactivity of 1,2, 
3-selenadiazoles towards strong base have made these easily available 
heterocyclic compounds, the subject of numerous investigation during 
the last decade. 1,2,3-Selenadiazoles are readily decomposed by 
extrusion of nitrogen, selenium or both of these elements. On the basis of 
these properties 1,2,3-selenadiazoles are remarkable chemical reagents 
for the synthesis of different types of compounds such as alkynes, 1,3-
diselenafulvenes, thiaselenols, selenophenes, 1,4-diselenines, seleno-
esters, selenomides and alkynyl selenocarboxyUc acid\ 
1,2,3-Selenadiazoles are prepared by selenium dioxide oxidative 
ring closure of semicarbazones as described in 1969 by Lalezari et al . 
Semicarbazones with different types of substituents including cyclic or 
heterocyclic systems and semicarbazone of aldehydes or ketones 
including cyclic ketones with two germinal a-hydrogen atoms are 
reacted in acetic acid or dioxane with selenium dioxide to afford 1,2,3-
selenadiazoles"'''*. 
Selenadiazoles resemble to that of tniadiazoles which belong to 
the class of compounds that have been broadly applied in the areas of 
pharmaceuticals '^^ , agricultural^ "^ *^ , industrial and polymer chemistry""^ .^ 
As far as the synthesis of selenium, nitrogen heterocyclic compounds is 
concerned, a number of such compounds have been synthesized during 
last three or four decades but not much work has been done to evaluate 
their pharmacological activities. Similarity of selenium and sulfur and 
some medicinally important activities as shown by selenium^ '^^ '',can 
predict the potentiality of these compounds. 
Lalezari et al. reported some biological activities of 1,2,3-
selenadiazoles^ .^ Srivastava and Robins^ ^ synthesized 2-P-D 
ribofuranosyl-4-selenazolecarboxamide 'selenazofurin', the selenium 
analogue of tiazofurin, 2-P-D-ribofuranosyl-4-thiazolecarboximide 
which has pronounced antitumor activity in animals and broad spectrum 
IT 
in vitro antiviral activity . Selenazofurin is 5 to 10 fold more dose potent 
than tiazofurin in several in vitro and in vivo antitumor screens and in 
biochemical studies^ *. 
Hanson et al.'^ reported the synthesis and characterization of (±)-
P-(2-amino-l,3-selenazol-4-yl) alanine (IVa) The synthesis was achieved 
in four steps sequence similar to that employed by Silberg, et al. for 
sulfur analogue (IVb). First step involved the condensation of selenourea 
with l,3-dichloropropan-2-one to yield 2-amino-4-chloromethyl selena-
zol hydrochloride la which was then con '^erted to acetamido derivative 
Ila. Ila On reaction with sodium diethyl formamido malonate provided 
the protected amino acid III a, which on hydrolysis gave the target 
compound IV a. (Scheme 1). 
Scheme - 1 
H2N/ ^NHs 
a X = Se 
b X = S Ia,b IIa,b 
H 
HCI^ C(C02C2H5)2 0 N 
O 
H3C N X 
H 
/ 
III a,b 
(C02C2H5)2 
NH-CH 
II 
O 
CO2H 
IVa,b 
21 Lalezari et al. systhesized selenium analogues of glycerol from 
1,2,3-selenadiazole. They reported that when potassium t-butoxide was 
added to a tetrahyrofuran solution of 4-aryl 1,2,3-selenadiazole (V), 
potassium 2-arylethynyl selenolate (VI) generated which reacted with 
epichlorohydrin (VIII) to afford 1-(2-arylethynyl selenomercapto) 2,3-
epoxy propane (IX) and l,3-di(2-arylethynylselenomercapto)-2-propanol 
(X). The anion (VI) is a powerful nucleophile, thus reacted with 
epichlorohydrin at room temperature and completed the reaction in less 
then 2 min. Dimerization of selenolate anion (VI) also take place to form 
1,4-diselenafulvenes (VII). 
Ac 
.N 
N 
"Se' / THF 
(CH3)3COK 
—»-ArC=C-SeK 
VI 
Ar< 
-Se 
\=CHAr 
S^e 
VII 
CH 2 \ THF 
VI -f-CH > 
CH2CI 
(VIII) 
CH2 \ 
CH/^ 
O 
CHo 
CH 
> , 
P H j — S e — C = C —Ar 
+ CH—OH 
CH2—Se—C=C — Ar CH2—Se — C = C —Ar 
(IX) ( X ) 
H-
CH2—OH 
in—OH 
CH2—Se—C=C—C6H4-P-OCH3 CH2—Se—C=C—C6H4-P-OCH3 
(Xa) 
l-(2-arvlethvnvl selenomercapto)-2,3-epoxvpropane (IX) 
C,,H,oOSe; M.P- 88. 
IRv„,axCm"': 2175 (-C = C-) 
^HNMR (CDCI3): 6 2.8 (m, 4H); 3.6 (m, IH); 7.5 (br, s, 5H). 
1, 3-di(2-arvlethvnvl seIenomercapto)-2-propanol (X) 
CgHigOSe; 
IRV™,(cm"'): 
Oil. 
2170(-C = C-);3500(OH) 
^HNMR (CDCI3): 5 3.1 (m, 5H); 4.5 (m, IH); 7.5 (s, lOH) 
3-r2-(p-methoxvphenvl) ethvnvlselenomercepto1-l,2-propa-
nediol (Xa): 
C,2H,403Se 
IRV max (cm"') 
^HNMR (CDCI3) 
Oil 
3500 (OH); 2170 cm' ' (C^C) 
5 3.4 (br, s, 2H); 3.9 (s, 3H); 3.5 - 4.3 (m, 
5H);7.0(d,2H);7.6(d,2H) 
Shafiee et al. have synthesized a series of 4-(2 aryl-4-
selenazolyl)-l,2,3-selenadiazole XI and 4-(2-substituted-4-thiazolyl)-l, 
2, 3-selenadiazole (XII) from readily available 2-substituted-4-formyl 
thiazoles and selenazoles. 
N=N \ 
N- < 
Se 
H 
Ar 
"Se 
(XI) (XII) 
Compounds XI and XII are prepared according to following 
scheme- 2. 
N-
.CHO 
R X' 
Scheme - 2 
N-
O 
II 
•CH3 
R' X y 
N-
N=Nv 
\ 
N—NHCONH2 
CH3 
< 
Se 
H 
R •'^  X 
(XI), Se 
(XII), S 
Decomposition of compound XII with ethanolic potassium 
hydroxide and subsequent addition of carbon disulfide in 
tetrahydrofurane afforded 5-substituted 2-thioxo-l, 3-thiaselenoles XIII. 
N=N \ 
N- < 
Se 
H 
R 
N- -C=C—SeK 
"-R 
CS, N-
R 
S 
L-Se 
(XII) (XIII) 
Addition of potassium hydroxide pellets to the alcoholic solution 
of XII gave cis-1, 4-diselenafulvene (XIV), which when heated to 200 °C 
for 15 minutes converted to trans-1, 4-diselenafulvene (XV) 
N=N •V \ 
Se 
N- N-
KOH 
R 
XII 
EtOH R / "S y 
XIV 
-Se H 
•Se •N 
H 
/ ^ < N-
A, 200°C R 
-Se 
-Se^  
XV 
N = 
R 
y ^ 
J 
H 
4-(2-Methvi-4-thiazolvl) 1,2 ,3-selenadiazole XII (R= CH )^; 
CfiHsNjSSe; M.P 119-121 °C 
^H-NMR (CDCI3) : 5 9.70 (s, IH, H5); 8.0 (s, IH, aromatic) and 2.80 
ppm (s, 3H, CH3) 
Mass(m/z%) : 231 (M^ 37), 229 (19), 203 (98), 201 (44), 162 
(78), 160 (37); 123 (13), 118 (59), 110 (30), 82 (100), 69 (30), 45 (33) 
and 38 (30). 
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Cis-2, (0-(2-MethvL-4-thiazoIyl)-l. 4-diselena fulvene (XIV, 
R = CH.); 
C12H10N2S2 Se2 ; M.P. 155-157 °C. 
^H-NMR (CDCI3) : 67.70 (s, IH, H3), 7.03 (s, 2H, aromatic), 6.80 (s, 
IH, Hco), 2.80 (s, 3H, CH3) and 2.70 (s, 3H, CH3). 
Mass (m/z, %) : 406 (M^ 100), 404 (88), 402 (52), 283 (27), 281 (25), 
279 (14), 242 (13), 203 (22), 123 (25), 82 (40) and 32 (48). 
5-(2-Methvl-4-thiazolyl)-2-thioxo-l, 3-thiaselenole (XIII, 
R = CH.): 
C7H5NS3Se ; M.P. 142-144 °C. 
^H-NMR (CDCI3) : 6 8.0 (s, IH, H4); 7.10 (s, IH, Hj-thJazole) and 
2.70 (s, 3H, CH3). 
Mass (m/z, %) : 279 (M^ 100), 277 (49), 203 (41), 201 (20), 162 (37), 
160 (19), 118 (12), 117 (13), 112 (14), 82 (24) and 69 (12). 
Sonoda et al. have given a novel synthesis of selenium 
containing heterocyclic compounds, by carbonylation of ortho 
substituted anilines with carbon monoxide in presence of selenium. They 
reported the reaction of o-cyano aniline (XVI) and o-amino 
11 
acetophenone (XVIII) with carbon monoxide and selenium to give 
selenoxoquinazolinone (XVII) and benzoselenazinone (XIX). 
NH2 
R ^ " " ^ CN 
R 
XVI a H 
XVI b CI 
XVI c OMe 
^ x \ NCO 
Se 
H 
1 
n Se 
XVII a H 
XVII b CI 
XVII c OMe 
12 
NH2 
Se,CO 
> • 
O 
XVIII 
H20 
o 
II 
NHC-SeH Q 
o 
OH 
N. ^O 
XIX (58%) 
6-Chloro-4-selenoxo-3,4-dihvdroqumazoIin-2-(lH)-one 
(XVII b): 
CgHsNjClOSe. : M.P. 289 - 290 °C 
IR (KBr) : 3240 - 2900, 1705, 1000 
^H-NMR (MezSO/ Me4Si) : 6 13.40 (br, 2H, NH), 8.37 (d, J = 2.9 Hz, 
IH, aromatic), 7.89 (dd, J = 9.6, 2.6 Hz, IH, aromatic), 7.21 (d, J = 9.6, 
IH, aromatic). 
^^C-NMR (MejSO - d6 / Me4Si) : 6c 194.45, 146.72, 135.94, 135.14, 
131.71,127.59,124.34, 118.38. 
MS m/z 262 (M^) 
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4-Methvl-3,4-dihvdro-3a-benzoselenazin-2(lH)-one (XIX): 
C9H9NOSe : M.P. 135-136 
IR(KBr) : 3280-3150, 1614, 822, 757 CM"'. 
^HNMR (MeaSO / Me4Si) : 5 10.72 (br, s, IH), 6.95 - 7.61 (m, 4H, 
aromatic), 4.55 (q, J = 7.6 Hz, IH, CH) 1.75 (d, J = 7.6 Hz, 3H, CH3), 
3.28 (s, H2O). 
"C-NMR (MejSO / Me4Si): 5c 166.07, 140.21, 137.49. 129.04, 127.09, 
124.75, 119.42,36.26,25.21 
MS (m/z) : 227 (M^). 
De Munno et al.^ '^  have given a new synthesis of 1,2,5-
selenadiazoles from unsubstituted or mono-substituted 1,2,5-thiadia-
zoles. They utilized easily accessible monosubstituted 1,2,5-thiadiazole 
derivatives which are transformed to 1, 2, 5-selenadiazoles in the 
presence of Grignard reagent, selenium (IV) chloride and elemental 
selenium. The reaction is carried out by treating the thiadiazolic substrate 
first with a proper Grignard reagent then with homogenized mixture of 
selenium (IV) chloride and elemental selenium corresponding to 
selenium (I) chloride. 
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// W ^ //^ + I W +R'SH + R'2S 
•sg. 2)SeCl4,Se iN.^^.N .^^, 
3) hydrolysis 
XX XXI 
Following mechanism have been suggested for the formation of 1, 
2, 5-selenadiazole. 
R 
N N 
1) R'MgX 
R 
XMgN 
H 
I 
C - C - R 
0 I 
NMgX 
R 
SR 
SeCU, Se 
-RSH 
N N 
(XXa-c) 
XMgN^ VsR 
RMgX 
+ 
R9S u -1^2 
RSN' ' ^MgX 
R'MgX 
„-R'2S 
R H 
C - C 
XMgN NMgX 
R 
SeCl4, Se 
St 
(XXI) 
N N 
' t 
In the case of the unsubstituted 1,2,5-thiadiazole the reaction 
affords only one intermediate (R = H) la, containing the sulphenimine 
system connected to a CH group. No nucleophillic attack at hydrogen 
atom of starting thiadiazole or intermediate occurs as no hydrocabron 
15 
R'H was formed from the Grignard reagent before the addition of 
selenium chloride. 
3-Cvdohexvl-4-methvl-l, 2, 5-selanadiazole (XX-a) R = 
CH,, R^  = CHn: 
C9H,4N2Se : M.P. 52 -54 
IR' (V) (cm-^): 735, 712, 403, 428. 
^HNMR : 5 1.11 - 2.01 (m, lOH); 2.58 (s,3H); 2.74-3.08 (m, 
IH). 
Mass (m/z) : 230 (M^, 43) 
3-(l-naphthvl)-4-methyl-l, 2, 5-seIanadiazole (XX-b) R = 
CH ,^ R^  = 1-Naphthvl: 
CijHioNaSe : M.R 117-118 
IR'(V) (cm-^): 755,716,490,430. 
^HNMR : 5 2.40 (s, 3H); 7.41 - 7.65 (m, 6H); 7.87 - 8.07 (m, 
IH) 
Mass (m/z) : 274 (M^ , 8). 
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3 (2-thienvl)-l, 2. 5-selanadiazole (XX-C) R = H. R^  = 2-
Thienyl; 
M.P. 9 1 - 9 2 
IR' (V) (cm"'): 752, 707, 487, 437. 
' H N M R : 5 7.12-7.36 (m,lH); 7.56 (dd, IH); 7.72 (dd, IH); 
9.64 (s, IH). 
Mass(m/z) : 216 ( M M 8). 
Hori et. al^ ^ reported the synthesis and reactions of first stable 
selenabenzene analogue, 2-cyano-1 -methyl-4-phenyl-1 -selenanaphtha-
lene (XXII). The synthetic route is 5hown in Scheme - 3. 
The reported bands are tentatively assigned to the ring on the basis of a comparison 
with ir and Raman spectra of 1, 2, 5-selenadiazole. 
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Scheme - 3 
2-Cvano-l-methvl-4-phenvl-l-selenanaphthelene (XXII); 
CnHijN Se ; M.P. 114 - 115 °C (decomp) 
IRVmax:2140cm"'(CN) 
'HNMR : 5 2.23 (3H, s, CH3), 6.74 (IH, s, Hp)), 7.05 - 7.58 (5H, m, 
aromatic H). 
These spectral data indicates that the selenabenzene is an ylide 
and ylidic carbanion is delocalized over cyano group. The 
selenanaphthalene (XXII) when refluxed in dry benzene for 24 hr under 
nitrogen atmosphere gives 2-cyano-2-methyl-4-phenyl-l-selenochro-
18 
mene (XXIII) and 2-cyano-4-methyl-4-phenyl-l-selenochromene 
(XXIV) in 18 and 11% yield. 
XXII 
XXIII XXIV 
2-Cvano-2-methv[-4-phenvl-l-selenochromene (XXIII): 
CnHnNSe ; Oil 
IRVn,ax: 2230 (CN) 
' H N M R : 5 1.94 (3H, s, CH3), 5.68 (IH, s, H(3)), 7.05 - 7.6 (9H, m, 
aromatic H). 
"C-NMR (5, ppm) : 25.6 (CH3), 26.2 (C(2)); 121.2 (CN), 123.8, 127.1, 
127.2, 128.3, 129.0, 129.1, 129.7, 130.2, 133.8, 140.0 (aromatic (c)), 
145.0 (C3), 151.0 (C4). 
2-Cvano-4-methvl-4-phenvM-selenochromene (XXIV): 
C,7H,3NSe 
M.P. 84.5 - 86 °C 
IR (v„,ax, cm-'): 2210 (CN). 
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' H N M R : 6 1.86 (3H, s, CH3), 7.08 - 7.49 (lOH, m, olefinic and 
aromatic H). 
^^CNMR : 6c 26.5 (CH3), 49.6 (C4), 103.1 (CN), 127.0, 127.3, 128.0, 
128.3, 128.7, 139.7 (aromatic C), 145.4 (C2), 151.1 (C3). 
Okuma et al.^ ^ reported the regioselective synthesis of bicyclic 
diselenides, by treating 3,3-diphenyl-2-selenabicyclo [2.2.1]hept-5-ene 
(XXVa) with elemental selenium in toluene. Other bicyclic selenide 
(XXV) were successfully converted to (XXVIII) in moderate yield (table 
- 1). The reaction is regioselective; only one isomer of (XXVIII a - c) 
was obtained in this reaction 
(Se)n+ \ \ // 
XXV VYVTTT R 
R' 
XXVIII 
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Table - 1 Reaction of XXV with elemental selenium 
Compound 
R 
a Ph 
a Ph 
b p-MeC6H4 
c P-FC6H4 
XXV 
R' 
Ph 
Ph 
p-MeC6H4 
P-FC6H4 
Temperature 
90°C 
Reflux 
90°C 
90°C 
Solvent 
Benzene 
Toluene 
Toluene 
Toluene 
Products 
XXVIII 
a 
a 
b 
c 
(% Yield) 
34 
38 
38 
40 
There are two possible mechanisms to explain the formation of 
(XXVIII). First (XXV) was decompose to give selenobenzophenone via 
retro-Diels-Alder reaction, which further reacted with elemental 
selenium to afford diary 1 selenoselenine (XXVI). 
Compound (XXVI) reacts with cyclopentadiene to give endo-
selenoselenide (XXVII) which rearranges to bicyclic diselenide 
(XXVIII) (Route A)^'. A radical mechanism is another explanation on 
the formation of bicyclic diselenides (XXVIII). The adducts (XXV) 
homolytically decompose to biradicals which further reacted with 
selenium followed by recombination to afford bicyclic diselenide 
(XXVIII) (route B). ESR study of this reaction supports route B. 
21 
+ C=Se 
A . / 
(Se)n 
(B) 
"Ar 
\ 
C=Se 
/ W Ar 
XXVI 
Se 
\ / / 
(Se)n 
(B) 
CQ^ 
Ar Ar 
XXVIII 
i28 Nadler et al synthesized a new heterocycle 1,3, 4-selenadiazin-
2-one based on the preparation of the analogue heterocycle 1,3,4-thiazin-
2-one, which shows promising cardiotonic activity. 
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N^ NH2 
H 
I 
XXXI 
H XXX 
(i) AICI3, CH3 CH Br COCl, DMF, 70°. 
Se 
(ii) NH2 -NH NH CH3CN, CF3COOH, reflux. 
(iii) DMF, NaN02, H2O, CF3COOH, 40' 
(iv) HCl ION, reflux. 
Selenadiazinones (XXX) showed interesting cardiotonic activity 
as excellent PDE III inhibitors. Moreover they are of particular interest 
as they possess significant sensitizing properties of myocardial 
contractile proteins to calcium. 
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l,3-Dihvdro-5-(3-amino-2,3-dihvdro-2-amino-5-methvI-2-
imino-13-selenazol-4-vI)-33-dimethvl-2H-indol-2-one 
(XXXI): 
C,4H|6N40Se ; M.P. 225°C 
IR v^ ax (KBr): 3380, 3200 (NH); 1720, 1628 (CO) cm-'. 
^HNMR (DMSO) : 5 1.25 (s, 6, CH3C); 2.38 (s, 3, CH3C); 4.96 (s, 2, 
NH2), 6.83 (d, 1, Ar, J = 8 Hz), 7.28 (d, lAr, J = 8 Hz); 7.41 (s, 1, Ar); 
8.50 (s, 1,NH); 10.36 (s,l,NH). 
5-(2-Amino-6-methyl-6H-l, 3< 4-selenadiazm-5-vl)-l,3-dihv-
dro-3,3-dimethvl-2H-indoI-2-one (XXIX): 
C,4H,6N40Se ; M.P. 205°C. 
IR Vmax (KBr): 3380, 3120 (NH); 1705, 1615 cm-' (CO). 
^HNMR (DMSO) : 5 1.28 (s, 6, CH3C); 1.37 (d, 3, CH3CH); 4.46 (q, 1, 
CH3CH, J = 7.1 Hz), 6.80 (m, 2, NH2); 6.89 (d, 1, Ar, J = 8.2 Hz); 7.67 
(dd, 1, Ar, J = 8.2); 7.85 (d, 1, Ar, J = 1.5 Hz); 10.51 (s, 1, NH). 
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1, 3-Dihvdro-5-(3, 6-dihvdro-6-methvl-2-oxo-2H-l, 3. 4-sel-
enadiazin-5-yl-3,3-dimethvl-2H-indol-2-one (XXX): 
CnHisNaOzSe ; M.P. 235°C. 
IR v„,ax (KBr): 3200 (NH); 1705, 1620 (CO) cm-'. 
^HNMR (DMSO) : 5 1.28 (s, 6H, CH3C); 1.69 (d, 3, CH3CH, J = 7.2 
Hz); 4.69 (q, 1, CH3CH, J = 7.2 Hz), 6.92 (d, 1, Ar, J = 8.2 Hz); 7.63 
(dd, 1, Ar, J = 8.2 Hz); 7.75 (d, 1, Ar, J = 1.7 Hz); 10.59 (s, 1, NH); 
11.60 (s, 1,NH) 
Mass : m/z 337.0339. 
29 Regitz et al. reported the synthesis of 1,3-selenaphospholes from 
1,2,3-selenadiazoles. 1,2,3-selenadiazoIes on photolysis or thermal 
decomposition yielded highly reactive intermediates (XXXIII), which on 
1,3-dipolar cycloaddition with phosphaalkynes gave 1,3-selenaphosp-
holes (XXXIV). 
,R'x 
/ 
t 
\ 
XXXII 
R'v 0 
.Se , ' ^ \ ^ S e 
\ , hv is Et20 or ,' I 
,N ^ *- [ I 
.^' A (without Solvent) ' ^ - D - ^ ® XXXIIIA 
-N 
/ 
I 
X J . 
'"R^XXXIIIB 
25 
R -^C 
[3 + 2] 
.R'-
XXXIV 
•N 
R" 
R' 
R^  f' 
R^ = tBu, CMe2 Et 
\ 
30 Lowe et al. have given a new method for preperation of 
organoselenium compounds, they synthesize selenium-bridged 
bisquinolone (XXXV), the synthetic route of which is shown in 
scheme - 4. Selenium-bridged bisquinolone on methylation gives N-
methyl derivative (XXXVI) and when treated with phosphorus 
oxychloride yielded 4-chloroquinoline (XXXVII) which was converted 
to novel selenium heterocycles (XXXVIII, XXXIX, XL) as shown in 
scheme-5. 
Scheme - 4 
26 
XXXV 
27 
Scheme - 5 
31 Shafiee et al. have synthesized 1,2,3-thiadiazolo and 1,2,3-
selenadiazoloquinolines. The synthetic route of title compounds is shown 
is Scheme - 6. 
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Scheme - 6 
NNHCONHo 
XLIV 
O 
Br 
^ 
^ 
N' 
Se 
II 
NH2C-NH2 
Se 
R—(' ^>—C-NH2 
f' ^—C-NH2 
XLVII 
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4,5-Dihvdro \1,2,31 thiadiazolo [4,5-f] quinoline (XLI) : 
C9H7N3S ; M. P. 76 - 77 °C 
^H-NMR (CDCI3) : 5 8.55 - 8.4 (m, 2H, H,,?); 7.40 - 7.20 (q, IH, Hg); 
3.36 (s, 4H, H4,5) 
Mass (m/z, %) : 189 (M^ 49); 161 [(M^ - N2), 100]; 160 (50), 117 (88) 
116 (17); 89 (16), 63 (12). 
4,5-Dihvdro-l, 2,3-selenadiazolo [4,5-f1 quinoline (XLII): 
CgHvNaSe ; M. P. 82 - 83 °C 
^H-NMR (CDCI3) : 6 8.55 - 8.40 (m, 2H, Hv,?); 7.40 - 7.20 (q, IH, Hg); 
3.36 (s, 4H, H4,5) 
Mass (m/z, %) : 237 (M^ 8); 209 [(M^ - N2), 36]; 129 (100), 117 (20) 
102 (21); 63 (12). 
1,2,3-seIenadiazolo [4,5-fl quinoline (XLIII); 
C9H5N3Se;M.P. 123-124°C 
^H-NMR (CDCI3) : 6 9.45 (q, IH, H9); 9.09 (q, IH, H7); 8.36 (s, 2H, 
H4,5) and 7.70 (q, IH, Hg). 
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Mass (m/z, %) : 235 (M^ 2); 207 [(M* - N2), 20]; 127 (100), 117 (27) 75 
(13). 
2-Amino-4,5, dihydroselenazolo [4,5-f1 quinoline (XLV) : 
CioHgNsSe: M.P. 205-207. 
IR Vmax (KBr) : 3280, 3110 (NH2), 1640 (NH2), 1550-1440 cm-' 
(aromatic). 
^H-NMR (CDCI3) : 5 8.31 (q, IH, H7); 7.95 (q, IH, H9), 7.16 (q, IH, Hg) 
and3.14(m, 4H, H4,5). 
Mass (m/z, %) : 251 (M^ 82), 170 (100), 143 (13), 128 (37), 102 (12), 
89 (10) and 63 (10). 
Koketsu et al. has given the novel synthesis of 1,3-selenazine 
derivatives by the reaction of primary selenomides with a,P unsaturated 
ketones in the presence of BF3-OEt2. Among the 1,3-selenazine 
diastereomers bearing two assymmetric carbon at the C4 and Cg 
positions, the cis form is predominant. 
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R' 
Se Rl 
R ^ N H , ' ^ ' ° 
•^ BF3-Et20 R. Se ^ 
CH2CI2 
0 °C, 3h 
11 H 
XLVIII XLIX 
N 
HO V 
L 
R" 
R" 
Mechanism: 
Se 
A ^^ ~ 
R NH2 o 
Se 
^ 
R ^NH (o., 
H BF3 
R 
ll 
N^ 
I 
,Se 
V 
Ao® 
_ 
H^N D 
R Se 
H-
-BF, •N 
R Se 
V-
N 
OH 
OBF3H 
/y 
Entry 
1 
Selenomide 
(XLVIII) 
R = 4-CH3C6H4 
XLVIII a 
a-p-Unsaturated 
Ketone (XLIX) 
0 
XLIX a 
1,3-selenazine 
(L) 
•X5 
" 0 La 
71 4 
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2 
3 
4 
XLVIII a 
R = n-C5H,, 
XLVIII b 
XLVIII b 
XLIX b 
XLKb 
0 
XLIX 
" 0 Lb 
87 9 
HO Lc 
4-Hvdroxv-4-methvl-2-(4-methvl phenvl)-5,6-dihvdro-4H-l, 
3-selenazine (L a): 
C,2 HisNOSe ; M.P. 89.0 - 89.6 °C 
IR(KBr):3160, 1594 cm' 
UVA^is (CH2CI2) ?imax(log (E/dm^mor'cm-')) 341 (2.42), 255 (3.98). 
^H-NMR (CDCI3): 8 1.28 (3H, s), 2.99 - 3.07 (2H, m), 3.81 (IH, br, s) 
7.07 (2H, d)), 7.54 (2H, d). 
13 C-NMR (CDCI3) : 6c 18.3, 21.4 24.9, 30.0, 85.1, 126.5, 129.1, 137.5, 
141.0 
4-Ethvl-4-hvdroxy-2-(4-methvl phenvl)-5, 6-dihvdro-4H-l, 
3-selenazine (L b): 
C,3 H,7N0Se ; M.P. 60.6 -61.3 °C 
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IR(KBr) :3150,1593 cm-' 
UVA i^s (CH2CI2) ^max(log (E/dm^mor'cm-')) 345 (3.17), 260 (3.94). 
*H-NMR (CDCI3): 5 1.02 (3H, t, CH3), 1.62 - 1.74 (3H, m), 2.01 - 2.05 
(IH, m), 2.36 (3H, s, CHsPh), 2.86 (IH, br, s, OH), 3.08 - 3.19 (IH, m), 
7.17 (2H, d, Ar), 7.64 (2H, d, Ar). 
'^C-NMR (CDCI3) : 6c 7.1, 17.7, 21.3, 27.6, 30.3, 86.6, 126.5, 129.0, 
137.6, 140.9, 156.4 
4-Ethvl-4-hvdroxv-2-pentvI-5,6-dihvdro-4H-l,3-selenazine 
(Lc): 
C|,H2iN0Se: Oil 
IR (Neat): 3408, 1713 cm-' 
UVA^is (CH2CI2) ?imax(log (E/dm^mor'cm-')) 305 (3.34), 245 (3.34). 
^H-NMR (CDCI3) : 5 0.89 (3H, t, CH3), 0.97 (3H, t, CH3), 1.32 (4H, t), 
1.47 - 1.57 (IH, m), 1.58 - 1.65 (4H, m), 1.98 (IH, dt), 2.34 - 2.42 (2H, 
m), 2.99 - 3.03 (2H, m), 3.95 (IH, br, s, OH). 
^^C-NMR (CDCI3) : 6c 7.09, 13.9, 17.2, 22.3, 27.5, 27.7, 29.8, 31.0, 
31.0,43.5,86.2 
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The enzyme steroid 5a-reductase is a system of two NADPH-
dependent membrane bound isoenzymes that catalyzes the conversion of 
testosterone to dehydrotestosterone (DHT).""^ '* DHT is related with 
certain disorder such as baldness^ ,^ acne''^ , alopecia in men^ ^ and 
hirsutism in women^ ^ . Thus great efforts have been made towards the 
synthesis of 5a-reductase inhibitors which led to the discovery of two 
class of inhibitors based on steroidal structure of testosterone, A 
(4-azasteroids) or B ring (6-azasteroids)^^" .^ Further work on aza-
steroids reveal that it belongs to a class of compounds that are associated 
with diverse biological activities.'*^ ''*^  Recent survey of literature on 
selenium shows that various physiological activities are influenced by it. 
Margerate et al. very recently reported that rat thioredoxin reductase 
activity increases by supranutritional selenium and decreases by 
selenium deficiency, Novarro et al.''^  discovered that vit-E & selenium 
deficiency induced expression of ubiquinone-dependent antioxidant 
system at plasma membrane, Scholz °^ et al. reported the effect of Vit E 
and selenium on antioxidant defence in rat heart. Thus these important 
activities of azasteroids and selenium and wide spectrum of 
pharmacological activities shown by thiadiazole , prompted us to 
undertake the synthesis of steroidal selenadiazoles (LXIII, LXIV and 
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LXV) from semicarbazones (LIV, LV & LVI), metal carrier steroids 
which may prove to be potent pharmaceutically active compounds. 
X H II 11 
N-N-C-NH2 1 
1 
H 
X 
CI 
OAc 
H 
(LIV) 
(LV) 
(LVI) 
Reaction of 3B-chloro-5a-cholestan-6-one semicarbazone 
(LIV) with selenium dioxide in acetic acid : 
The semicarbazone (LIV) was taken in acetic acid to this 
selenium dioxide was added. The reaction mixture was then heated on 
water bath for about 20 hrs. Then it was poured into cold water and 
extracted with ether. The ethereal layer was washed with water, sodium 
bicarbonate solution (5%) and water and dried over anhydrous sodium 
sulphate. Evaporation of the solvent gave an oily residue which was 
chromatographed on a silica gel column. Elution with petroleum ether-
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ether afforded 3P-chloro-5a-cholest-6-eno [6, 7-d] selenadiazole (LXIII) 
as a glassy semisolid. 
H II II 
N-N-C-NH2 
I 
(LIV) H 
CI' i - = y ^se 
H H \ / ^ 
N=N 
(LXIII) 
Characterization of the compound as 33-chIoro-5a-cholest-
6-enor6,7-d1 selenadiazole(LXIII) : 
The elemental analysis of the compound corresponded to the 
molecular formula C27H43N2ClSe (positive Beilstein test). The IR 
spectrum of the compound exhibited bands at 1620 (C=C), 1370 (C-N); 
750 (C-Cl) 590 cm"' (C - Se)^°'. These values suggest the presence of 
selenadiazole moiety fused in the steroid nucleus. The ' H N M R spectrum 
of the compound displayed a multiplet centered at 54.2 which was 
assigned to Cs-aH (wVi = 16 Hz, axial)^', A triplet at 62.7 was observed 
accounted for Cs-aH and at 63.0 (dd) for Cg-pH. Methyl protons were 
observed at 5 1.15 (C10-CH3), 0.66 (C13-CH3), 0.92 and 0.83 (for other 
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side chain methyl protons). Additional support to the structure (LXIII) 
was provided by its mass spectrum which showed respective molecular 
ion peaks with characteristic isotopic abundance pattern for a selenium 
containing compounds , due to the number of naturally occuring stable 
isotopes of selenium. Those of significant abundance are "^^ Se (0.9%), 
^^ Se (9.1%), ^^ Se (7.5%), '^Se (23.6%) °^Se (50%) and ^^ Se (8.8%), for 
the sake of simplicity here, the molecular ion peaks are given 
considering ^°Se '^*. The mass spectrum gave molecular ion peaks at m/z 
512/514, other notable peaks were found at 482/484, 468/470, 442, 
369/371, 353/355, 402/403, etc. The tentative mechanism for the 
formation of these fragment ions is given below. 
512/514, (M +) 
- N , 
484/486. 
H 
484/486 
-CH4 
Se+ 
m/z 468/470 
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m/z442 
nVz442 
m^z444 
m/z 369/371 nVz 353/355 ^^ 
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m/z 402/404 CgHn 
Nn 
N=N 
m/z 512/514 
m/z 402/404 
On the basis of above evidences the compound was characterized 
as 3[3-chloro-5a-cholest-6-eno [6, 7-d] selenadiazole (LXIII). 
Reaction of 3B-acetoxv-5a-cholestan"6-one semicarbazone 
(LV) with selenium dioxide and acetic acid : 
3|3-Acetoxy-5a-cholestan-6-one semicarbazone (LV) was taken 
in acetic acid and then selenium dioxide was added to it. The suspension 
was heated under reflux on water bath for about 20 hrs. It was then 
poured into ice-cooled water and extracted with ether. After work up and 
the solvent removal, the crude product thus obtained was chromato-
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graphed over silica gel column. Elution with petroleum ether-ether gave 
3P-acetoxy-5a-cholest-6-eno [6, 7-d] selenadiazole (LXIV) as semisolid. 
CgHn 
AcO^ H 
(LV) 
N-N-C-NH2 
I 
H 
CgHi' 
H \ / 
N=N 
(LXIV) 
Characterization of the compound as 33-acetoxv-5a-chol-
est-6-eno [6,7-d1 selenadiazole (LXIV): 
The elemental analysis of the compound corresponded to the 
molecular formula C29H46N202Se. The IR spectrum of the compound 
exhibited strong absorption bands at 1730 and 1240 indicating the 
presence of acetate group. Other bands observed were 1610 (C=C), 1375 
(C-N) 590 cm'' (C - Sef^\ These values indicate the presence of 
selenadiazole moiety attached with steroid nucleus. The ' H - N M R 
spectrum of the compound displayed a multiplet centered at 54.9 which 
was assigned to Ca-aH (W1/2 = 16Hz, axial)^', 2.1 (s, CH3COO). A 
triplet was observed at 52.75 was assigned to Cs-aH and at 5 2.95 (dd) to 
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Cg-PH respectively. Annular methyl groups were observed at 1.13 
(Cio-CHj), 0.67 (C,3-CH3), 0.91 and 0.85 (for side chain methyl 
protons). The structure of the compound was further supported by mass 
spectrum which gave the molecular ion peak at 534. The base peak was 
observed at 365 arising by the loss of N2, Se and AcOH. Other important 
peaks include 506, 490, 474, 446, 252 and 333 etc. A tentative 
mechanism explain the formation of these fragment ions given below. 
QHi-
m/z506 
AcO 
N, 
AcO 
m/z534(M+) 
C«H 8^117 
AcO AcO 
m/z506 
m/z506 
C«H 8^17 
nVz490 
42 
—I + 
m/z474 C«H 8^17 
AcO 
AcOH 
m/z534 
CRH 8^17 
nVz474 
nVz446 
CsH 8"17 
nVz 365 - base peak 
m/z474 
43 
nVz365 
mIzlSl 
C«H 8^17 
nVz252 
CsH 8"I7 
nVz333 
m'z446 
m/z333 
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Reaction of 5a-cholestan-6-one semicarbazone (LVI) with 
selenium dioxide and acetic acid : 
5a-Cholestan-6-one semicarbazone (LVI) dissolved in acetic acid 
and selenium dioxide was then added to it. The suspension was heated 
under reflux on water bath for about 20 hrs. It was then poured into cold 
water and extracted with ether. After usual work up and evaporation of 
the solvent, the crude product thus obtained was chromatographed over 
silica gel column. Elution with petroleum ether-ether afforded 5a-
cholest-6-eno-[6, 7-d] selenadiazole (LXV) as a glassy semisolid. 
C«H 8^17 
N-NHCONH2 
(LVI) 
CgHiv 
Characterization of the compound as 5a-cholest-6-eno [6, 
7-d1 selenadiazole (LXV): 
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The elemental analysis of the compound corresponded to the 
molecular formula C27H44N2Se. The IR spectrum of the compound 
showed absorption bands at 1615 (C=C), 1380 (C-N) and 580 cm"' 
(C - Se)^ °^  indicating the presence of selenadiazole moiety attached to 
steroidal nucleus. The ^HNMR spectrum of the compound displayed a 
triplet at 5 2.9 and at 6 3.5 (dd) were assigned to Cs-aH and Cg-pH 
respectively. Annular methyl protons were observed at 8 1.14 (C10-CH3), 
0.67 (C,3-CH3), 0.91 and 0.84 (for other side chain methyl protons). The 
structure of the compound was further supported by its mass spectral 
study. The mass spectrum showed molecular ion peak at m/z 474, 
followed by base peak obtained at 446 arising by the loss of N2, other 
notable peaks include 367, 333. A tentative scheme is given for the 
formation these fragment ions. 
Base peak - 446 
H \ I 
N = N 
m/z 474 
-N2 
'Se 
m/z 446 +• 
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m/z367 C«H 8^17 
m/z333 
nVz367 
nVz446 ni/z333 
A mechanism is proposed for the formation of steroidal 
selenadiazoles from corresponding scmicarbazones, various steps are 
written as follows. 
47 
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All melting points were observed on a Kofler hot block and are 
uncorrected. IR spectra were obtained as neat with a Perkin-Elmer 237 
spectrophotometer. IR values are given in cm"'. NMR spectra were run 
in CDCI3 on a Bruker AC 300 (300 MHz) with Me4Si as internal 
standard and its values are given in ppm (6) (s, singlet; br, broad; mc, 
multiplet centered at). Mass spectra were measured on VG micromas 
model ZAB - IF apparatus at 70 eV ionization voltage. The values (m/z) 
of fragment ions from various compounds are given in parentheses 
which are the relative abundance (%) of the peaks with respect to the 
base peak as 100%. Thin layer chromatographic plates (TLC) have 
coated with silica gel. Silica gel (~ 20g ) was used for each gram of the 
material to be separated in column chromatography. Petroleum ether 
refers to a fraction of b. p. 60 - 80°. Sodium sulphate (anhydrous) was 
used as the drying agent. 
33-Chloro cholest-5-ene (LI) 
Freshly purified thionyl chloride (75ml) was added gradually to 
cholesterol (lOOg) at room temperature. A vigorous reaction ensued with 
the evolution of gaseous products. When the reaction slackened, the 
mixture was gently heated at the temperature of 50-60° on a water bath 
for Ihr and then poured onto crushed ice-water mixture with stirring. 
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The yellow solid thus obtained was filtered under suction and washed 
several times with ice cooled water and air dried. Recrystallization of 
crude product from acetone gave 3(3-chlorocholest-5-ene (LI) (95.5g), 
m.p. 95-96 (reported^^ 96-97°). It gave positive Beilstein test and a 
yellow colour with tetranitromethane in chloroform. 
33-Chloro-6-nitrocholest-5-ene (LID : 
To a well stirred mixture of 3P-chlorocholest-5-ene (LI) (12g) 
glacial acetic acid (80ml) and nitric acid (25ml, d, 1.52) at temperature 
below 20°, was added sodium nitrite (3.0g) gradually over a period of 
3 hrs. After the complete addition of sodium nitrite, the mixture was 
further stirred for about 1 hr, ice cooled water (200ml) was added and 
the yellowish solid thus separated was filtered and air dried. The desired 
product (LII) was recrystallized from methanol as needles (8.3g) 
m.p. 151- 152 (reported" m.p. 153°). 
33-Chloro-5a-cholestan-6-one (LIII): 
A solution of (LII) (12g) and glacial acetic acid (240ml) was 
heated just to get a clear solution. To this zinc dust (24g) was added 
gradually in small portions with constant shaking. The suspension was 
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heated under reflux for 4 hrs and water (24ml) was added at regular 
intervals during the course of the reaction. The hot solution was poured 
into ice-cooled water. The organic matter was extracted with ether and 
ethereal solution was washed successively with water, sodium 
bicarbonate solution (5%) and again with water and dried over sodium 
sulphate (anhydrous). Evaporation of the solvent furnished the ketone as 
an oil which was crystallized from methanol (8.7g), m.p. 128-129, 
(reported^^ m.p. 129). 
33-Chloro-5a-cholestan-6-one semicarbazone (LIV): 
SemicarbazidQ hydrochloride (4g) and sodium acetate (6g) were 
dissolved in water (32ml), to this 3(3-chloro-5a-cholestan-6-one (LIII) 
(2g) and ethyl alcohol (200ml) was added. The reaction mixture was 
then heated under reflux for 4 hrs. Progress of the reaction was 
monitored through TLC. After the completion of reaction, it was allow 
to stand overnight. The product thus obtained was filtered under suction 
and crystallized from ethyl alcohoP (1.5g) m.p. 148°. 
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Reaction of 3B-chloro-5a-cholestan-6-one semicarbazone 
(LIV) with SeOi ; 3B-Chloro-5a-cholest-6-eno [6, 7-dl 
selenadiazole (LXIII): 
The semicarbazone (LIV) (Ig) in acetic acid (100ml) was treated 
with selenium dioxide (Ig) and heated on water bath for 20 hrs. Then it 
was poured in ice cold water and extracted with ether. The ethereal layer 
was washed with water, sodium bicarbonate (5%) and water and dried 
over anhydrous sodium sulphate. Evaporation of the solvent gave an oily 
residue which was chromatographed on a silica gel column. Elution with 
petroleum ether- ether (4:1) afforded 3P-chloro-5a-cholest-6-eno-[6, 7-
d] selenadiazole (LXIII), as a glassy semi solid, (0.75 g). 
Analysis found : C, 63.17; H, 78.37; N, 5.47 
C27H43N2ClSe requires: C, 63.15; H, 8.3; N, 5.4% 
IR (Neat): v^ ax 1620 (C=C), 1370 (C-N), 750 (C-Cl), 590 cm"' (C - Se). 
^HNMR (CDCI3): 6 4.2 (br, m, Ca-aH); 3.0 (dd, Cg-pH); 2.7 (t, Cj-aH); 
1.15 (C10-CH3); 0.66 (C13-CH3); 0.9 & 0.83 (for other side chain methyl 
protons). 
MS : m/z 512/514, 513 (M + ), 482/484, 483 468/470, 469 442/443, 440 
369/371 353/354, 351 402/403, 400 
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3[3-Acetoxv cholest-5- ene (LVII); 
A mixture of cholesterol (50g), pyridine (75ml, freshly prepared 
over KOH) and freshly distilled acetic anhydride (50ml) was heated on 
water bath for 2 hrs. The resulting brown solution was poured into 
crushed ice water mixture with stirring. A light brown solid was obtained 
which filtered under suction, washed with water untill free from pyridine 
and air dried. The crude product on recrystallization from acetone gave 
pure 3p- acetoxy cholest-5-ene (45.g), m.p.l 12° (reported^^ m.p.ll3°) 
33-Acetoxv-6-nitro cholest-5-ene (LVIII); 
3[3-Acetoxycholest-5-ene (LVII) (lOg) was covered with nitric 
acid (250ml; d, 1.42) and sodium nitrite (8.0g) was gradually added over 
a period of 1 hr with continuous stirring. Slight cooling was also affected 
during the course of reaction and stirring was continued for additional 2 
hrs. When the yellow spongy mass separated on the surface of the 
mixture, the mixture was diluted with cold water (200ml) resulting a 
green coloured solution. The whole mass was extracted with ether. The 
ethereal solution was washed with water, sodium bicarbonate solution 
(5%) (untill washing was pink) and water and dried over sodium 
sulphate (anhydrous). Removal of the solvent provided the nitro 
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compound as an oil which was crystallized from methanol (7.0g) 
m.p.l04° (reported" m.p. 102-104°). 
33-Acetoxv-5a-cholestan-6-one (LIX): 
Nitro compound (LVIII) (6.0g) was dissolve in glacial acetic acid 
(250ml) and zinc dust (12.0g) was added in small portions with shaking. 
The suspension was heated under reflux for 4 hrs, water (12ml) was 
added during the course of reaction. The hot solution was filtered, cooled 
to room temperature and diluted with large excess of water. The 
precipitate thus obtained was taken in ether and the ethereal solution was 
washed with water, sodium bicarbonate solution (10%), water and dried 
over sodium sulphate (anhydrous). Removal of the solvent gave an oil 
which was crystallized from methanol (3.9g) m.p. 128 (reported 
m.p.l27-128°). 
33-Acetoxv-5a-cholestan-6-one semicarbazone (LV); 
Semicarbazide hydrochloride (Ig) and sodium acetate (1.5g) were 
dissolved in 8-lOml of water. Then 3P-acetoxy-5a-cholestan-6-one 
(LIX) (0.5g) was added to it, the resultant mixture was shaken for few 
minutes and then ethyl alcohol (100ml) was added. The suspension was 
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refluxed for 4 hrs. Now the resultant compound was allowed to stand 
overnight, usually the semicarbazone crystallized out in cold condition. 
The compound was then filtered under suction, which on crystallization 
from ethyl alcohol gave fine crystals^^ (0.35 g), m.p. 240 °C. 
Reaction of 3B-acetoxv-5a-cholestan-6-one semicarbazone 
(LV) with selenium dioxide: 3B-Acetoxv-5a-cholest-6-eno 
[6,7-d1 selenadiazole (LXIV); 
3p-Acetoxy-5a-cholestan-6-one semicarbazone (LV) (Ig) in 
acetic acid (100ml) was treated with selenium dioxide (Ig) and heated on 
a water bath for 20 hrs. Then it was poured in ice cold water and 
extracted with ether. The ethereal layer was washed with water, sodium 
bicarbonate solution (5%) and water and dried (anhydrous Na2So4). 
Evaporation of the solvent gave an oily residue which was 
chromatographed on a silica gel column. Elution with petroleum ether-
ether (7:3) afforded 3P-acetoxy-5a-cholest-6-eno [6, 7-d] selenadiazole 
(LXIV) as a glassy semisolid, (0.55 g). 
Analysis found: C, 65.17; H, 8.65; N, 5.25 %. 
C29H46N202Se requires: C, 65.16; H, 8.6; N, 5.2 
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IR (Neat) : v^ ax 1730, 1240 (CH3 COO), 1610 (C=C) 1375 (C-N), 590 
cm'' (C - Se). 
^HNMR (CDCI3) : 6 4.9 (m, WA = 17Hz, C3 a-H, A/B ring function 
trans)^' 2.75 (t,C5-H); 2.95 (dd, Cg); 2.1( s, CH3COO); 1.13 (Cjo- CH3), 
0.67 (C13-CH3); 0.91, 0.85 (for side chain methyl protons). 
MS : (m/z) 534 (M^ molecular ion peak); 506/507, 504, 490/491, 488, 
474/475, 472, 446/447, 444, 252, 333/334, 331. 
Cholest-5-ene (LX): 
3P-Chlorocholest-5-ene (LI) (15g) was dissolved in warm amyl 
alcohol (300ml) and sodium metal (35.Og) was added in small portions 
to the solution with continuous stirring over a period of 8 hrs. The 
reaction mixture was heated now and then during the course of reaction 
in order to keep the sodium metal dissolved. The reaction mixture was 
poured into water, acidified with HCl and allowed to stand overnight. A 
white crystalline solid was obtained which was filtered under suction and 
washed thoroughly with water and air dried. Recrystallization of the 
crude material from acetone gave cholest-5-ene (LX) in cubes (10.8g) 
m.p. 93° (reported^^ m.p. 89.5-91.2°). ^^  ;,,au / , ; / -^ 
. - ^ - "^^ \ vV 
' r \)\ 
, "i ,\CC. Ko 
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6-Nitro Cholest-5-ene (LXI): 
A suspension of finely powdered cholest-5-ene (LX) (6.0g) in 
glacial acetic acid (50 ml) was stirred at room temperature for 5 min. 
Fuming nitric acid (20ml, d, 1.5) was rapidly added and the stirring was 
continued for 2 hrs. The temperature of the reaction mixture was 
controlled between 20-25 °C by external cooling. The reaction mixture 
was then poured into ice cooled water. A yellow solid thus obtained was 
filtered under suction, washed thoroughly with water and air dried. 
Recrystallization from ethanol furnished (LXI) (3.5g), m.p. 117-118 
(reported^" m.p. 117-118) 
5a-Cholestan-6-one (LXII) 
6-Nitro cholest-5-ene (LXI) (6.0g) was dissolved in glacial acetic 
acid (200ml) by heating and to this solution zinc dust (12.0g) was added 
in small portions. After the initial exothermic reaction had subsided, the 
suspension was heated under reflux for 3 hrs and water (12ml) was 
added gradually during the course of reaction. The solution was then 
filtered and the residue was washed with two (10ml) portions of warm 
acetic acid. To the filtrate, a few ml of water was added till tubidity 
developed and it was allowed to stand overnight at room temperature. 
The crystalline material thus separated was filtered under suction and 
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washed thoroughly with water in order to remove zinc acetate. The 
organic solid was air dried and then recrystallized from ethanol (3.6 g), 
m.p. 96 - 98° (reported '^ m.p. 95 - 86°). 
5a-Cholestan-6-one semicarbazone (LVI): 
Semicarbazide hydrochloride (4 g) and sodium acetate (6 g) were 
dissolved in water (32 ml), 5a-cholestan-6-one (LXII) (2 g) was added 
to it then ethyl alcohol (200 ml) was added and refluxed for 4 hrs. The 
progress of reaction was monitored through TLC. After the completion 
of reaction, the resultant product was allowed to stand overnight. The 
product was then filtered under suction and was recrystallized from ethyl 
alcohol^^ (1.5 gm), m.p. 190 °C. 
Reaction of 5a-cholestan-6-one semicarbazone (LVI) with 
selenium dioxide : 5a-Cholest-6-eno [6, 7-d1 selenadiazole 
(LXV): 
5a-Cholest-6-one-semicarbazone (LVI) (1 g) is acetic acid (100 
ml) was treated with selenium dioxide (1 g) and heated on a water bath 
for 20 hrs. Then it was poured into ice cooled water and extracted with 
ether. The etherial layer was washed with water, sodium bicarbonate 
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(5%) and water and dried over anhydrous sodium sulphate. Evaporation 
of the solvent gave an oily residue which was chromatographed over 
silica gel column. Elution with petroleum ether - ether ( 9 : 1 ) afforded 
5a-cholest-6-eno [6, 7-d] selenadiazole (LXV) as a glassy semisolid, 
(0.67 g). 
Analysis found : C, 68.08; H, 9.27, N, 5.92. 
C27H44N2Se requires: 68.06; H, 9.2; N, 5.88. 
IR (Neat): V^ a^x 1615 (C=C), 1380 (C-N), 580 cm'' (C - Se) 
^H-NMR (CDCI3): 5 3.5 (dd, Cg-H); 2.9 (t, Cja-H); 1.14 (Cio-CHj), 0.67 
(C13-CH3), 0.91 and 0.84 (for other side chain methyl protons). 
MS : m/z 474 (M +, moleculer ion peak); 446/447,444; 367/334, 331. 
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Chapter Two 
Synthesis of N-hydroxy 
alkyl Steroidal Lactams 
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Insertion of nitrogen atom into steroid nucleus has been affected 
mostly by the Beckmann rearrangement of steroidal ketoximes and 
Schmidt reaction of steroidal ketones. Other methods like suitable 
reactions with respective seco-keto acids, oxasteroids, imide synthesis, 
Curtius and Hofmann rearrangements, total synthesis etc are employed 
in the preparation of azasteroids. Photochemical reaction and 
microbiological amidation''^ have also been used for the preparation of 
different azasteroid analogues. The photochemical rearrangement is a 
valuable alternative to Schmidt and Beckmann rearrangements which 
usually require strongly acidic conditions causing serious problems such 
as low regioselectivity of the reactions or decomposition of products^"^. 
Limitation of Schmidt reaction for the synthesis of N-substituted laclams 
led the scientists to replace hydrozoic acid with alkyl azide but attempts 
under classical Schmidt reaction conditions (strong acid) were generally 
unsuccessful. 
In late 1950s, Boyer and co-workers did manage to establish a 
narrow range of azides that react with aromatic aldehydes but bonafide 
migration of an alkyl group was not observed in any case " . In 1991 
Aube et al.'"* accomplished intramolecular reaction of alkyl azides with 
ketones under remarkably mild and straight forwards reaction conditions 
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they further modified Schmidt reaction by the realization of 1,2 or 1,3-
hydroxy azides, which were superior to simple alkyl azides'^  
16 Shoppee et.al. accomplished the Beckmann rearrangement of 
steroidal 1- and 2- ketoximes using thionyl chloride followed by alkaline 
treatment. 5a-Cholestan-l-one oxime (I) gave l-aza-A-homo-5a-
cholestan-2-one (II) and 1-cyano-l, 10-seco-5a-cholest-10 (19)-ene (III), 
a product of second order Beckmann rearrangement. 
C«H 8"!? 
NC 
H 
(III) 
The photo Beckmann rearrangement of A-nor-5a-cholestan-3-one 
oxime (IV) afforded 4-aza-5a-cholestan-3-one (V) and 3-aza-5a-
cholestan-4-one (VI)''. 
HO-N 
•av) 
0 H H 
(V) 0 (VI) 
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.18 Black and Johnstone reported the synthesis of medium sized 
oxo-lactams by ring opening of fused tricyclic oxaziridines and nitrones. 
OH (CH2)n 
MeCOsH 
O) (CH2)n 
(Villa) n = 2 
(Vlllb) n = l 
O 
(CH2)n 
Fe2 + 
^^' \ ^ T O 
aXa) n = 2 
(IX b) n = l 
Photo rearrangement of hydroxy nitrones (X a-d) in ethanol by 
means of light of wavelength 254nm afforded isomeric mixtures of 
oxaziridines which on treatment with iron (II) sulphate afforded the keto 
lactams (XI a-d). 
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Me 
M 
OH 
J^(CH2)n 
I 
o-
(Xa) n = 3 
(Xb) n = 4 
(Xc) n = 5 
(X d) n = 6 
(i)hv Me 
(ii)Fe^^ Me 
O 
N-
H 
O 
:(CH2)n 
(XIa) n = 3 
(XI b) n = 4 
(XI c) n = 5 
(XI d) n = 6 
19 Ishibashi et al. accomplished a novel synthesis of five, six and 
seven membered lactams by alkene cyclization of N-alkenyl-a-(methyl 
sulphinyl) acetamides and N-alkenyl-a-chloro-a-(methylthio)-5 
acetamide. 
O O 
JL /SMe 
MeN ^ ^ 
CH2 
Me'^  H 
(XII) 
O 0 
MeN 
O 0 
Trifluoro acetic 
anhydride (TFAA) 
CH2CI2, 0°C 
MeN 
SMe 
\ Me 
H 
H Me 
(XV) 
Me 
(XIII) 
MeN 
SMe 
CH2 
(XIV) 
(XVI) 
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O 
CI 
MeN 
SMe 
\ 
Me 
MeN 
(CH2)2 
(XVII) 
o o 
\ 
SnCU, MeN 
CH2CI2 
(XVIII) 
O OCOCF3 
.SMe 
Me 
TFAA, CH2CI2 
MeN 
< 
H 
Trifluoro 
acetic acid 
MeN 
x^CH2 
SMe 
H H 
(XIX) 
l-Methvl-5-methvlene-3-methvlthio piperidin-2-one (XIV): 
CsHnNOS; Oil 
IRv^ax: 1630cm"'(C = O) 
^H-NMR : 5 2.27 (3H, s, SMe); 2.58 (IH, dd); 2.8 - 3.1 (IH, m, 4-H); 
2.95 (3H, s, NMe); 3.37 (IH, t, 3-H); 3.96 (2H, brs, 6H) and 4.98 (2H, 
brs, C = CH2). 
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4-Vmvl-l-methvl-3-methvlthio pvrrolidin-2(lH)-one(XVI): 
CgHizNOS; Oil 
IR Vmax: 1680 (C = 0) and 920 cm"' (C = C) 
^H-NMR : 5 2.25 (3H, s, SMe); 2.5-3.7 (4H, m, 3-, 4-, 5-H); 2.89 (3H, s, 
NMe); 4.9 - 5.3 (2H, m, CH = CH2); 5.6 - 6.1 (IH, m, CH=CH2). 
l-Methvl-3-methvlthio-5-trifluoroacatoxyazepan-2-one (XX); 
CoHuFjNOsS ; M.P. 116-117.5 
IR Vmax : 1780 (OCOCF3) and 1640 (CONMe) 
^H-NMR : 6 1.6 - 2.6 (4H, m, 4 and 6H); 2.14 (3H, s, SMe); 3.04 (3H, 
s, NMe); 3.39 (IH, ddd); 3.64 (IH, dd, 3-H); 3.78 (IH, ddd, 7-H) and 
5.18 (lH,dt, 5-H). 
Hoffman et al. given one flask conversion of cyclic ketones to 
N-methyl lactams. They reacted ketone with triethyl orthoformate to 
generate an acetal which is reacted in situ with N[(p-nitrobenzene) 
sulfonylj oxy methyl amine la (CH3NH-OSO2 C6H4NO2). Dealkylation 
of the resulting 0-ethyl imidate with sodium iodide gave the lactam. 
RO, OR 
}f 
R = Et, Me 
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+ CH3NH0Ns(la) 
CH3 
I 
RO NHONs 
OR ONs 0 
N-CH3 
(XXI) (XXII) 
This method was considered as versatile and more efficient as 
compare to other methods effecting direct conversion of cyclic ketones 
to N-substituted lactams. Conversion of cyclopropanes to N-substituted 
(3-lactams by Wesserman's carbinol amine method is excellent but this 
procedure is not adaptable to larger rings. This method is superior to 
photochemical rearrangement of oxaziridines and nitrones as the former 
requires preparation and isolation of oxaziridines by two step procedure 
followed by photolysis, the latter require isolation of N-methyl nitrone 
and gives much poorer yield. 
Aube et al.^' have given the TiCl4 mediated reactions of alkyl 
azides with cyclic ketones. 
R 
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O OH 
Ri Ri 
H^ 
+ R—N3 *• 
R 
.N 
^N, 
Ri R2 
(XXIII) 
(XXIII) 
Path A^ 0 \ / N 
N 
Ri 
y-^R. o 
R 
V 
R > 
ath 
R 
LI >==N 
(for R=H) 
N 
/ 2 -N 
Ri 
N 
A ^R2 
H2O 
-H + 
2 ^ \ = N 
R9 
Table - 1. Reaction of Ketones with alkyl azides 
Entry Ketone Azide Product 
0 
R 
(XXIV a) R = H n - HexNj (XXV a).R = H, R' = n-Hex 
(XXIV b) R = H BnNs (XXV b).R = H, R' = Ben 
(XXIV c) R = t-Bu n-HexN3 (XXV c) R=t-Bu, R'=n-Hex 
(XXIV d) R = t-Bu BnN3 (XXV d) R=t-Bu, R'=Bn 
73 
(XXVI) 
(XXVIII) 
6' n-HexN 
(XXVna) (XXVnb) 
n-HexN3 
0 
N 
O n-Hex 
(XXIXa) 
In the experiments using equimolar amounts of ketone and azide, 
aldol type condensation of cyclohexanone led to the formation of by 
products; which could be minimized by using excess of azide. -
Kohji and co-workers reported Mangnese (III) tetraphenyl 
porphyrin, Mn (tpp) CI as a new and specific catalyst for stereo and 
regio-selective rearrangement of N-phenyl-spirooxaziridine into lactams. 
Ph-N 
0-^^ 
(XXX) 
a 
b 
c 
d 
e 
Mn 
n 
1 
2 
3 
4 
5 
Ph-
"'p)n 
0 
(XXXI) 
a 
b 
c 
d 
e 
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They have examined catalytic activity of tetraphenyl porphyrin 
complexes of the first series transition metals. Trivalent metallo-tpp 
complexes with chloride as an axial ligand such as Mn (tpp) CI, Fe (tpp) 
CI and Co (tpp) CI were found to be mild and specific catalyst for the 
rearrangement. In presence of these catalysts the rearrangement 
smoothly proceeded in aprotic solvents. Mn (tpp) CI was the most 
effective catalyst, the order of catalytic activity was Mn (tpp) CI > Fe 
(tpp) CI > Co (tpp) CI. Divalent metallo-tpp complexes such as Cu (tpp), 
Fe (tpp) and Co (tpp) showed no catalytic activity. 
Table - 2 Rearrangement of N-phenylspirooxaziridines 
into Lactams in the presence (A) and absence (B) of 
Mn (tpp) CI in acetonitrile 
Oxaziridines 
(xxx) 
a 
a 
b 
b 
c 
c 
Times 
B 15 min 
A 15 min 
B 40 min 
A 15 min 
B 20 min 
A 20 min 
T/°C 
30 
30 
30 
30 
30 
30 
Lactams 
(xxxi) 
a 
a 
b 
b 
c 
c 
Yield % 
0 
60 
34 
77 
Trace 
97 
75 
d 
d 
e 
e 
B24h 
A7.5h 
B24h 
A 5 h 
Reflux 
50 
Reflux 
50 
d 
d 
e 
e 
62 
72 
58 
90 
23 Takacs et al. reported the synthesis of pentadienyl-substituted 
lactams by the reaction of pentadienyl trimethylsilane with N-
acyliminium-ion intermediate. 
0 
R 
O 
(XXXII) 
Li(Et3BH) 
THF,-78 C 
V^ 
(XXXIII) CHi 
BF3OE2 CH2CI2 
(PDS) 
When dienylation is carried out at higher temperature (Ca. 0°C), 
S'E reaction (addition at y-position of PDS) competes and the formation 
of a substantial amount of the isomeric product (XXXIV) is observed. 
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(XXXIV) 
O ^XH2 
N'' l.Li[Et3BH] 
0 
f - ^ N -
R 
^ 2. MeOH, H^  
O 
BF3 - 0Et2 
PDS, CH2CI2 
(XXXV) 
OMe 
(XXXVI) 
0 
R 
N 
^ ^ ^ C H 2 
(XXXVII) 
24 Zard et al. described a radical based synthesis of y-Lactams 
using Nickel powder / Acetic acid system. 
Ph—N Ph—N 
(XXXVIII), R = X = CI 
(XXXIX), R = Me, X = Br 
Ph—N Ph—N 
(XLa)R = R' = CI;Y=H 
(XLb)R = Cl;R = Y=H 
(XLc)R = R' = M e ; Y = H 
(XLd)R = R' = M e ; Y = B r 
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The kind of product form and yield depends upon the reaction 
conditions and solvent used. The slow addition of N-allyl trichloro 
acetanilide (XXXVIII) to an excess of nickel powder in refluxing 
mixture of acetic acid and 2-propanol gave lactams (XL b) in 20% and 
29% yield. Where as addition of trichloro acetamide all at once increases 
the yield of (XL a) to 56%. The yield could be further improved by using 
better hydrogen donor such as thiol, which increased the yield upto 76%. 
Dimethylbromoacetanilide analogue (XXXIX) also reacted 
smoothly with nickel powder in acetic acid-2-propanol gave bromo 
lactam (XL d) in 68% yield and (XL c) in 23% yield. When 2-propanol 
is replaced by cyclohexane, poorer hydrogen donor none of the reduced 
lactam (XL c) formed, bromo lactam became the sole product. 
Morimoto et al.^ ^ recently reported the first catalytic carbonylative 
[4+1] cyclo addition using a 1,3-conjugated system, where a, P-
unsaturated imines transformed to unsaturated y-lactams catalyzed by 
RU3 (C0)i2. 
f, ^ +C0 
RU3(CO),2 
pj^  / / N Bu-t toluene, 10 atm 
O 180°C (XLI) (XLII) 
36 % (20 h) .. 
70yert^0hi^V,%. 
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The yield of the product depends upon reaction time, pressure and 
temperature. Prolongation of the reaction time increases the yield. When 
the reaction is carried out at 160° only 7% yield is obtained. Both lower 
pressure (3atm) and higher pressure (30 atm) decreased the yield to 26 
and 12% respectively. The reaction was supposed to proceed via 
pathway shown below. 
(C0)4 
\ u ^ R4(CO)4 V / ^ ^ \ 
(co)3 ^ o II !! 
NR 
,NR 
0 O 
Antonio et al. recently reported the synthesis of (+)-19-nor-10-
azatestosterone and (+)-17|3-(acetyloxy)-(5P)-10-azaestr-l-en-3-one, 
which are considered to be as steroid 5a-reductase inhibitors. Their 
synthesis was based on tandem N-(acyloxy)-iminium-ion Michael 
addition reaction, as described by Pilli and co-workers, which provided 
the 19-nor-lO-aza steroidal skeleton in only six steps from commercially 
available (+)-3-[(3aS)-(3aa, 4a, 7a|3)-l,5, dioxo-7a- methyl octahydro-
(lH)-inden-4-yl] propionic acid. 
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0 
HOOC 
O 
H 
H 
(XLIII) 
OH 
a N 
> • 
O 
O o 
H V , 
H + 
O 
N' 
/ / ^ ^ 
H 
(XLIV) 
OAc 
(XLV) 
OAc 
(XLVII) (XLVIII) 
OAc 
(XLIX) 
H (LI) 
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OAc OAc 
(a) HCOOH, NH4HCO3; 
(b) NaBHsCN, Me OH; 
(c) AC2O, pyridine; 
(d) B0C2O, EtjN, CH2CI2; 
(e) LiEtjBH, THF and 2N HCl, Et OH; 
(f) l-methoxy-3-[(trimethylsilyl)oxy]-l,3-butadiene, EtsN, TMSOTf, 
CH2CI2, NaHCOj; 
(g) Methyl vinyl ketone, TMSOTf, EtjN, CH2CI2, NaHCOa; 
(h) Hg (0Ac)2 EDTA tetra sodium salt, 20% Ac OH, 90°C; 
(i) KOH, Me OH-H2O. 
(+)-173-(Acetvloxy)-(5B)-10-azaestr--l-ene-3-one (L); 
' H N M R (CDCI3): 5 7.20 (d, IH); 4.91 (d, IH); 4.58 (m, IH); 3.75 5(m, 
IH); 3.19 (dt, IH), 2.50- 2.03 (m, 3H), 2.02 (s, 3H); 1.90-1 (m, 13H), 
0.81 (s, 3H). 
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'^ CNMR (CDCI3): 6c 191.3 (s); 173.0 (s), 149.6 (d), 96.7 (d), 81.6 (d); 
59.7 (d); 53.1 (d); 50.2 (d); 42.5 (s); 42.4 (d); 35.3 (t); 34.8 (t), 29.6 (t), 
27.8 (t); 25.6 (t); 23.6 (t); 22.6 (t), 21.1 (q), 12.1 (q). 
MS (m/z): 317 (M^ 29); 302 (10); 274 (37); 258 (59) 84 (100). 
(+)- 17(3-(Acetoxy)-10-azaestr-4-en-3 one (LID : 
M.P. 142-143 °C. 
IR: 1721,1611,1539,1242 cm"'. 
^H-NMR (CDCI3) : 5 4.92 (s, IH); 4.62 (t, IH); 3.69 (ddd, IH); 3.16 
(ddd, IH); 2.65 - 2.05 (m, 5H); 2.03 (s, 3H); 1.85 - 1.14 (m, 12H); 0.85 
(s, 3H). 
^ V N M R (CDCI3) : 6c 191.5 (s); 171.l(s); 164.3 (s); 100.5 (d) 81.5 (d); 
64.4 (d); 48.2 (d); 45.7 (s); 42.8 (t);39.0 (d); 36.1 (t); 35.2 (t); 30.9 (t); 
29.7 (t); 27.1 (t); 24.1 (t); 22.6 (t); 21.1 (q); 12.2 (q). 
MS (m/z): 317(M\ 100); 258 (51); 175 (26); 149 (31). 
Evans and co-worker described a novel approach to lactam via 
photo induced Schmidt rearrangement of the a-azidotriisopropylsilyl 
ethers. a-Azidotriisopropylsilyl ethers were prepared by direct 
azidonation of the triisopropylenol ethers, which on photolysis furnished 
iminoethers which were then hydrolyzed to lactams. 
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OSiPra 
R yx' 
PPTS 
TMSN^ 
N. PSiPrs 
X=CH2, O and S 
OSiPrs 
N X 
77% 
OSiPra 
89% 
OSiPrj 
(LIVa) X = 0 
(LIVb) X = S 
N3 pSiPra O H P 
N3, OSiPrg 
" X " 
(LVa) 
(LVb) 
75 
1.6:1 
x-
(LVI a) 83 % 
(LVI b) 64 % 
•28 Goti and Brandi described the thermal rearrangement of an 
isoxazolidine derivative (LIX) to the azepin-4-one (LXI). The 
isoxazoHdine (LIX) was prepared by the cycloaddition reaction of 
nitrone (LVII) with methylenecyclobutane (LVIII). The cycloadduct 
83 
(LIX) was then subjected to FVP conditions to fecilitate N - 0 bond 
cleavage and generate the diradical (LX). Recombination of (LX) 
furnished the azepin-4-one (LXI) and l-benzazonin-4-one (LXII). 
r Ph 
, N . O 
Ph 
(LVII) 
/ 
(LXH) Ph 
benzene 
A , 77% / 
Ph 
N - 0 
(LIX) 
FVP 
500°C \ ° ^ l l 
Ph 1 
Ph 
(LX) 
(LXII) 
_29 Alper has developed the cobalt mediated carbonylation of 2-
vinyl azetidines (LXIII) to afford ring expanded seven membered 
lactam. 
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/ ^ Co(CO)8, CO 
-NR' 3,4 atm, benzene 
0,24h 
R' = CH2CH2CO2CH3 
CH2CH2CN 
(LXIII) 
:^co(co)4 
-co Co(CO)3 
(LXV) 
CO 
\ Co(CO)4 
R' O 
(LXVII) 
^ ^ 0 ( C 0 ) 4 
l_N- -Co(CO)4 
(LXIV) 
Co(CO)4 
N Co(CO)4 
' 1 R 
(LXVI) 
The photoinduced ring expansion of the azidocyclohexenone 
(LXIX) via the nitrene (LXX) and its insertion products (LXXI) to the 
30 
azepindione (LXXII) was described by Sato . The reaction was found to 
proceed more efficiently when it was carried out in wet benzene rather 
731 than THF . This method has also been successfully applied to the 
preparation of benzazepines from naphthyl azides and pyridoazepines 
from quinolyl and isoquinolyl azides. 
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Lactams are particularly important molecules owing to their 
versatility as synthetic intermediates and widespread occurrence in 
,32-33 biologically important compounds " . They have also proven extremely 
34 informative as transition state models in amide reactivity studies . 
Caprolactam is considered as the most useful and important azepine 
derivative. This seven membered lactam has been extensively used as a 
precursor in the manufacture of Nylon-6^^. Interestingly simple 
N-substituted caprolactams are known to posses significant CNS 
activity^^ and hexahydroazepine-4-ol derivatives have shown useful 
analgesic properties. Similarly N-substitut^d hexahydroazepines have 
found use as an antitussives, mydriatics, antispasmodics and oral 
hypoglycemics . The tricyclic product (LXXIII) is a potent in vitro 
antihypertensive agent^'. 
(LXXIII) 
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Azasteroids have always been considered as potent biologically 
active compounds, in early 1960s Alauddin and Martin-Smith^°"^^ and 
,40 Martin-Smith and Sugrue had reviewed the biological activity of these 
compounds. 
During last decade a number of azasteroids have been synthesized 
as 5a-reductase inhibitors'*'"'*'* and among the foremost contributors in 
this area are Guama and co-workers, who very recently reported the 
synthesis and biological evaluation of a novel class of potent azasteroidal 
inhibitors (IQ-nor-lO-azasteroids/^ having a bridgehead nitrogen atom at 
position 10 of the steroidal skeleton. Vivian and co-workers'*^ recently 
prepared azasteroid of structure (LXXIV) [R' = H, alkyl; R^ R-* = alkyl] 
for the use in inhibiting bone loss, thus uset J1 for treating and preventing 
osteoporosis and osteopenia and other desease where inhibiting bone 
loss may be beneficial including Pagent's desease, malignant 
hypercalcemia, periodontal desease, joint loosening, metastatic bone 
desease. 
(LXXIV) 
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Several papers dealing with the preparation of azasteroids have 
been appeared from our laboratory"*^ '^ ^ following different procedures. 
Despite the development of a variety of new methods^ °-^ '- ''-'' the 
Schmidt and Beckmann reactions remain the most convenient and 
general methods for lactam synthesis. Here we utilize slightly modified 
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version of Schmidt reaction as described by Aube et al. where 
hydrazoic acid had been replaced by hydroxy alkyl azide. The present 
work describes the synthesis of N-hydroxyalkyl lactams from easily 
accessible steroidal ketones such as 3P-acetoxy-5a-cholestan-6-one 
(LXXVII), 3p-chloro-5a-cholestan-6-one (LXXVIII) 5a-cholestan-6-
one (LXXIX) cholest-5-en-3-one (LXXX) 5a, 6P-dibromo-cholestan-3-
one (LXXXI) and cholest-4-ene-3, 6-dione (LXXXII). 
CsHn QHn 
X 
AcO (LXXVII) 
CI (LXXVIII) 
H (LXXIX) 
(LXXX) 
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CsHn CgHn 
Reaction of 3B-acetoxy-5a-choIestan-6-one(LXXVII) with 
2-azidoethanol in presence of BF^ - OEti: 
3p-Acetoxy-5a-cholestan-6-one (LXXVII) (200 mg) in CH2CI2 
(5ml) was treated with 2-azidoethanol (247 mg) and cooled to 0°C. 
BF3-OEt2 (0.5 ml) was then added drop wise over 5 minutes, immediate 
gas evolution was noted upon addition. The reaction was allowed to 
warm to room temperature over 30 minutes and was stirred nearly for 
five hours. The solution was concentrated, 5 ml of saturated NaHCOs 
was added to the residual oil and the mixture was stirred to 30 min. After 
concentration, an additional 100 ml of CH2CI2 was added and the 
organic layer was separated, dried (Na2S04) and concentrated to afford 
an oil which was chromatographed over silica gel column. Elution with 
pet. ether : acetone (9:1) affords 3P-acetoxy-N-2'-hydroxyethyl-6-aza-B-
homo-5a-cholestan-7-one as oil. 
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C«H s^i? 
AcO 
CH2CI2, BF3 - 0Et2 
AcO 
HO 
(LXXXIII) 
Characterization of the compound as 3B-acetoxv-N-2'-
hvdroxvethvl-6-aza-B-homo-5a-cholestan-7-one(LXXXIII): 
The elemental analysis of the compound corresponded to the 
molecular formula C31H53NO4. The IR spectrum exhibited strong bands 
at 3480 (OH), 1730 and 1240 (CH3COO), 1670 (CON-), 1360 (C-N), 
1280 (amide band). The ' H - N M R spectrum displayed multiple! centered 
at 8 4.4 (WV2 = 16Hz) ascribed to C3-aH, a broad peak appeared at 5 5.0 
for C5 - aH , a triplet was observed at 5 3.6, J = 5.3 Hz ascribed to 
CH2-N, another at 3.1, J = 5.1 Hz for two hydrogens of CH2-OH. A 
doublet at 6 2.2 J = 6.6 Hz integrated for 2H was ascribed to C^a - H, 
three hydrogens of acetate group was appeared as singlet at 6 2.1, OH 
proton was observed at 6 2.0, which was dissappeared when exchange 
with deuterium. Methyl protons were observed at 1.2 (C10-CH3) 0.67 
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(C13-CH3), 0.91 and 0.85 for other side chain methyl protons. The 
structure was further supported by its mass spectrum which gave away 
respective fragment ion peaks. Molecular ion peak was observed at m/z 
503 [M+ ] other notable peak include m/z 488, 485, 460, 390, 255, 186 
etc. A tentative mechanism for the formation of fragment ions given 
below. 
m/z485 
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C«H 8^17 
HO 
nVz 503 [M+] 
^ ^ 3 ^ nVz488 
nVz 390 
AcO H / ^0+ 
HO 
Q H n 
AcO' 
HO 
CgHi? 
HO 
nVz 475 
m/z 460 
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AcO' 
CgHn 
nVz 255 
C«H 
AcO 
8"17 C«H 8"I7 
AcO 
m/zl86 
On the basis of above analytical and spectral data the compound 
was characterized as 3(3-acetoxy-N-2'-hydroxyethyl-6-aza-B-homo-5a-
cholestan-7-one (LXXXIII). 
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Reaction of 3B-chloro-5a-cholestan-6-one (LXXVIII) with 
2-azidoethanol in presence of BF^- OEti: 
3[3-Chloro-5a-cholestan-6-one (LXXVIII) (200 mg) in 
dichloromethane (6 ml) was treated with 2-azidoethanol (250 mg) and 
was cooled to 0°C, BF3-OEt2 (0.5 ml) was added dropwise over 5 
minutes, immediate gas evolution was noticed upon addition. The 
reaction was then allowed to warm to room temperature over 30 min. 
and stirred for nearly six hour. The solution was concentrated, 5 ml of 
saturated NaHCOa solution was added to the residual oil and mixture 
was stirred for additional 30 min. After concentration an additional 100 
ml of CH2CI2 was added, the organic layer was washed with water and 
dried over anhydrous sodium sulphate, evaporation of the solvent affords 
an oil which was chromatographed over silica gel column, elution with 
petrol-acetone (19:1) gave 3P-chloro-N-2'-hydroxyethyl-6-aza-B-homo-
5a-cholestan-7-one (LXXXIV) as an oil. 
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(LXXVIII) 
CgHn 
CH2CI2, BF3 - 0Et2 
HO 
(LXXXIV) 
Characterization of the compound as 3B-chloro-N-2'-hvdr-
oxvethvl-6-aza-B-homo-5a-cholestan-7-one (LXXXIV): 
The elemental analysis of the compound corresponded to the 
molecular formula C29H50NO2CI (Positive Beilstein test). The IR 
spectrum showed bands at 3500 (OH), 1665 (-CO-NR), 1360 (C-N), 
1270 (amide band), 1050 (C-0), 750 (CI). The ' H - N M R spectrum 
displayed a multiplet at 5 5.0 ascribed to aH at C5, another multiplet for 
C3 - aH was appeared at 5 4.1, two hydrogens of CH2 - OH appeared at 
6 3.4 as multiplet, a triplet at 5 3.7, J = 5.4 Hz was assigned to 2H of 
CH2 - N, Cva - aH was appeared as doublet J = 6.6 Hz, OH proton 
observed as a singlet at 5 2.2 exchangable with deuterium. Methyl 
protons were observed at 1.2 (CIO - CH3), 0.67 (Cn - CH3) 0.91 and 
0.85 for other side chain methyl protons. The mass spectral data further 
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support the structure. The molecular ion peaks were observed at m/z 
479/481 [M +]. Other significant fragment ion peaks include 464/466, 
461/463, 451/453, 443, 436/438 433/435, 366/368, 231, 162. A tentative 
mechanism for the formation of fragment ions is shown below. 
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m/z 461/463 
A 
nVz 464/466 
•'CU-x 
nyz443 
HO 
m/z 479/4^1 [M+] 
'8^17 
8"17 
m/z433-* m/z436 
HO m/z 451/453 
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8"17 
m/z231 
HO' 
nVz 162/164 
On the basis of above analytical and spectral data the compound 
was characterized as 3P-chloro-N-2'-hydroxyethyl-6-aza-B-homo-5a-
cholestan-7-one. 
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Reaction of 5a-cholestan-6-one (LXXIX) with 2-azidoetha-
nol in presence of BF^- OEt^  : 
5a-Cholestan-6-one (LXXIX) (200 mg) in dichloromethane 
(5 ml) was treated with 2-azidoethanol (260 mg) and was cooled to 0°C. 
BF3 - 0Et2 (0.5 ml) was added dropwise over 5 min. immediate gas 
evolution was noticed upon addition. The reaction was allowed to warm 
to room temperature over 30 min. and was stirred for nearly 5 hrs. The 
solution was then concentrated, 5 ml of saturated solution of sodium 
bicarbonate was added to the residual oil and mixture was stirred for 30 
minutes. After concentration an additional 100 ml of CH2CI2 was added, 
the organic layer thus separated was washed with water and dried 
(Na2S04) and concentrated to afford an oil which was chromatographed 
over silica gel column. Elution with pet. ether : acetone (19 : 1) afforded 
N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (LXXXV). 
CgHn 
CH2CI2, BF3 - 0Et2 
(LXXIX) 
CgHn 
HO 
(LXXXV) 
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Characterization of the compound as N-2'hydroxvethvl-6-
aza-B-homo-5a-cholestan-7-one(LXXXV): 
The elemental analysis of the compound corresponded to the 
molecular formula C29H51NO2. The IR spectrum of the compound 
exhibited strong bands at 3480 ascribed to OH, 1685 (CO-NR) 1375 (C-
N), 1280 (Amide band), 1050 cm"' (C-0). These values strongly support 
the presence of hydroxy alkyl lactam moeity attached to steroid nucleus. 
The structure was further supported by its ^H-NMR spectrum exhibiting 
expected peaks. A multiplet centred at 5 5.0 was ascribed to C5 - aH, a 
triplet for 2H of CH2 -OH was observed at 5 4.2, J = 5.1 Hz, another 
triplet J = 5.1 Hz for 2H of CH2 - N appeared at 5 4.4, C7a - aH appeared 
as doublet at 6 2.5, J = 6.6 Hz, OH proton was appeared at 6 2.0. Methyl 
protons were observed at 1.2 (C10-CH3) and 0.67 (C13-CH3), 0.85 and 
0.95 for other side chain methyl protons. The mass spectrum gave 
molecular ion peak at m/z 440, base peak obtained at 427 by the loss of 
water molecule. The other notable fragment ion peaks include 430, 332, 
197. 
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HO 
m/z 445 [M+] 
CgHn -•CH3 
m/z 430 
H 
N^ - ^ O 
HO 
m/z 197 
CgH]-
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8^17 
nVz445 
The above spectral data unambiguously supported the compound 
as N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one (LXXXV). 
Reaction of cholest-5-en-3-one (LXXX) with azidoetha-nol 
in presence of BF^  - OEtg; 
Cholest-5-en-3-one (600 mg) in dichloromethane (20ml) was 
treated with azidoethanol (750 mg) and was cooled to 0°C. BF3 - 0Et2 
(1.5 ml) was added dropwise. Immediate gas evolution was noted upon 
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addition. The reaction was allowed to warm to room temperature over 30 
minutes and was stirred for an additional three hours. The solution was 
concentrated, 15 ml of saturated solution of NaHCOs was added to the 
residue and mixture was stirred for 30 minutes. After concentration an 
additional 200 ml of dichloromethane was added and organic layer was 
separated, dried over anhydrous sodium sulphate and concentrated to 
afford an oil which was chromatographed over silica gel column. Elution 
with pet. ether - acetone (9:1) afforded N-2'-hydroxyethyl-3-aza-6P 
(2'-azidoethoxy)-A-homocholest-4a-en-4-one (LXXXVI) as glassy 
semisolid. 
0 
(LXXX) 
CgHn 
2 - Azidoethanol HQ 
BF3 - 0Et2 
(LXXXVI) 
Characterization of the compound as N-2^-hvdroxvethvl-3-aza-
6B- (2'-azidoethoxv)-A-homocholest-4a-en-4-one (LXXXVI); 
Cholest-5-en-3-one on treatment with 2-azidoethanol gave an 
unexpected product as N-2' hydroxyethyl-3-aza-6(3-(2'-azidoethoxy)-A-
homocholest-4a-en-4-one, the elemental analysis of which corresponded 
to the molecular formula C31H54O3N4 The IR spectrum of the compound 
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gave a very sharp peak at 2120cm'' which clearly show the presence of 
azido group (N=N=N). This peculiar peak did not appear in the IR 
spectrum of other compound where saturated ketones had been used as 
substrates. Thus it was assumed that attack of 2-azidoethanol took place 
at C5 double bond. Other notable peaks include 3480 (OH), 1650 
(C=C-CO-), 1610 (C=C), 1375 (C-N) and 1030 cm'' (C-0). These 
values strongly supported the structure which was further confirmed by 
its ' H - N M R and Mass spectra. The ' H - N M R spectrum exhibited as 
singlet at 5 6.7 which was assigned to vinylic proton at €43, a multiplet 
was observed at 6 4.1 assigned to €5 hydrogen, a singlet at 5 3.8 was 
assigned to OH proton which disappeared when exchanged with 
deuterium, a triplet at 5 3.65, J = 4.9 Hz integrated for two hydrogens 
ascribed to CH2 - N, CH2 - OH protons also appeared as triplet at 6 3.5 J 
= 4.9 Hz. Two more triplets one at 6 2.6 J = 8.6 and other at 5 2.35 were 
assigned to O - CH2 and CH2 - N3 hydrogens. Methyl protons were 
observed at 6 1.2 (Cio- CH3), 0.68 (C13- CH3), 0.91 and 0.83 for other 
side chain methyl protons. The mass spectrum gave molecular ion peak 
at m/z 529. The other significant fragment ion peaks include peak at 515, 
514, 443, 439, 428, 415 (base peak), 371, 330 etc. A tentative 
mechanism for the formation of fragment ions is given below. 
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m/z443 
H-N. 
nVz371 
Thus on the basis of above analytical and spectral data the 
compound was characterized as N-2''-hydroxyethyl-3-aza-A-homo-6)3 (2' 
azidoethoxy)-cholest-4a-en-4-one. 
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Reaction of 5a, 6B-dibromocholestan-3-one- (LXXXI) with 
2-azidoethanol in presence of BF^- OEti: 
5 a, 6p-Dibromocholestan-3-one (200mg) in dichloromethane 
(5ml) was treated with 2-azidoethanol (247mg) and was cooled to 0°C. 
BF3-OEt2 (0.5ml) was added dropwise over 5 minutes. Immediate gas 
evolution was noted upon addition. The reaction was allowed to warm to 
room temperature over 30 minutes and was stirred for additional four 
hours. The solution was concentrated, 5 ml saturated solution of sodium 
bicarbonate was added to the residual oil and mixture was further stirred 
for 30 minutes. After concentration an additional 100 ml of 
dichloromethane was added and the organic layer was separated, washed 
with water and dried over anhydrous sodium sulphate, evaporation of the 
solvent afforded an oil which was chromatographed over silica gel 
column. Elution with pet.ether : acetone. (8:2) afforded N-2'-
hydroxyethyl-3-aza-6p-bromo-A-homocholest-4a-en-4-one (LXXXVII). 
CgHiy 
CgHp 
CH2CI2, 2-azidoethanoI 
BF3 - 0Et2 *-no 
(LXXXI) 
(LXXXVI) 
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Characterization of the compound as N-2^-hvdroxvethvl-3-
aza-6B-bromo-A-homocholest-4a-en-4-one (LXXXVII): 
The elemental analysis of the compound corresponded to the 
molecular formula C29H48N02Br (Positive Beilstein test) IR spectrum 
exhibited bands at 3485 (OH), 1660 (N-CO-C=C), 1600 (C=C), 1375 
(C-N), 1050 (C-0), 760 (Br). These value strongly suggested the 
presence of lactam moiety. The structure was further supported by its 
' H - N M R spectrum showing expected peaks such as at 5 5.9 (s,lH, €43-
H) Ce - H was appeared as triplet at 6 4.9, a broad peak at 6 4.35 was 
assigned to OH proton, disappeared when exchange with deuterium, CH2 
- N protons appeared as triplet 5 3.65, J = 5.1 Hz, another triplet at 6 3.5, 
J = 5.5 Hz was assigned to 2H of CH2 - OH, hydrogens at C2 appeared 
as triplet at 6 2.6, a multiplet at 6 2.3 ascribed to C7 - aH. Methyl 
protons were observed at 1.2, 0.96, 0.88 and 0.68 Mass spectrum gave 
molecular ion peat at m/z 521/523. The other significant peaks include 
503/505, 482, 414, 400 (base peak), 301, 331/333 etc. A tentative 
mechanism is written to explain the fragment of these fragment ions. 
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The above analytical and spectral data strongly recommend the 
compound as N-2'-hydroxyethyl-3-aza-6P-bromo-A-homocholest-4a-en-
4-one (LXXXVII). 
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Reaction of cholest-4-ene-3, 6-dione (LXXXII) with 2-
azido-ethanol in presence of BFg^ - OEti: 
Cholest-4-ene-3, 6-dione (200mg) in dichloromethane (10ml) was 
treated with azidoethanol (450mg) and was cooled to 0°C BF3 - 0Et2 
(0.75 ml) was added dropwise over 5 minutes. Immediate gas evolution 
was noted upon addition. The reaction was allowed to warm to room 
temperature over 30 minutes and was stirred for an additional 3 hrs. The 
solution was concentrated, 10ml of saturated solution of sodium 
bicarbonate was added to the residual oil and mixture was stirred for 30 
minutes. After concentration an additional 100ml of CH2CI2 was added 
and the organic layer thus separated was washed with water and dried 
over anhydrous sodium sulphate. Evaporation of the solvent afforded an 
oil which was chromatographed over silica gel column. Elution with pet. 
ether - acetone (9:1) affords N, N bis (2' hydroxyethyl) 3, 6-diaza A,B-
bishomocholest-4a-ene-4, 7-dione (LXXXVIII). 
CgHn 
O 
(LXXXII) 
CH2CI2, Azidoethanol 
BF3-OEt2 p N 
HO-1 
CgHn 
(LXXXVIII) 
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Characterization of the compound as N, N bis (2'-hydr-
oxvethvl)-3, 6-diaza-A,B-bishomocholest-4a-ene-4,7-dione: 
The elemental analysis of the compound corresponded the 
molecular formula as C31H52N2O4 The IR spectrum of the compound 
exhibited bands at 3470 cm'' (OH), 1690 (N-CO-) 1640 (C=C-CO), 1600 
(C=C) and 1375 (C-N), 1050 (C-0), which unambiguously predict the 
presence of bilactam moiety which was later confirmed by its ' H - N M R 
and mass spectra. The 'H -NMR spectrum displayed two singlets one at 
6 6.65 ascribed to OH proton, another at 5 6.1 assigned to vinylic 
hydrogen at C4a, 2H of CH2 - N (6-N) appeared as triplet at 3.7 J = 4.9 
Hz CH2 - OH (6-N) hydrogens appeared as multiplet at 5 3.6, two 
triplets at 5 3.52, J = 5.1 and 8 3.4, J = 5.6 Hz were ascribed to 
hydrogens of CH2 - N and CH2 - OH attached to 3 - N. Methyl protons 
were observed at 6 1.2 (Cio - CH3), 0.68 (C13 - CH3). The structure was 
further supported by mass spectrum giving prominent molecular ion 
peak at m/z 526; other significant fragment ions peaks include 511, 498, 
470,456,439,412,343. 
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Following mechanism have been suggested for the formation of 
the lactam. 
t ! ) ^ " ^ 
HO ^ O - ^ 0 + 
H 
CgHn 
N \-J 
N E N r N t / O 
CgHis CgHis 
R ^ ^ ^ ^ 
WAL 
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All the melting points were observed on a kofler hot block and are 
uncorrected. IR spectra were obtained as neat with a Perkin-Elmer 237 
spectrophotometer. IR values are given in cm"'. ' H - N M R were run in 
CDCI3 on a Bruker AC 300 (300 MHz) instrument with Me4Si as the 
internal standard and its values are given in ppm (5) (s, singlet; br, broad 
and mc, multiplet centered at). Mass spectra were measured on VG 
micromas model ZAB - IF apparatus at 70 eV ionization voltage. The 
values (m/z) of fragment ion from various compounds are given in 
parenthesis which are relative abundance (%) of the peaks with respect 
to the base peak as 100%. Thin layer chromatographic plates (TLC) were 
coated with silica gel. Silica gel (~20g) was used for each gram of the 
material to be separated in column chromatography, petroleum ether 
refers to a fraction of b.p.60-80°. Sodium sulphate (anhydrous) was used 
as the drying agent. 
3B-Acetoxv cholest-5-ene (LXXV); 
A mixture of cholesterol (50g), pyridine (75ml, freshly distilled 
over KOH) and freshly distilled acetic anhydride (50ml) was heated on 
water bath for 2hrs. The resulting brown solution was poured into 
crushed ice-water mixture with stirring. A light brown solid was 
obtained which was filtered under suction, washed with water untill free 
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from pyridine and air dried. The crude product on recrystallization from 
acetone gave pure 3p-acetoxycholest-5-ene (45.0 mg) m.p.ll2° 
(reported^°m.p.ll3°C). 
33-Acetoxv-6-nitrocholest-5-ene (LXXVI): 
3[3-Acetoxy cholest-5-ene (LXXV) (lO.Og) was covered with 
nitric acid (250ml; d, 1.42) and sodium nitrite (8.0g) was gradually 
added over a period of 1 hr with continuous stirring. Slight cooling was 
also affected during the course of reaction and stirring was continued for 
additional 2 hrs. When the yellow spongy mass separated on the surface 
of the mixture, the mixture was diluted with cold water (200ml) resulting 
a green coloured solution. The whole mass was extracted with ether. The 
ethereal solution was washed with water, sodium bicarbonate solution 
(5%) and water and dried over anhydrous sodium sulphate. Removal of 
the solvent provided the nitro compound as oil which was crystallized 
the from methanol (7.0g) m.p.l04° (reported '^ m.p.102-104). 
3B-Acetoxv-5a-cholestan-6-one (LXXVII); 
Nitro compound (LXXVI) (6.0 g) was dissolved in glacial acetic 
acid (250 ml) and zinc dust (12.0 g) was added in small portions with 
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shaking. The suspension was heated under reflux for 4 hrs., water (12 
ml) was added during the course of reaction. The hot solution was 
filtered, cooled to room temperature and diluted with large excess of 
water. The precipitate thus obtained was taken in ether and washed with 
water, sodium bicarbonate solution (10%), water and dried over sodium 
sulphate (anhyd.) Removal of the solvent gave an oil which was 
recrystallized from methanol (3.9 g) m.p. 128° (reported^^ m.p. 127 -
128°). 
Reaction of 33-acetoxv-5a-cholestan-6-one (LXXVII) with 
2-azidoethanol in presence of BFj-OEti : 3B-Acetoxv-N-2'-
hvdroxvethvl-6-aza-B-homocholestan-7-one(LXXXIII): 
3P-Acetoxy-5a-cholestan-6-one (LXXVII) (200 mg) in CH2CI2 
(5 ml) was treated with 2-azidoethanol (247 mg) and cooled to 0°C. 
BF3-OEt3 (0.5 ml) was then added dropwise over 5 min. Immediate gas 
evolution was noted upon addition. The reaction was allowed to warm to 
room temperature over 30 minutes and was stirred for nearly 5 hrs. The 
solution was concentrated, 5 ml of saturated NaHCOs solution was 
added and the reaction mixture was stirred for 30 minutes. After 
concentration an additional 100 ml of CH2CI2 was added and the organic 
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layer was separated, dried (Na2S04) and concentrated to afford an oil 
which was chromatographed over silica gel column. Elution with pet. 
ether-acetone (9:1) gave 3P-acetoxy-N-2'-hydroxyethyl-6-aza-B-homo-
5a-cholestan-7-one (LXXXIII). 
Analysis found : C, 73.92; H, 10.49; N, 2.72. 
C31H53NO4 requires : C, 73.95; H, 10.54; N, 2.78. 
IR : V^ ax 3480 (OH) 1730, 1240 (CH3 CO - 0), 1670 (- CO - N), 1360 
(C-N), 1280 (Amide band). 
^H-NMR : 5.0 (br, Cj-aH), 6 4.4 (m, C3a-H, WA = 16 Hz), 3.6 (t, J = 
5.3 Hz, 2H, CH2-N), 3.1 (t, 5.1 Hz, 2H, CH2-OH), 2.1 (s, CH3COO), 2.0 
(s, IH, OH), 2.2 (d, J = 6.6 Hz, 2H, C7a-H), 1.2 (C10-CH3) 0.67 (C13-
CH3), 0.91 and 0.85 (for side chain methyl protons). 
MS : m/z 503 [M + ], 488, 485, 475, 390, 25, 186. 
3B-Chlorocholest-5-ene (LXXXIX); 
Freshly purified thionyl chloride (75 ml) was added gradually to 
cholesterol (100 g) at room temperature, a vigorous reaction ensued with 
the evolution of gaseous products. When the reaction slackened, the 
mixture was gently heated at a temperature of 50 - 60° on a water bath 
for Ihr. and then poured onto crushed ice - water mixture with stirring. 
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The yellow solid thus obtained was filtered under suction and washed 
several times with cold water and air dried. Recrystallization of the crude 
product from acetone gave 3P-chlorocholest-5-ene (LXXXIX) (95.5 g) 
m.p. 95 - 96 (reported^^ 96 - 79). 
33-Chloro-6-nitrocholest-5-ene (XC): 
To a well stirred mixture of 3P-chlorocholest-5-ene (LXXXIX) 
(12.0 g), glacial acetic acid (80 ml) and nitric acid (25 ml, d, 1.52) at 
temperature below 20° was added sodium nitrite (3.0 g) gradually over a 
period of 3 hrs. After the complete addition of sodium nitrite, the 
mixture was further stirred for about 1 hr, ice cooled water (200 ml) was 
added and the yellowish solid thus seperated, was filtered and air dried. 
The desired product (XC) was recrystallized from methanol as needles 
(8.3 g), m.p. 151 - 152° (reported^^ m.p. 153°). 
3B-Chloro-5a-cholestan-6-one (LXXVIII); 
A solution of (XC) (12 g) and glacial acetic acid (240 ml) was 
heated just to get a clear solution. To this zinc dust, (24 g) was added 
gradually in small portions with constant shaking. The suspension was 
heated under reflux for 4 hrs. and water (24 ml) was added at regular 
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intervals during the course of reaction. Tlie hot solution was poured into 
ice - cooled water. The organic matter was extracted with ether and 
ethereal solution was washed successively with water sodium 
bicarbonate solution (5%) and water and dried (Na2S04). Evaporation of 
the solvent furnished ketone as an oil which was crystallized from 
methanol (8.7 g) m.p. 128 - 129° (reported^^ 129°). 
Reaction of 33-chloro-5a-cholestan-6-one (LXXVIII) with 
2-azidoethanol in presence of BFyOEti : 3B-Chloro-N-2'-
hvdroxvethvl-6-aza-B-homo-5a-cholestan-7-one : 
3p-Chloro-5a-cholestan-6-one (LXXVIII) (200 mg) in CH2CI2 (6 
ml) was treated with 2-azidoethanol (250 mg) and was cooled to 0°C. 
BF3-OEt2 (0.5 ml) was added over 5 min. immediate gas evolution was 
noticed upon addition. The reaction was then allowed to warm to room 
temperature over 30 min and stirred for nearly 6 hrs. The solution was 
concentrated, 5 ml of saturated solution of NaHCOs was added to the 
residual oil and the mixture was further stirred for 30 min. After 
concentration, an additional 100 ml of CH2CI2 was added. Organic layer 
was seperated washed with water and dried over anhydrous Na2S04. 
Evaporation of the solvent afforded an oil which was chromatographed 
123 
over silica gel column. Elution with pet. ether : acetone (19 : 1) gave SP-
chloro-N-2'-hydroxyethyl-6-aza-B-homo-5a-cholestan-7-one(LXXXIV) 
as semisolid. 
Analysis found : C, 72.71; H, 10.45; N, 2.8 
C29H50NO2CI requires : C, 72.65; H, 10.43; N, 2.92. 
IR : Vniax 3500 (OH), 1665 (-CO-N), 1360 (C-N), 1270 (Amide band), 
1050 (C-0), 750 (CI). 
'H-NMR : 5.0 (m, IH, Cg-aH), 6 4.1 (m, Cj-a-H), 3.4 (m, 2H, CH2-
OH), 3.7 (t, J = 5.4 Hz, 2H, CH2-N), 2.2 (s, IH, OH), 2.6 (d, J = 6.6 Hz, 
2H, Cv-aH), 1.2 (C10-CH3), 0.67 (Cn-CHa), 0.91 and 0.85 (for other side 
chain methyl protons). 
MS : m/z 479/481 [M +], 464/466, 461/463, 451/453, 443, 436/438, 433, 
435,366/368,231,162. 
5a-Cholestan-6-one (LXXIX): 
6-Nitrocholest-5-ene (6.0 g) was dissolved is glacial acetic acid 
(200 ml) by heating and to this solution, zinc dust (12.0 g) was added in 
small portions. After the initial exothermic reaction had subsided, the 
suspension was heated under reflux for 3 hrs and water (12 ml) was 
added now and then during the course of reaction. The solution was 
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filtered and the residue washed with two (10 ml) portions of warm acetic 
acid. To the filterate few ml of water was added till the turbidity 
developed and it was allowed to stand overnight at room temperature. 
The crystalline material thus seperated was filtered under suction and 
washed thoroughly with water in order to remove zinc acetate. The 
organic solid was air dried and then recrystallized from ethanol (3.6 g) 
m.p. 96 - 98 (reported^^ m.p. 95 - 96). 
Reaction of 5a-cholestan-6-one (LXXIX) with 2-azido-
ethanol in presence of BF^-OEti: N-2'-Hvdroxvetlivl-6-aza-
B-home-5a-cholestan-7-one(LXXXV): 
5a-Cholestan-6-one (LXXIX) (200 mg) in CH2CI2 (5 ml) was 
treated with 2-azidoethanol (260 mg) and was cooled to 0°C BF3 - 0Et2 
(0.5 ml) was added dropwise over 5 min, immediate gas evolution was 
noted upon addition. The reaction was allowed to warm to room 
temperature over 30 min and was stirred for nearly 5 hrs. The solution 
was then concentrated, 5 ml of saturated solution of NaHCOa was added 
to the residual oil and further stirred for 30 min. After concentration an 
additional 100 ml of CH2CI2 was added, the organic layer was separated 
washed with water and dried (Na2S04). Evaporation of the solvent 
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afforded an oil which was chromatographed over silica gel column. 
Elution with pet. ether : acetone (19 : 1) gave N-2'-hydroxyethyl-6-aza-
B-homo-5a-cholestan-7-one (LXXXV) as semisolid. 
Analysis found : C,. 78.51; H, 11.57; N, 3.25 
C29H5,N02 requires : C, 78.20; H, 11.46; N, 3.14. 
IR : V^ ax 3480 (OH), 1685 (-CO-N), 1375 (C-N) and 1280 (Amide 
band), 1050 (C-0). 
' H - N M R : 6 5.0 (m, Cj-aH), 4.2 (t, J = 5.1 Hz, 2H, CH2 - OH), 4.4 (t, J 
= 5.1 Hz, 2H, CH2-N), 2.0 (s, IH, OH). 2.5 (d, J = 6.6 Hz, 2H, C-j, - aH), 
1.2 (C10-CH3) 0.67 (C13-CH3), 0.85 and 0.95 (for side chain methyl 
protons). 
MS : m/z 440 [M + ], 427, 430, 332, 197. 
33-Hvdroxv-5a, 6B-dibromocholestane (XCI): 
To the solution of cholesterol (14g), ether (150ml), bromine 
solution (50ml) was added gradually with stirring. The solution turns 
yellow and promptly set to a stiff paste of dibromide. The mixture was 
cooled to 20°C by stirring with a glass rod for 5 minutes to ensure 
complete crystallization. The product was then filtered under suction and 
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washed with cold ether-acetic acid mixture (3:7) untill the filterate 
completely colourless m.p.l 12° '^. 
5a, 63 DibromochoIestan-3-one (LXXXI): 
3P-Hydroxy-5a, 6(3 dibromo cholestane (lOg) was suspended in 
acetone (300ml) in a three necked round bottom flask fitted with a stirrer 
and dropping funnel. Jones reagent (15 ml) was then added in small 
portion from dropping funnel in course of 30 minutes. The temperature 
of the reaction mixture during oxidation was maintained between 0-5 °C 
by external cooling. After the addition was completed, stirring was 
continued for 15 minutes and cold water (200 ml) was added. The 
product was filtered under suction and washed thoroughly with water, 
and methanol and air-dried m.p.73^^ 
Cholest-5-en-3-one (LXXX): 
To a solution of 5a, 6p dibromocholestan-3-one (LXXXI) (5 gm) 
in ether (100 ml) and acetic acid (2.5 ml) was added, zinc dust (7.5 g) in 
small portions during 30 min, with continuous shaking. After the 
complete addition, the ethereal solution containing zinc dust was filtered, 
taken in seperating funnel. The ethereal layer was washed with water, 
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sodium bicarbonate solution (5 %) and water and dried over anhydrous 
sodium sulphate. The oily residue obtained on evaporation of solvent 
was crystallized from method to give the desired product (3 g) m.p. 127 
- 128^1 
Reaction of cholest-5-en-3-one (LXXX) with 2-azidoethanol 
in presence of BF -^OEti ; N-2'-hvdroxvethvI-3-aza-6B {t 
azidoethoxv)-A-homo-cholest-4a-en-4 one (LXXXVI): 
Cholest-5-en-3-one (600mg) in CH2CL2 (20ml) was treated with 
2-azidoethanol (750mg) and was cooled to 0°C. BF3- 0Et2 (1.5ml) was 
added dropwise over 5 minutes. The reaction was allowed to warm to 
room temperature over 30 minutes and was stirred for an additional 3 
hrs. The solution was concentrated, 15 ml of saturated solution of 
sodium bicarbonate was added to the residual oil and mixture was stirred 
for 30 minutes. After concentration, an additional 200ml of CH2CL2 was 
added and organic layer thus seperated was washed with water, dried 
(Na2So4) evaporation of the solvent afforded an oil which was 
chromatographed over silica gel column. Elution with pet. ether : 
acetone (9:1) afforded N-2'-hydroxyethyl-3-aza-6(3 (2'-azidoethoxy)-A-
homo-cholest-4a-en-4-one (LXXXVI). 
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Analysis found: C, 70.75; H, 10.75; N, 10.7 
C31H54O3N4 requires : C, 70.45; H, 10.22; N, 10.6 
IR: Vmax 3480 (OH) 2120 cm'' (N=N=N), 1650 (C=C-CO-NR), 1610 
(C=:C), 1375 (C-N) and 1030 (C-0). 
' H - N M R : 5 6.7 (s, IH, C4), 4.1 (m, IH, C(,), 3.8 (s, IH, OH), 3.5 (t, J = 
4.9 Hz, 2H, CH2-OH), 3.65 (t, J = 4.9 Hz, 2H, CH2-N), 2.6 (t, J = 8.6 Hz, 
2H, -O-CH2), 2.35 (t, 2H, CH2-N3), 1.12 (Cjo-CHs), 0.68 (C13-CH3), 0.91 
and 0.83 (for side chain methyl protons). 
MS : m/z 529 [M + ], 515, 486, 471, 443, 439, 415, 400, 386, 371, 355, 
165, 151, 121,83. 
Reaction of 5a, 6(3-dibromo-cholestan-3-one (LXXXI) with 
2-azidoethanol in presence of BFj-OEti: N-2'-
Hvdroxvethvl-3-aza-63-bromo-A-homocholest-4a-en-4-one 
(LXXXVII): 
5a, 6P-Dibromocholestan-3-one (200 mg) in CH2CL2 (5ml) was 
treated with 2-azidoethanol (247mg) and was cooled to 0°C. BF3 - 0Et2 
(0.5ml) was added dropwise over 5 minutes. Immediate gas evolution 
was noticed upon addition. The reaction was allowed to warm to room 
temperature over 30 minutes and was stirred for additional 4 hrs. The 
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solution was concentrated, 5ml of saturated solution of NaHCOs was 
added to the residual oil and mixture was further stirred for 30 min. After 
concentration an additional 100ml of CH2CI2 was added and organic 
layer thus seperated was washed with water and dried (Na2S04), 
evaporation of the solvent afforded an oil which was chromatographed 
over silica gel column. Elution with pet. ether: acetone (8:2) gave N-2'-
hydroxyethyl-3-aza-6(3-bromo-A-homocholest-4a-en-4-one (LXXXVII). 
Analysis found: C, 67.01; H, 9.32; N, 2.46. 
C29H48N02Br requires: C, 66.79; H, 9.21; N, 2.68. 
IR: v^ ax 3485 cm"' (OH), 1660 (N-CO-C=C), 1600 (C=C), 1375 (C-N), 
1050 (C-0), 760 (Br). 
'H-NMR: 5 5.9 (s, IH, C4a-H), 4.9 (IH, Cg-H), 4.35 (br, s, IH, OH), 3.5 
(t, J = 5.5 Hz, 2H, CH2-OH), 3.65 (t, J = 5.1 Hz, 2H, CH2-N), 2.6 (t, 2H, 
C2-H), 2.3 (m, 2H, C7-aH). 
MS : m/z 521/523 [M + ], 503/505, 440/442, 414, 400, 382, 301, 
331/332,247, 135,107,95,81. 
Cholest-4-ene-3.6-dione (LXXXII): 
To a solution of cholesterol 10 gm in dimethylformamide 
(220ml), pyridinium dichromate (PDC) (44 gm) was added and reaction 
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mixture was stirred at room temperature for 4 iirs. The reaction was 
monitored with TLC, after completion of reaction, water (2200 ml) was 
added and work up with ether. The ethereal layer was washed with 
water, dil HCl, sodium bicarbonate (5%) and water, dried over 
anhydrous sodium sulphate. Evaporation of the solvent, provide yellow 
solid which was crystallized from methanol to give diketone (8.7g) 
m.p.l24° (reported^^ m.p. 125). 
Reaction of cholest-4-ene-3, 6-dione (LXXXII) with 2-
azido-ethanol in presence of BFj-OEtgi N, N Bis {!'-
hydroxyethyl) 3,6-diaza-A,B-bishomocholest-4a-ene-4, 7-
dione (LXXXVIII): 
Cholest-4-ene-3, 6-dione (200 mg) in CH2CI2 (10 ml) was treated 
with 2-azidoethanol (450 mg) and was cooled to 0°C BF3 - OEtj (0.75 
ml) was added dropwise over 5 min. The reaction was allowed to warm 
to room temperature over 30 min and was stirred for nearly 3 hrs. The 
reaction mixture was concentrated, 10 ml of saturated solution of sodium 
bicarbonate was added to the residual oil and was stirred for additional 
30 min. After concentration, 100 ml of CH2CI2 was added and the 
organic layer thus seperated was washed with water and dried (Na2S04). 
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Evaporation of the solvent afforded an oil which was chromatographed 
over silica gel column. Elution with pet. ether : acetone (4 :1 ) gave the 
product. 
Analysis found : C, 73.0; H, 11.07; N, 5.72 
C31H52N2O4 requires: C, 72.09; H, 10.07; N, 5.42 
IR : Vmax 3470 cm'' (OH), 1690 (N-CO), 1640 (C=C-CO), 1600 (C=:C) 
and 1375 (C-N), 1050 (C-0) 
' H - N M R : 6 6.65 (s, IH, OH), 6.1 (s, €4^ - H), 3.6 (m, 2H, CH2 - OH, 
6 - N), 3.7 (t, J = 4.9 Hz, 2H, CH2 - N, 6 - N), 3.4 (t, J = 5.6 Hz, 2H, 
CH2 - OH, 3 - N), 3.52 (t, J = 5.1 Hz, 2H, CH2 - N, 3 - N). 
MS : m/z 526 [M + ], 511, 498, 470, 456, 439, 412, 385, 370, 326, 266, 
150,107. 
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Chapter Three 
Synthesis ofs-Triazole 
and its Schiff bases 
THEOmTlCAL 
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Owing to the versatility of substituted s-triazoles as potent 
biologically active'""^ as well as magnificient substrate especially 4-
amino-5-mercapto-l,2,4-triazole for the synthesis of various 
heterocycles of medicinal importance, we have undertaken the synthesis 
of 4-amino-5-mercaptotriazole attached to the steroidal nucleus and their 
Schiff bases which also belongs to same category i.e. good substrate as 
well as medicinally important. The history of Schiff bases dates back to 
1864 when Schiff^  first of all reported the reaction of aldehydes and 
ketones with amines to give imines which are often referred to as Schiff 
bases. 
R2CO + H2NR" -
OH H 
I I 
R - C - N - R' 
I 
R' 
R \ 
R' / 
C = NR" + H20 
Hammett^ proposes that the acids protonate the carbonyl group to 
give a carbonium ion which adds to the amine in a very fast reaction, 
deprotonation of this intermediate give a carbinol amine which rapidly 
eliminate water molecule to give Schiff base. Other methods include the 
hydrogenation of nitriles over nickel or platmum catalysts . 
RC = N + H2 • RCH = NH. 
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a-Nitrostyrenes can be reduced with lithium aluminum hydride 
below 0° then hydrolyzed with 20 % aqueous potassium sodium tartrate 
to give the imines^. 
PhCH = CHNO2 • PhCH2CH = NH 
Heindel et al.^  have developed two improved methods for the 
synthesis of 5-substituted-4-amino-3-mercapto-(4H)-l,2,4-triazoles. One 
of these method involves the direct hydrazinolysis of potassium-3-
aroyldithiocarbazates and other involves ring opening and reclosure of 5-
substituted-2-mercapto-l,3,4-oxadiazoles to the aminomercapto tria-
zoles. Earlier Hoggarth'° have given the synthesis of 5-substituted-4-
amino-3-mercapto-(4H)-l,2,4-triazoles where carboxylic acid hydrazides 
were condensed with carbon disulfide in ethanolic potassium hydroxide 
to yield the potassium-3-aroyldithiocarbazates (I) which were 
S-alkylated with methyl iodide. These methyl-3-aroyldithio-carbazates 
(II) were cyclized with hydrazine to the triazoles. 
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O 
R-C-NH-NH2+CS2+KOH-
KOH or pyridine^  
N-
R 
N l[ 
O ' ^ S H " 
III 
O 
II 
-+ 
N2H4 
(Method BT 
-•R-C-NH-NH-C-SK CH31 
I 
N2H4 
(Method A) 
O S 
II II 
R-C-NH-NH-C-SCH3 
N N 
R N 
I 
NH2 
SH 
IV 
These modified methods are considered to be superior to classical 
Hoggarth method as one of the method (method A) utilizes the 
conversion of salt I directly to the triazoles (IV) with an excess of 
hydrazine thereby avoids the S-methylation thus results in higher over all 
yield. Kalluraya et al." described the synthesis of some nitrothienyl-
triazolo [3, 4-b]-l,3,4-thiadiazines (VIII). They condensed 3-aryl-2-
bromo-l-(4-nitro-2-thienyl)-2-propen-l-ones (VI) which is obtained by 
dehydrobromination of 3-aryl-2,3-dibromo-1 -(4-nitro-2-thienyl)-propan-
1-ones (V), with 3-substituted-4-amino-5-mercapto-l,2,4-triazoles (VII) 
using sodium acetate as catalyst 
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OoN 
O Br 
O2N 
S C—CH-
(V) 
- A . Et3N/ 
•CH—Ar 
dry CeUe 
Br 
O 
C—C=CH—Ar 
Br 
(VI) 
O2N 
N N 
N N 
0 
Br R I NaOAc.A 
(VI) NH2 
(VII) 
R 'N I 
N 
O2N 
CH—Ar 
(VIII) 
.12 Pankaja K.Kadaba has given the synthesis of l-aryl-5-amido-
1,2,3-triazolines. He reported for the first time the 1,3-cycloadition 
reaction of aryl azides with two enamides, the N-vinyllactam N-vinyl-2-
pyrrolidinone (NVP) (IX a) and the open chain enamide, N-methyl-N-
vinylacetamide (NYA) (IX b). 
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R—CH=CH2 + N3 
(IXa—b) 
a = 
O K 
N — 
J 
0 
II 
H3C—C 
* • R 
A,EtOH 
(Xa—b) 
KOH,MeOH 
reflux, 30 min 
X 
b = 
H3C 
N-
/ 
•N 
N 
(XI) 
Reaction of equimolar amounts of the enamide and aryl azide at 
room temperature, over a period of time depending on the reactivity of 
both reagents yielded the triazohne adducts (Xa and Xb) as stable, 
colourless, crystalline products. In refluxing ethanol the reaction yielded 
the triazoles XI as the major product. 
Mogilaiah et al. reported the synthesis of 6-aryl-3-(2'-methyl-r, 
8'-naphthyridin-3'-yl)-l, 2,4-triazolo-[3, 4-b] [1, 3, 4] thiadiazoles. 
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,^^^^^^^^^^^2^5 
N2pi4 • H2O 
O 
II 
.C — NHNH2 
N N CH3 
(XII) 
N N CH3 
N N 
N ^ ^ S H N2H4.H20 
I < 
NH, 
N - < 
N N CH3 Ar 
(XVI) 
"N N CH3 
5-Mereapto-2 (2-methvl-l', 8'-naphthvridin-3'-vI)-l, 3, 4-
oxadiazole (XIV): 
C,,H8N40S;M.P. 225° 
IR (KBr): 3410 (NH) and 1605 cm"' (C = N) 
Mass : m/z 244 (M+, 5.2%), 211 (3.2), 183 (100), 171 (4.6), 169 (22), 
156 (35), 143 (4.3), 102 (27.4) and 101 (23.6). 
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4-Amino-5-mercapto-3-(2'methvl-l\ 8'-naphthvridin-3'-vI)-
1, 2, 4-triazole (XV) ; 
CiiH,oN6S;M.P.284° 
IR (KBr): 3390, 3280 (NH2), 2800 (SH) and 1610 cm-' (C = N) 
'H-NMR (CDCI3): 6 2.7 (s, 3H, CH3), 5.2 (s, 2H-NH2), 5.5 (s, IH, SH), 
8.25 (m, IH, H-4'), 8.45 (m, IH, H-5'), 7.5 (m, IH, H-60 and 8.9 (m, 
IH, H-7') 
Mass : m/z 258 (M+, 100), 225 (5.7), 169 (12.5), 143 (9.1). 
3-(r-Methvl-l\ 8'-naphthvridin-3'-vI)-6-phenvl-l. 2. 4- tri-
azolo [3,4-b1 \h 3,41 thiadiazoles (XVI): 
C,8H,2N6S;M.P.228° 
IR (KBr): 1600 cm"' (C=N). 
'H-NMR (CDCI3): 8 3.2 (s, 3H, CH3), 7.7 (m, IH, H-7'), 7.9 (m, IH, H-
50, 8.3 (m, IH, H-7') and 7.0 - 7.5 (m, 6H, H-6' and 5', Ar-H). 
Mass : m/z 344 (M+, 14.6 % ) , 343 (65.2), 241 (12.8), 240 (70.9) 143 
(9.1), 121 (100), 103 (25.1) and 102 (13.6). 
Bahajaj et al.''* reported the synthesis and antimicrobial activity of 
some 4-amino-5-aryl-l,2,4-triazol-3-thiones and their derivatives. They 
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have synthesized a group of twelve 4-amino-5-aryl 1,2,4-triazole-3-
thiones following procedure given by Reid and Heindel^. 
YC6H4CO (NH)2CSSK 
N2H4. H2O 
N-NH 
YC6H4' "N S 
NH2 
(XVII) 
N - N H 
YC6H4" N ' 
CICH2CN. 
N - N 
Y Q H 4 ^ N'^^SCH2CN 
NH2 
(XX) 
BrCHjCOsMe 
.CH2I2 
HNCOR 
R= C6H5, CH3 
(XVIII) 
N - N 
II } 
YC6H4^^N "SCH2C02Me 
I 
NH2 
(XXI) 
N - N 
YC6H4" N S-I-CH2 
NH2 
(XIX) 
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N-N 
'I V 
YC6H4'^  N "SCHsCOsMe 
NH2 
(XXI) 
N2H4. H2O 
N - N 
YC6H4^ N "SCH2CONHNH2 
NH2 
(XXII) 
RCOCl I RCHO 
N - N N - N 
[I \ Jl \\ 
YC6H4'' N'^sCH2CO(NH)2COR YC6H4' '^N^ ^SCH2CbNHN=CHR 
NH2 NH2 
(XXIII) (XXIV) 
R=OC6H5; MeOC6H4, 4 ^02C6H4 
The structure of compound (XVII) was confirmed from analytical 
and spectral data. The IR showed stretching band in the regions 
3280 - 3350 cm"' and 1610 - 1635 cm"' (C = N) respectively. Their 
' H - N M R spectra showed a singlet at 5.14 - 5.87 (2H, NH2) and a singlet 
at 5 13.61 - 14.79 (IH, SH or NHCS). The aromatic protons of the aryl 
gp resonated as a multiplet at 5 6.93 - 8.27. 
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Kurasawa et al.'^ had given a new method for the synthesis of 
1,2,4-triazolo [3, 4-f] [1, 2, 4] triazines. 
Ac OH 
(XXV) 
RC(0Et)3 
in Ac OH 
Me 
N: 
V N 
(XXVIII a,b) 
a 
b 
Me 
Y NH2 
• ^ ^ N H 
• N ^ O " 
H 
A 
RC (OEt )3 
Me 
N: 
/ = ( 
0, 
(-H2) 
(XXVI a,b) 
R 
H 
CH3 
.N 
^%y^-^^2 
NH2 
N - ^ O 
H 
B 
RC(0Et)3 
Me 
} N 
H 
• N ^ O 
H 
(XXVII a,b) 
The reaction of (XXV) with orthoesters (R = H, Me) and Fe 
powder in acetic acid afforded (XXVI a, b) and the 7, 8-dihydro-l, 2, 4-
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triazolo [3, 4-f] [1, 2, 4] triazines (XXVII a, b), while the absence of Fe 
powder did not provide the N-oxides (XXVIII a, b) but recovered the 
starting material (XXV). 
8-(3-Oxo-3.4-dihvdroquinoxalin-2-vl)-3-methvl-l. 2, 4-tria-
zolo f3,4-fl [1,2,41 triazine (XXVI a): 
CijHgNvOiM.P. 313-314° 
IR(KBr): 1665, 1605 cm-' 
' H - N M R (DMSO-dg): 5 13.07 (brs, IH, NH), 9.34 (s, IH, Cg-H) 8.00-
7.30 (m, 4H, aromatic), 2.80 (s, 3H, Cj-Me) 
Mass: m/z 279(M-H). 
8-(3-Qxo-3, 4-dihvdroquinoxalin-2-vl)-3,6-dimethvl-l, 2, 4-
triazolo [3,4-f1 \h 2,41 triazine (XXVI b): 
C,4H,iN70;M.P. 311-312°. 
IR (KBr): 1665, 1630, 1605 cm"' 
' H N M R (DMSO-de): 5 13.00 (brs, IH, NH), 8.00-730 (m, 4H, 
aromatic), 2.77 (s, 6H, Cs-and Cg-Me). 
Mass: m/z 293 (M+). 
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A number of mesoionic compounds (XXIX) derivatives of the 
1,2, 4-triazolo [4, 3-b]-l,2,4-triazole ring system have been prepared 
from 4-amino-l-methyl-3,5-bis (methyl thio)-l,2,4-triazolium cation and 
aryl isothio cyanates'^. 
N N ' 
Me 
MeS N' I 
•SMe (i) 
,Me Me 
N N ' N N ' 
-••MeS I 
N = 
(XXIX) V 
N N' 
Me 
<;>V ^Ar 
MeS^ ^N N 
(XXXI) CN 
N -
(XXX) 
^ SMe 
N N ' 
Me Me 
II I ^ ^ ' 
J^x+V\ .Ar (iv) j[ L 
N N ' 
Me 
CN 
N-
(XXX) 
'SMe H ' ^ C = N - A r 
I 
SMe 
(XXXII) 
- • M e S ^ N 
I 
N 
CN 
•NH, 
(XXXIII) 
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(i) Ar - NCS / EtsN / Ultrasound; (ii) ICHs/r.t; (iii) A ; 
(iv) CH2(CN)2/KF/TEBA 
Compound (XXIX) reacts with methyl iodide to give methiodide 
(XXX) which undergoes ring opening to the monocyclic compounds 
(XXXI) through sulfur extrusion under thermal condition. Methiodides 
(XXX) by sequential treatment with malononitrile and hydrochloric acid' 
lead to the pyrazolo [5, l-c]-l, 2, 4-triazole (XXXIII). 
1 7 
Peng - Fei Xu et al. have recently given a facile synthesis of bis 
(4-amino-5-mercapto-l,2,4-triazol-3-yl) alkanes and bis (5-mercapto-
4H-l,2,4-triazol-3-yl) alkanes. They reacted aliphatic dicarboxylic acid 
with two molar equivalents of thiocarbohydrazide at the melting 
temperature for 30 minutes to yielded bis (4-amino-5-mercapto-1,2,4-
triazol-3-yl) alkanes (XXXIV a - d). 
N N N — N 
S HS"'^  N ^(CH2)n N 3 ^ 
NH2—NHCNHR>.^ I R 
H00C(CH2)nC00H 
R 
> melting point 
HN N N NH 
^ I (CH2)n I ^ 
R R 
(XXXIVa-d) (XXXVa-d) 
n = l - 4 ; R = NH2 (XXXIV a - d), R = H (XXXV a - d) 
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Compound 
(XXXIV a) 
(XXXIV b) 
(XXXIV c) 
(XXXIV d) 
IR (KBr, cm-^ ) 
3256, 3119 (N-H), 1625 
(C=N), 1230 (C=S) 
3286, 3156 (NH), 1614 
(C=N), 1246(C=S) 
3266, 3159 (NH), 1618 
(C=N), 1241 (C=S) 
3247, 3118 (NH), 1613 
(C=N), 1234 (C=S) 
'HNMR [(CD3)3SO, ppm 
13.62 (s, 2H, 2NH), 5.33 
(s, 4H, 2NH2), 4.03 (s, 
2H, CH2) 
13.62 (s, 2H, 2NH), 5.47 
(s, 4H, 2NH2), 3.07 (s, 
4H, 2CH2) 
13.51 (s, 2H, 2NH), 5.4 
(s, 4H, 2NH2), 2.71 (m, 
4H, 2CH2), 2.0 (m, 2H, 
CH2) 
13.46 (s, 2H, 2NH), 5.51 
(s, 4H, 2NH2), 2.66 (m, 
4H, 2CH2) 1.69 (m, 4H, 
2CH2) 
MS (m/z, %) 
258 (M+, 19) 
272 (M+, 100) 
286 (M+, 100) 
Bala et al.'^ have reported the synthesis of s-triazolo [3, 4-b] [1, 3, 
4] thiadiazine, s-triazolo[3, 4-b] [1,3,4] thiadiazino [6, 7-b] quinoxaline 
and s - triazino [3, 4-b] [1, 3, 4] thiadiazines. They treated 3-ethyl-4-
amino-5-mercapto-5-triazole (XXXVI) with a-haloketone and heated 
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under reflux in absolute ethanol for 6 hr, subsequent basification with 
ammonium hydroxide gave (XXXVII) in good yield. Similarly when 
(XXXVI) was condensed with chloroacetaldehyde diethylacetal and 2, 3-
dichloro quinoxaUne yielded 7H-3-substituted-s-triazolo [3, 4-b] [1, 3, 4] 
thiadiazine (XXXVIII) and 5H-3-substituted-s-triazolo [3,4 : 2',3'] [1,3, 
4] thiadiazino [5', 6'-b] quinoxaline (XXXIX) respectively. 3-Mercapto-
4-amino-6-methyl-l,2,4-triazin-5(4H)-one(XL), prepared by the reaction 
of pyruvic acid with thiocarbohydrazide followed the method of Domow 
et al.'^, when condensed with a-halo-ketones, yielded 8H-3-methyl-7-
aryl-1, 2, 4-triazino [3, 4-b] [1, 3, 4] thiadiazin-4-one (XLI). 
R 
N 
HCl 
(XXXVIII) 
H,C 
R 
R 
N 
/^^N 
.NH2 
N' -SH 
(XXXVI) 
H 
.N. 
R 
N 
(XXXVII) 
<X,IQIQ N - s " 'N 
(XXXIX) 
N "SH 
(XL) 
N^^V 
R 
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20 Golec et al. have synthesized [1,2,4] triazolo [3',4':3,2] pyrazolo 
[3, 4-d] pyrimidines and pyrimido [5', 4 ' : 4, 5] pyrazolo [3,2-c] [1, 2, 4] 
tnazmes. 
N " ^ 
NHNH2 
N 
?h^ N 
(XLI I ) 
•N 
H 
N 
Ph 
NHNH2 
N 
N 
(XLII) 
•N 
H 
N 
Me N+ 
Ph 
N " ^ 
•N' 
Triethylortho-
formate, DMF 
0 
•N 
N Ethyl aceto _ 
(XLV) 
acetate 
Ph 
// N 
(xLiii r 
R = H ; C6H4 CI - p ; 
NH C6H4 CI • p 
R 
(XLVI) X=Ac 
(XLVII) X=C02Et. 
2-Phenvl-9H [1, 2, 41 triazolo [ 3\ 4'; 3,21 prvazolo [3, 4-d1 
pvrimidine (XLIII) (R = H); 
CiaHgNe; M.P. 245 - 247. 
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IR : 3250 NH cm"' ; 
H^ - NMR : 6 9.17 and 8.85 (s, IH, 4-H, 7-H) 
Mass: 236 (M+) 
2-Phenvl-9H-ri, 2, 41 triazolo \ 3\ A'; 3, 21 pvrazolo [3, 4-d1 
pvrimidine-7 (6H)-thione (XLIV): 
CsHgNgS : Oil 
IR : 1350 (C = S), 3250 (NH) cm'' ; 
H^ - NMR : 8 10.0 (2H, br, 2xNH) and 8.92 (IH, s, 4-H) 
Mass : 268 (M+) 
7-Acetvl-4, 8-dimethvl-2-phenvl pyrimido [5", 4' : 4, 51 
pvrazolo [3,2-c1 Fl, 2,41 triazine (XLVI): 
CnHnNgO ; M.P. 270 °C. 
IR: 1700 (C = 0) 
H^ - NMR (CDCI3): 5 3.06 (3H, s, Ac) and 3.46 (6H, 4-Me, 8-Me). 
Ethyl 4, 8-dimethvl-2-phenvl pyrimido [5", 4' : 4, 51 pvra-
zolo [3,2-c1 n, 2,41 triazine-7-carboxvlate (XLVII): 
C,8H,6N6O2;M.P.210-212. 
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IR: 1730 (ester C = 0 ) 
*H - NMR : 6 1.56 (3H, t, CHzMe), 3.40 (6H, brs, 4-Me and 8-Me) and 
4.72 (2H, q, CHiMe) 
A series of chiral Schiff bases, 2,2'-bis (3-R'-5-R^-2-hydroxy-
benzylideneamino)-l-, I'-binaphthyl H2L and their complexes [ C U L ' ] - 1 
and [MniL'j (OMe)2]2 ( R ' = R^= CI) have been prepared by Chun-Wah 
Ho et al.^' 
U2V 
H2L' 
H2L' 
H2L' 
H2L** 
H2L' 
H2L* 
U2V 
10 
R' R ' ^ " ^ 
(XLVIII) 
R' 
CI 
Me 
Et 
H 
Me 
Et 
Pr* 
Bu' 
CI 
Bu* 
R^  
CI 
CI 
CI 
NO2 
NO2 
NO2 
NO2 
NO2 
NO2 
Me. 
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The compund (R)-(S)-H2L' was prepared by a one pot reaction of 
(R) or (S)-2, 2'-diamino-l, I'-binaphthyl respectively with 3, 5-dichloro-
saUcylaldehyde in absolute ethanol at room temperature. 
(S)-2, 2'-Bis (3, 5-dichloro-2-hvdroxv benzylideneamino)-!, 
l^binaphthvl (S)-HX^: 
C34H20CI4N2O2; m.p. 174 
IR : 3290 - 3650 (OH) and 1611 (C = N) 
H^ - NMR (CDCI3) : 5 7.08 [IH, d, J (H "^, H^")], 7.18 (IH, d, J 8.31 H^ 
or H^), 7.26 [IH, d, J 8.06 H^ or H^], 7.28 - 7.31 (IH, m, H^ or H^), 
7.44 - 7.50 (IH, m, H^ or H^), 7.59 [IH, d, J(H^ H'*) 8.78 H^], 8.55 (IH, 
s, CH = N) and 12.76 (lH,s, OH). 
"C - NMR (CDCI3) : 6c 116.8, 120.4, 122.4, 123.1, 126.4, 126.5, 127.3, 
128.5, 129.7, 130.5, 132.5, 132.9, 133.1, 142.8, 155.4 and 160.4 
(S) Bis (2-hvdroxv-3-isopropvl-5-nitrobenzvlideneamino)-l, 
r-binaphthvl (S)-HiL^: 
C40H34N4O6 
IR (Nujol) : 2000 - 3495 (br, OH), 1582, 1602 (C = N), 1518 and 1333 
(NO2) cm"' 
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^H - NMR (CDCI3) : 5 1.08 (6H, m, CH(CH3)2), 3.06 [IH, m, 
CH(CH3)2], 7.26 - 7.52 [3H, m), 7.67 [IH, d, J(H^ H^) 8.58 H'*], 7.99 -
8.01 (2H, m, H^" and H^ or H^) 8.06 [IH, d, J (H^", H^") 2.75 H^"], 8.15 
[IH, d, J (H^ H'*) 8.85 Hz H^], 8.74 (IH, s, CH = N) and 13.56 (IH, s, 
OH). 
*^ C - NMR (CDCI3) : 8c 21.7 [CH(CH3)2, 26.7 [CH(CH3)2], 116.4, 
117.4, 124.6, 125.8, 126.4, 126.5, 127.5, 128.4, 129.8, 130.5, 133.1, 
133.2, 138.2, 139.5, 142.2, 160.4 and 164.4 
Maurya et al. described the synthesis of some cis-
dioxomolybdenum (VI) complexes of bidentate and tetradentate Schiff 
bases derived from 3-methyl-l-phenyl-4-propionyl-2-pyrazolin-5-one 
and certain aromatic amines. The Schiff bases were synthesised by 
refluxing ethanolic solution of the appropriate aromatic amine and 3-
methyl-l-phenyl-4-propionyl-2-pyrazolin-5-one over a hot plate at 80°C 
for 5h. The resulting precipitate was filtered by suction and washed 
several times with ethanol and dried in vacuo. 
H3C ^^Hs ^—^ _x 
N' 
n\ 
(XLIX) 
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X = OCHa (0) 
X = OCH3 (m) 
X = 0CH3(E) 
X = OC2H5 (0) 
X = OC2H5 (E) 
C2H5 C2H5 
R = C6H4 (0) (La) 
R = C6H4 (m) (Lb) 
R = C6H4 (E) (Lc) 
R = H4C6-C6-H4 (Ld) 
5-Cholesten-3P-0-acetic acid hydrazide (LI) on condensation 
with aromatic aldehydes (benzaldehyde, p-nitrobenzaldehyde, p-
chlorobenzaldehyde and p-methoxybenzaldehyde) in presence of 
piperidine furnished 5-cholesten-3P-0-acetic acid benzylidenehydrazide 
(LII a), 5-cholesten-3[3-0-acetic acid p-nitrobenzylidenehydrazide (LII 
b), 5-cholesten-3P-0-acetic acid p-chlorobenzylidenehydrazide (LII c) 
and 5-cholesten-3P-0-acetic acid p-methyoxybenzilidenehydrazide (LII 
df. 
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CH2—C0NHNH2 
(LI) 
Llla 
Lllb 
LIIc 
Llld 
R 
H 
NO2 
CI 
OCH3 
The IR spectrum of these Schiff base (LII a - d) showed 
characteristic absorption bands around 3218 (NH), 1645 (-CO-NH), 
1630 (C = N) 1600 - 1450 (C = C, aromatic) and 1140 cm"' (C-O-C). 
^H-NMR spectrum of (LII a) showed a broad peak at 6 8.5 assigned to 
IH of NH, aromatic protons were appeared as multipet at 5 7.2 - 7.4, 
benzylic proton was appeared as singlet at 5 6.1, two multiplets one at 5 
5.4 and other at 5 4.6 were assigned to vinylic proton at Cg and aH at C3, 
a singlet at 5 4.8 ascribed to 2H of O-CH2-CO-. 
Xioming et al.^ '* reported the synthesis and SHG activity of chiral 
Schiff base derivatives. 
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Me 
I 
OCH2 CH CH2 Me 
(LIII) 
Chiral Schiff bases (LIII R ' = H , CI, N02, OH, CH2O, NME2; 
r=cH2 , NO2) were synthesized by the condensation of chiral aromatic 
amine with aromatic aldehydes. They also examined the second 
harmonic generation (SHG) of LIII by solid powder method. 
Tai-Xing and co-worker have established a facile method for the 
synthesis of Schiff base 4-amino-5-hydrocarbon-2,4-dihydro-3H-1,2,4-
triazole-3-thione using acetic acid as solvent and catalyst. 
(LIV) R 
R=CH3, Et, C6H5,4-C1 C6H4,3,4,5-(Me 0)3 CeHj. 
R^=4-CI, 2CI, 4-Br, 4-NMe2, O Me, 5-CI3-NO2; R^=H, OH. 
Azomethines (LVI) were synthesized by Mironowich^^, by the 
reaction of nitroso thioxo-1, 2, 4-triazinones (LV) with acetyl acetone 
and Et aceto acetate . 
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ONN Acetyl acetone 
and Et aceto acetate 
O 
Me—^ 
R C = N N 
O 
R 
O S 
(LVI) 
N' 
H 
.N 
R= Ph, CMea R= ph R^=Me, EtO, 
R=CMe3, R^=EtO. 
Zuocai and Ligong^' given the synthesis of LVII & LVIII from 3-
aminophenol and 1-amino naphthalene-7-sulfonic acid respectively. 
O-CH2-CH2-CH2—CH2—0 
(LVII) 
^^^^^ 
•N=CH 
.OH 
' ^ ^ ^ 
OH 
// V_CH= 
OCH2-CH2-CH.-CH2O 
(LVIII) 
HO. 
N=CH- / \ 
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28 Metri et al. reported the synthesis and biological activity of p-bis 
(4-amino-5-mercapto-l, 2, 4-triazole-3-yl) benzene and its Schiff bases 
from diamines and salicyldehyde. 
R=H, CI, Me, OMe. 
(LIX) 
-29 Deshmukh and co-worker reported the synthesis and 
antimicrobial activity of Schiff bases. 
R^  = Br, NO2, R^ R^ = H, Me; R^* = H, NO2 
(LX) 
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Schiff bases (LX) were prepared by the condensation of 2-
hydroxy-3-nitro-5-methyl acetophenone and 2-hydroxy-3-bromo-5-
methyl acetophenone with aniline, o-nitro aniline p and m toluedine in 
ethanol in presence of 2-3 drop of cone. Hj S04. 
Interaction of 4-amino-2, 3-dimethyl-l-phenyl-3-pyrazolin-5-one 
(amino antipyrine) with 2-furan carboxaldehyde and 5-nitro-2-furan 
carboxaldehyde yielded new Schiff bases (LXI; R=H, N02)^°. 
/ / V y Me 
J^ NMe 
R =H, NO2 
(LXI) 
Ph 
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In a continuing effort towards the synthesis of modified steroids 
which are expected to be biologically active, here we have described the 
synthesis of steroidal 4'-amino-5'-mercapto-r, 2', 4'-triazoles and their 
Schiff bases. 
1, 2, 4-triazoles constitute a class of compounds associated with 
widespread industrial uses, as evident from more then thousand patents, 
covering the preparation and uses. Here we have discussed briefly some 
important derivatives and their applications. 3-Amino-l, 2, 4-triazole 
was the first 1, 2, 4-triazole to be manufactured on a large scale from 
amino guanidine formate for the use as a neutral herbicide and 
defoliant of cotton. Aminotriazole has been shown to give protection to 
mice against irradiation with X-rays. Aminotriazole in low concentration 
may promote growth where as bistriazole (LXII) prepared from triazole 
and dichlorodiphenyl methane has opposite effect. 
[ ^N—CPh2-N I 
(LXII) 
4-Butyltriazole is a fungicide but injures seedling, such damage is 
avoided if used as complex (LXIII)''^  
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Bu 
,CS. N 
^ \\ /I 
-CS2 N - N 
(LXIII) 
Newer herbicides include triazolidinonethiones with aromatic and 
lower aliphatic substituents, compounds with similar nature are 
insecticides, acaricides and nematicides '^*'^ .^ Many alkyl and aryl 
derivatives of mercaptotriazole are active against fungi and other 
bacteria '^^ . Simple 1,2,4-triazoles display biological activity such as 
inhibition of cholinesterase , mterference with mitosis and reversible 
39 denaturation of serum protems . 
Many dyes and whitening agents have been successfully modified 
by incorporation of triazolium salts into their structure . A combination 
of 1, 2, 4-triazole and dimethyl sulfide gold (I) chloride can be used to 
gild glass"**^ . 
The preparation of polymers derived from 1, 2, 4-triazoles is the 
most important practical application of this heterocyclic system^^ ''*'"'* .^ 
Polyaminotriazoles have been used to improve antistatic, dyeing and 
laundering properties of polyalkene fibres, also as toners in 
electrophotography and to protect metals against corrosion. 
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As far as the synthetic methods are concerned, Hoggarth'° method 
is considered to be as classical and efficient procedure for the synthesis 
of 5-substituted-4-amino-3-mercapto-(4H)-l, 2, 4-triazoles. In late 70s 
Heindel^ established an improved method for the synthesis of triazoles 
having slight advantages over classical Hoggarth method. We have 
planed our synthesis of steroidal triazoles according to Heidel method 
but did not succeed. 
SCHEME 
CH2-C00Et 
(LXIV) 
(LXVI) 
CH2-CONHNH2 
CgHiv (LXV) 
(LXVII) 
8^17 
Failure of this scheme prompted us to search out an alternate 
method which led us to the idea of direct reaction of ester with 
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thiocarbohydrazide (TCH), though first few attempts met with failure but 
finally we succeeded. Very recently Peng-Fie et al.''' reported the one 
step synthesis of bis (4-amino-5-mercapto-l, 2, 4-triazole-3-yl) alkene 
by direct reaction of thiocarbohydrazide with aliphatic dicarboxyUc 
acids. 
Reaction of ethvl-5-cholestan-33-0-acetate (LXIV) with 
thiocarbohydrazide (TCH): 
Ethyl-5-cholesten-3P-0-acetate (LXIV) (200mg) was dissolved in 
absolute ethanol (30ml) then equimolar amount of thiocarbohydrazide 
(TCH) was added to it followed by addition of few drops of acetic acid. 
The reaction mixture was then heated on water bath for 8 hrs. The 
reaction mixture was poured in water and the crude product thus 
obtained was taken in ether and washed successively with water, dried 
over anhydrous sodium sulphate. Evaporation of the solvent afforded an 
oil which was chromatographed over siUca gel column. Elution with 
petroleum ether: ether yielded three compounds, unreacted ethyl-5-
cholesten-3p-0-acetate (LXIV), 3p-(4'-amino-5'-mercapto-r,2',4'-tri-
azole-3'-methoxy)cholest-5-ene (LXVII) and 5-cholestene-3P-ol 
(LXVIII). 
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/ 
CH2—COOC2H5 
(LXIV) 
C«H 8^17 
Abs.EtOH.A N N O 
CH2 
HS N' 
I , 
NH2 + 
(LXVII) CgHn 
(LXVIII) 
Characterization of the compound m.p.l58° as 3B-(4'-amino, 5^ -
C«H 8^17 
mercapto-l\2\4'-triazole-3'-methoxv)cholest-5-ene (LXVII): 
The elemental analysis of the compound m.p.l58 corresponded to 
the molecular formula C30H50N4OS. The IR spectrum of the compound 
exhibited bands at 3310, 3180 (-NH2), 2650 (SH), 1626(C=N), 1325(C-
N), 1120(C-O) where as peaks at 1740 and 1210 cm"' which were 
assigned to (C=0) and (C-0) of (CO - 0 - C2H5) disappeared. Thus 
these spectral value strongly suggest the presence of 4'-amino, 5'-
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mercapto-r,2\4''-triazole moiety which was further supported by 
*H-NMR, '^C-NMR and mass spectral studies. The ' H - N M R displayed 
a double at 6 5.35 (J = 8.3 Hz) assigned to vinylic protons at C6, two 
singlet appeared, one at 5 4.8 for NH2 protons and 4.4 for O-CH2-
protons attached to 3' carbon. C3 - aH appeared as a multiplet centred at 
3.5. Multiplet at 6 2.29 was assigned to 4H of C4 and C7. Methyl protons 
were observed at 1.0 (Cio - CH3), 0.69 (C,3 - CH3) and 0.92 and 0.85 for 
other side chain methyl protons. '^ C - NMR gave expected peaks at 6c 
160, 156, 145, 141, 121, 78,75,72, 58, 56, 49.6, 42, 40, 39, 37, 35, 32, 
28,24,23,20, 19, 18, 11.5. 
Mass spectral study also supported the proposed structure. Mass 
spectrum gave the molecular ion peak at m/z 514 [M+] followed by 
other significant fragment ion peaks at m/z 386 (base peak), 368, 300, 
275, 255, 213, 131 etc. A tentative mechanism for the formation of these 
fragment ion peaks is shown below. 
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N-N ?i? 
I 
NH2 
N N 
'/ W 
m/z 514 [M+] 
HS , ^N- CH3 
I 
NH2 
m/z 131 
m/z 275 
m/z 386 
CsH 8J^17 
CRH 
CsHn 
m/z 368 
m/z 255 m/z 353 
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CsHp 
CgH 
N - N I \ 
HS- ^N 
I 
NH2 
17 
nVz 301 [M+iJ 
N-N 
11 \\ 
1 
NH2 
nVz 147 [M 
0 
II 
"CH 
t + 1] 
Characterization of the compound m.p. 148° as 5-cholest-
ene-3B-ol (LXVIII); 
The elemental analysis of the compound corresponded to the 
molecular formula as C27H45OH having m.p. 148°. It's IR spectrum 
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exhibited bands at 3480 (OH), 1050 cm'' (C-0). ' H - N M R spectrum 
display multiplet at 6 3.4 which was assigned to C3 - aH, broad singlet at 
1.8 for OH proton, vinylic protons at C6 appeared at 8 5.5. Methyl 
protons were observed at 5 1.2 (C10-CH3) and 0.79 (C13-CH3) and 0.82 
and 0.92 for other side chain protons. Mass spectrum displayed base 
peak at 386 (M+ molecular ion), 368 (M + - OH) other notable peaks 
were 353, 326, 327, 300, 287, 275, 261, 255. 
Reaction of 3(3 (4"-amino-5"-mercapto-l\ 2 \ 4"-triazole-3'-
methoxy) cholest-5-ene (LXVII) with benzaldehyde in 
presence of p-toluene sulfonic acid (few crystals): 
3P(4'-Amino-5'-mercapto-r, 2\ 4'-triazole-3'methoxy) cholest-
5-ene (200 mg) was taken in dry benzene (10 ml), benzaldehyde 0.2 ml 
and few crystals of p-toluene sulfonic acid were added to it. The reaction 
mixture was then heated under reflux. The progress of the reaction was 
monitored through TLC. After the completion of reaction, the excess of 
solvent was removed under reduce pressure, the oil thus obtained was 
taken in ether and washed thoroughly with water and dried over 
anhydrous sodium sulphate. Evaporation of ether afforded an oil which 
was chromatographed over a silica gel column. Elution with petroleum 
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ether-ether (9:1) gave 3(3 [(4'-imino benzylidine)-5'-mercapto-r, 2', 4'-
triazole-3'-methoxy] cholest-5-ene (LXIX) M.P. 112 - 114, Yield 120 
mg 
HS 
N - N 
N 
I 
NH2 
(LXVII) 
CsHjT 
Benzaldehyde 
PTSA,benzene, A 
HS 
N - N O 
N 
N:CH-
(LXIX) 
/ / \ 
CRH 8^17 
Characterization of the compound m.p. 114° 33r(4'-imino 
benzylidine) 5'-mercapto-l\ 1\ 4'-triazoIe-3'-methoxv1 cho-
lest-5-ene (LXIX): 
The elemental analysis of the compound m.p. 114° corresponded 
to the molecular formula C37H54N4OS. The IR spectrum of the 
compound exhibited bands at 3030 (=C-H), 2650 (SH), 1635, 1620 
(C=N), 1600 (C=C, aromatic), 1330 (C-N) and 1110 cm"' (C-0). These 
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value unambiguously supported the proposed structure which was 
further confirmed by ' H - N M R and mass spectral data. The *H-NMR 
spectrum displayed expected peaks. The aromatic protons were appeared 
as multiplet at 5 7.5 - 8.0, benzylic proton was appeared at 6.4, vinylic 
proton at C6 appeared as doublet at 5.4 (d, J = 7 Hz,lH) a multiplet at 
2.5 was assigned to four hydrogens at C4 and CI. Methyl protons were 
appeared at 1.2 (C|o - CH3) 0.79 (C13-CH3), 0.95 and 0.85 (for other side 
chain methyl protons). Mass spectrum gave molecular ion peak at m/z 
604 (M +), other notable peaks include, 575, 560, 542, 458, 353, base 
peak obtained at 386 arised by the loss of bulky group at C3. The 
formation of these fragment ions can be explained as follows : 
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m/z 604 [U ] 
m/z 575 
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N - N 
I 
N - « -
CH 
m/z218 
H I 
nVz386 
n 
N - N ? 
I 
N 
CH 
m/z 604 [M ] 
CgHn 
CgH 17 
"^8" '7 ^ nV2 273 
CgHn 
Hisf 
CH 
nVz 105 
m/z 369 
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Reaction of 3B (4'-amino-5'-mercapto-l', 2\ 4'-triazole-3'-
methoxy) cholest-5-ene (LXVII) with p-toluene benzalde-
hyde in presence of p-toluene sulfonic add (few crystals): 
3p(4'-Amino-5'-mercapto-r, 2', 4'-triazole-3'-methoxy) cholest-
5-ene (200 mg) was dissolved in dry benzene (10 ml), aldehyde 0.22 ml 
and few crystal of p-toluene sulfonic acid were added to it. The reaction 
mixture was then heated under reflux. After the completion of reaction, 
excess of the solvent was removed under reduced pressure, the oily 
substance thus obtained was taken in ether and washed with water 
thoroughly. Evaporation of solvent afforded an oil which was run over 
silica gel column. Elution with petroleum ether-ether yielded 3P-[4'-
imino-p-toluedyl) S'-mercapto-T, 2', 4'-triazole-3' methoxy]-cholest-5-
ene (LXX). M.P. 172°, Yield 135 mg. 
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(LXVII) 
CsHn 
(LXX) 
8^17 
Characterization of the compound as 33r(4'-imino-p-
toluedvl) 5'-mercapto-l\ 1\ 4'-triazole-3'-methoxy1 chole-
st-5-ene (LXX): 
The elemental analysis of the compound m.p 172° corresponded 
to the molecular formula C38H56N4OS. The IR spectrum of the 
compound exhibited bands at 3030 (= CH), 2660 (SH), 1635 and 1620 
(C=N), 1600 (C=C, aromatic), 1325 (C-N), 1110 cm"' (C-0) and. The 
' H - N M R spectrum exhibited a multiplet at 7.5 - 8.0 assigned to aromatic 
protons, benzylic proton was appeared at 7.2, vinylic proton at 5 5.2 as 
doublet, J = 8, IH, C6, a multiplet at 5 3.3 ascribed to aH of C3, another 
multiplet integrated for four hydrogens was assigned to hydrogens C4 
and C7, singlet at 5 2.2 was assigned to methyl protons of toluene. 
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Methyl protons were appeared at 1.2 (C10-CH3), 0.71 (C13-CH3), 0.92 
and 0.85 (for other side chain methyl protons). The mass spectrum gave 
molecular ion peak at 618 (M"^ ) besides other fragment ion peaks. Base 
peak is again obtained at 369 arising by the loss of CnHiiN40S attached 
at C3. A tentative mechanism is given for the formation of these 
fragment ions. 
N-N 
N 
I 
N 
CH3 
CH 
CH3 
m/z232 
N-N I 
I 
N 
CH 
CH3 
m/z 618 [Nt] 
Cs^n 
•• m/z 368 
'^  m/z 386 CgHn 
m/z 369 
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Reaction of 33-(4'-amino-5'-mercapto-l', 1\ 4'-triazole-3'-
methoxy) cholest-5-ene (LXVII) with p-methoxy benzal-
dehyde in presence of catalytic amount of p-toluene 
sulfonic acid: 
3|3-(4'-Amino-5'-mercapto-r, 2', 4'-triazole-3'-methoxy) cholest-
5-ene (200 mg) was dissolved in dry benzene (10 ml), aldehhyde (0.2 
ml) and few crystals of p-toluene sulfonic acid were added to it. The 
reaction mixture was then heated under reflux untill the reaction is 
completed. The excess of solvent was removed under reduced pressure, 
the oily material thus obtained was taken in ether and washed thoroughly 
with water and dried (anhydrous sodium sulphate). The crude product 
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thus obtained on purification over silica gel column afforded 3P-[(4'-
imino-p-methoxy benzylidene) 5'-mercapto-l', 2', 4'-triazole-3'-meth-
oxy] cholesi-5-ene (LXXI) as solid m.p. 180°, Yield 135 mg. 
N - N 
'I V 
I 
NH2 
CH2-O 
(LXVII) 
C8H,7 
(LXXI) 
Characterization of the compound m.p. 180° 3B r(4'-imino-
p-methoxv benzylidine) 5'-mercapto-l\ 2\ 4'-triazole-3'-
methoxy] choIest-5-ene (LXXI): 
The elemental analysis of the compound corresponded to the 
molecular formula C38H56N4O2S. The IR spectrum showed bands at 3030 
(=C-H), 2660 (SH), 1635, 1625 (C=N), 1610 (C=C), 1325 (C-N) and 
1105 (C-O)cm''. The ' H - N M R spectrum displayed a multiplet at 5 7.0 -
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7.5 for aromatic protons benzylic protons was appeared at 6.9, a doublet 
at 5.3 assigned to vinylic proton at C6, a singlet at 3.7 was assigned to 
methyl protons of OCH3, multiplet centred at 3.3 corresponded to 
C3 - aH. Methyl protons were observed at 6 1.2 (Cio - CH3) 0.79 
(Ci3 - CH3), 0.92 and 0.85 for other side chain methyl protons. Mass 
spectrum gave molecular ion peak at m/z 634 (M +) besides other useful 
fragment ion peaks. Base peak obtained at 369 by the loss of 
C„HnN402S. 
A tentative mechanism is suggested for the formation of various 
fragment ion peaks. 
N-N 
W 
I 
N 
-CH3 
CH N-N 
HN 
CH 
^ 
OCH3 
m/z 248 
HS' ^N 
I 
N 
II 
CH 
OCH3 
m/z 135 
OCH3 
m/z 634 
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CRH 
N - N I 
I 
N 
II 
CH 
OCH3 
8^17 
-H2O/ "^ z 386 
m/z 368 
m/z 275 
Reaction of 33-(4'-amino-5'-mercapto-l\ 1\ 4^-triazole-3'-
methoxy) cholest-5-ene (LXVII) with p-nitro benzal-
dehyda in presence of catalytic amount of p-toluene 
sulfonic acid : 
3P-(4'-amino-5'-mercapto-r, 2', 4'-triazole-3'-methoxy) cholest-
5-ene (200 mg) was dissolved in dry benzene (10 ml) then p-
nitrobenzaldehyde (0.2 gm) and few crystals of p-toluene sulfonic acid 
were added to it. The reaction mixture was heated under reflux for four 
hours. The excess of solvent was removed under reduced pressure, the 
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oily material thus obtained was taken in ether and washed thoroughly 
with water and dried over anhydrous sodium sulphate. The crude product 
on purification over silica gel column afforded 3P-[(4'-imino-p-nitro-
benzylidine)-5'-mercapto-r, 2', 4'-triazole-3'-methoxy] cholest-5-ene as 
solid m.p 250°, Yield 145 mg. 
N - N 
(/ V 
HS" ^ N 
I 
NH2 
CH2-O 
(LXVII) 
(LXXII) 
Characterization of the compound m.p 250° 33r(4 -^imino-
p-nitro benzylidine) 5'-mercapto-l\ 2\ 4'-triazole-3'-meth-
8^17 
oxvl cholest-5-ene (LXXII): 
The elemental analysis of the compound corresponded to the 
molecular formula C37H53N5O3S. The IR spectrum of the compound 
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exhibited bands at 3030 (=C-H), 2660 (SH), 1630, 1620 (C=N), 1610 
(C=C, aromatic), 1320 (C-N) and 1110 (C-0). The ' H - N M R spectrum 
gave a multiplet centred at 7.0-7.5 for aromatic protons, 6.9 (benzylic 
proton) vinylic proton at C6 appeared at 5 5.3, C3 - aH appeared as 
multiplet at 8 3.3, a doublet at 8 2.3 integrated for four hydrogens was 
assigned to 4H of C4 and C7. Methyl protons were observed at 1.2 (Cjo-
CH3), 0.79 (C13-CH3), 0.91 and 0.84 for other side chain methyl protons. 
Mass spectrum gave molecular ion peak at 647 (M+) besides other 
useful fragment ion peaks 498, 301, 263, 149 etc. Base peak obtained at 
369 by the loss of C10H8N5O3S attached at C3. A tentative mechanism for 
the formation of various fragment ion peaks was shown below : 
186 
II m/z 647 [M+] 
CH 
NO2 
CgHn 
nVz369 
0 ' N - N ^T HN 
HS-" "N 
N 
II 
CH 
m/z 647 
NO, 
CgHi? 
N-N 
1 L 
I 
N 
CH 
NO2 
m/z 263 
187 

188 
All the melting points were observed on Kofler hot block and are 
uncorrected. IR spectra were determined in KBr with a Pye - Unicam 
SP3 - 100 spectrophotometer and its value are given in cm"' ' H - N M R 
spectra were run in CDCI3 on a Bruker Ac 300 (300 mHz) with 
tetramethyl silane (TMS) as standard and its values are given in ppm (5). 
Mass spectra were measured on VG micromas model ZAB-IF apparatus 
at 70 eV ionization voltage. Thin layer chromatographic plates (TLC) 
were coated with silica gel. Silica gel (~ 20 g) was used for each gram of 
material to be seperated in coloumn chromatography. Petroleum ether 
refers to a fraction of b.p. 60 - 80°. Sodium sulphate (anhydrous) was 
used as drying agent. The abbreviations denote s, singlet, br, broad and 
mc, multiplet centered at. 
Ethyl 5-cholesten-3B-o-acetate (LXIV): 
Cholesterol (LXVIII) (Ig) was refluxed with potassium metal 
(0.6g) in benzene (30ml) for one hour. After cooling ethylchloroacetate 
(5 ml) was added and mixture was further refluxed for 3 hrs then cooled 
and few drops of methanol were added to destroy unreacted potassium 
metal. There after excess of solvent was removed by distillation under 
reduced pressure and residual solution was poured into water and 
extracted with ether. The ether extract was washed with water and dried 
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over anhydrous sodium sulphate. Removal of the solvent yielded an oil 
which was crystallized from ethanol to obtain ethyl-5-cholesten-3P-o-
acetate (LXIV), yield (0.7 g). It was TLC homogeneous in benzene and 
one drop of acetone m.p.l45 . 
Reaction of ethvI-5-cholesten-3(3-o-acetate (LXIV) with thio 
carbohydrazide: 3B(4'-amino-5'-mercapto-l\ 1\ 4 -^tri-azol-
3'-methoxy)cholest-5-ene(LXVII) and cholesteroI(LXVIII): 
Ethyl-5-cholesten-3|3-o-acetate (LXIV) (200mg) was dissolved in 
absolute ethanol (30ml) then equimolar amount of thiocarbohydazide 
was added to it followed by addition of few drops of acetic acid. The 
reaction mixture was heated on water bath for 8 hrs. The reaction 
mixture was then poured in water and the crude product thus obtained 
was taken in ether and washed successively with water, dried over 
anhydrous sodium sulphate. Evaporation of solvent afforded an oil 
which was chromatographed over silica gel column. Elution with 
petroleum ether-ether (9:1) afforded 3(3 (4'-amino-5'-mercapto-r, 2', 4'-
triazol-3'-methoxy) cholest-5-ene (LXVII) yield (100 mg) m.p.l58°. 
Analysis found : C, 70.12; H, 9.82; N, 10.75. 
C30H50N4OS requires : C, 70.03; H, 9.72; N, 10.89. 
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IR: Vniax 3310, 3180 (NHj), 2650 (SH), 1626 (C=N), 1325 (C-N), 1120 
(C-0). 
^H - NMR: 5 5.35 (d, J = 8.3 Hz, IH, Cg-H); 4.4 (s, 2H, O-CH2) 4.8 (s, 
2H, NH2); 3.5 (m, Ca-a-H); 2.29 (m, 4H, C4 & C7); 1.0 (C10-CH3), 0.69 
(C13-CH3), 0.92 and 0.85 (other chain methyl protons). 
'^C-NMR: 6c 160, 156, 145, 141, 121. 
MS : m/z 514 [M +], 386, 368, 353, 300, 275, 255, 213 etc. 
Further elution with petroleum ether-ether (8:2) afforded cholesterol 
(LXVIII) (50 mg) m.p. 148 °C. 
Analysis found : C, 83.92; H, 12.94 
C27H46O requires : C, 83.95; H, 12.91 
IR : Vmax 3480 (OH), 1050 (C-0) 
' H - N M R : 6 5.5 (d, IH, Cg); 3.4 (m, Cs-aH), 1.8 (s, OH), 1.2 
(C10-CH3); 0.79 (C13-CH3) 0.82 and 0.92 (for other side chain methyl 
protons). 
MS : 386 [M +], 368, 353, 326, 327, 300, 287, 275, 261. 
Reaction of 3B-(4'-ammo-5'-mercapto-l\2',4'-triazol-3'-
methoxv) cholest-5-ene (LXVII) with benzaldehvde : 33-
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r(4'-Iminobenzvlidine)-5'-mercapto-l\2\4'-triazol-3'-meth-
oxvl cholest-5-ene (LXIX): 
3p-(4'-Amino-5'-mercapto-r, 2', 4'-triazol-3'-methoxy) cholest-
5-ene (LXVII) (200 mg) was taken in dry benzene (10 ml), 
benzaldehyde (0.2 ml) and few crystals of p-toluenesulfonic acid were 
added to it. The reaction mixture was then heated under reflux. The 
progress of the reaction was monitored through TLC. After the 
completion of reaction, the excess of solvent was removed by 
evaporating under reduced pressure, the oil thus obtained was taken in 
ether and washed thoroughly with water and dried over anhydrous 
sodium sulphate. Evaporation of the solvent yielded an oil which was 
chromatographed over silica gel column. Elution with petroleum ether -
ether (9 : 1) give 3P-(4'-imino benzylidine) S'-mercapto-T, 1\ 4'-triazol-
3'-methoxy) cholest-5-ene (LXIX) yield (120 mg) m.p. 112-114°. 
Analysis found : C, 73.65; H, 8.85; N, 10.77 
C37H54N4OS requires : C, 73.75; H, 8.9; N, 10.75 %. 
IR (KBr) : v^ ax 3030 (=C-H), 2650 (SH), 1635, 1620 (C=N), 
1600 (C=C), 1330 (C-N) and 1110 cm'' (C - 0). 
^H - NMR (CDCI3) : 8 7.5 - 8.0 (m, aromatic hydrogens), 6.4 (s, 
IH, benzyhc proton), 5.4 (d, J = 7 Hz, IH, Cg-H), 2.5 (m, 4H, C4 and 
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C-JI 1.2 (C10-CH3), 0.79 (C13-CH3), 0.95 and 0.85 (for other side chain 
methyl protons). 
MS : m/z 604 (M +), 574, 560, 542, 458, 353, 368 (base peak) 
Reaction of 3B-r4'-amino-5'-mercapto-l\ 2' 4'-triazol-3'-
methoxvl cholest-5-ene (LXVII) with p-toluene benzal-
dehyde in presence of catalytic amount of p-toluene 
sulfonic acid : 3B r(4'-Imino toluedyl)-5'-mercapto-l\ 2\ 4'-
triazol-3'-methoxy1 cholest-5-ene (LXX): 
3P-(4'-Amino-5'-mercapto-r, 2', 4'-triazol-3'-methoxy) cholest-
5-ene (200 mg) was dissolved in dry benzene (10 ml), p-toluene 
benzaldehyde (0.22 ml) and few crystals of p-toluene sulfonic acid were 
then added to it. The reaction mixture was heated under reflux. After the 
completion of reaction the excess of solvent was removed under reduced 
pressure, the oily substance thus obtained was taken in ether and washed 
thoroughly with water. Evaporation of the solvent yielded an oil which 
was chromatographed over siHca gel column, elution with petroleum 
ether - ether (9:1) afforded 3|3 [(4'-imino toluedyl)-5'-mercapto-r, 2', 
4'-triazol-3'-methoxy] cholest-5-ene (LXX) yield (135 mg) m.p. 172°. 
Analysis found : C, 73.75; H, 9.12; N, 9.05 
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C38H56N4OS requires : C, 74.02; H, 9.09; N, 9.02 
IR(KBr) : v^ ax 3030 (= C - H), 2660 (SH), 1620, 1635 
(C = N), 1600 (C = C, aromatic), 1325 (C - N) and 1110 cm"' (C - 0). 
H^ - NMR (CDCI3) : 8 7.5 - 8 (aromatic), 7.2 (IH, benzylic), 5.2 
(d, J = 8 Hz, IH, C6 - H), 3.3 (m, IH, C3 - aH), 2.3 (br, 4H, C4 and C7), 
2.2 (s, 3H, CH3), 1.2 (Cio - CH3), 0.71 {C^^ - CH3), 0.92 and 0.85 (for 
other side chain methyl protons). 
MS : m/z 620 [M +], 600, 585, 483, 470, 369 (base peak), 335, 
320, 300, 280. 
Reaction of 33 (4'-amino-5'-mercapto-l\ 2\ 4'-triazol-3'-
methoxy) choIest-5-ene (LXVII) with p-methoxy benzal-
dehyde in presence of p-toluene sulfonic acid: 33r(4'-Imino-
p-methoxy benzylidine) 5'-mercapto-l\ 2\ 4^-triazol-3'-
methoxy] cholest-5-ene (LXXI): 
3(3 (4'-Amino-5'-mercapto-r, 2', 4'-triazol-3'-methoxy) cholest-5-
ene (200 mg) was dissolved in dry benzene (10 ml), p-methoxy 
benzaldehyde (0.21 ml) and few crystals of p-toluene sulfonic acid were 
added to it. The reaction mixture was then heated under reflux. After the 
completion of reaction, the excess of the solvent was removed under 
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reduced pressure. The oily substance thus obtained was taken in ether 
and washed thoroughly with water and dried over anhydrous sodium 
sulphate. Evaporation of the solvent yielded an oily substance which was 
chromatographed over silica gel column. Elution with petroleum ether-
ether (9:1) gave 3(3 [4'-imino-p-methoxy benzylidine) 5'mercapto-r, 2', 
4'-triazol-3'-methoxy] cholest-5-ene (LXXI) yield (135 mg) m.p. 180°. 
Analysis found : C, 72.11; H, 8.77; N, 8.81 
C38H56N4O2S requires : C, 72.15; H, 8.86; N, 8.86 %. 
IR(KBr) : V^ a^x 3030 (=CH), 2660 (SH), 1635, 1625 (C=N), 
1610 (C=C), 1325 (C-N), 1105 (C-0). 
' H - NMR (CDCI3) : 5 7.0 - 7.5 (m, aromatic), 6.9 (benzylic 
proton), 5.3 (d, IH, Vinylic, Cg - H), 3.7 (s, 3H, OCH3); 3.3 (m, IH, 
Csa - H), 1.2 (C,o- CH3), 0.79 (C,3- CH3), 0.92 and 0.85 (for other side 
chain methyl protons). 
MS : m/z 632 (M +). 
Reaction of 3B(4'-amino-5'-niercapto-l\ 1\ 4'-triazol-3'-
methoxy) cholest-5-ene (LXVII) with p-nitrobenzaldehyde 
in presence of p-toluene sulfonic add: 33r(4'-Imino-p-
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nitrobenzylidine) 5^-mercapto-l\ 1\ 4'-triazol-3'-methoxv1 
cholest-5-ene (LXXII); 
3p(4'-Amino-5'-mercapto-r, 2', 4'-triazol-3'-methoxy) cholest-5-
ene (200 mg) was dissolved in dry benzene (10 ml), p-nitrobenzaldehyde 
(0.21 g) and few crystals of p-toluene sulfonic acid were added to it. The 
reaction mixture was heated under reflux for four hours. The excess of 
the solvent was removed under reduced pressure, the oily residue thus 
obtained was taken in ether and washed thoroughly with water and dried 
(anhydrous sodium suphate). The crude product obtained by evaporating 
solvent was chromatographed over silica gel column. Elution with 
petroleum ether - ether (9:1) gave 3P[(4'-imino-p-nitrobenzylidine)-5'-
mercapto-l', 2', 4'-triazol-3'-methoxy] cholest-5-ene (LXXII) as solid 
yield (120 mg)m.p. 250°. 
Analysis found : C, 68.59; H, 8.11; N, 10.80 
C37H53N5O3S requires : C, 68.63; H, 8.19; N, 10.81 
IR (KBr) : v a^x 3030 (= C - H), 2660 (SH), 1630, 1620 (C=N), 
1610 (C = C, aromatic), 1320 (C - N) and 1110 (C - O),. 
^H-NMR(CDCL3): 5 7.0 - 7.5 (m, aromatic protons), 6.9 
(benzylic proton), 5.3 (d, IH, Vinylic, Cg - H), 3.3 (m, C3 .aH), 2.3 (m, 
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4H, C4 and C7), 1.2 (Cjo - CH3), 0.79 (C13 - CH3) 0.91 and 0.84 (for side 
chain methyl protons). 
MS : m/z 647 (M +). 
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Chapter Four 
Application ofX-Ray 
Studies in Structure 
Elucidation of Steroidal 
Compounds 
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Over the 80 years since the first discovery of the diffraction of 
X - rays by crystals, crystallography has grown into a very precise, 
widely applicable and definitive tool. The undoubted success of this 
conventional crystallography (crystal structural determination) is due to 
very large extent, to the fact that the same basic method may be applied 
to material as diverse as a simple salt which contains only a few atom 
per cell to macromolecular crystals which may contain thousand of 
atoms per cell. The assumption in all case is that the crystal consists of a 
three dimensional array of identical units and this gives rise to a 
diffraction pattern consisting of discrete diffraction peaks (called Bragg 
reflection). 
A survey of literature on crystallographic studies of organic 
compounds reveals the utility and versatility of this widely applicable 
technique as evident from some examples we have discussed below. 
R. W. Schevitz and M. G. Rossamann^ established confirmed 
configuration of the new isomer (+)-cis-carvone tribromide (I) by X-ray 
crystallographic analysis. 
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Br CH3 
Br 
y 
—c— 
CH3 
CH3 
(I) 
© o O 
O C Br 
Flg-1 x-ray crystal structure of (+)-cis-carvone t r ibromide 
The crystal data of I : The crystals were orthorhombic, a = 18.40 
± 0.02, b = 11.12 ± 0.02, c = 6.32 + 0.02 A, space group P2i2i2i, Z = 4 
molecules of CioHisOBrs per unit cell. The observed density of 1.98 
g/ml determined by flotation compares well with the calculated value of 
2.01 g/ml. They solved the structure by the heavy - atom method using 
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bromine position determined from a Patterson synthesis. The light atoms 
appeared immediately in the first election - density map and refinement 
was carried out using Fourier methods and six cycles of full - matrix 
least squares analysis. A view of the molecule was given in the figure - 1 
and showed unequivocally the 2 - axial, 3 - equatorial (cis) bromine 
configuration. Comparison of observed and calculated differences for 
anomalous pairs allowed an assignment of absolute configuration. 
Davison et al.^  reported the X - ray crystal structure of 1[3, 9(3 -
diacetyl - 7a - chloro - cis - hydrindane (II). 
COCH3 
COCH3 
ai) 
'''"' m L l T ' ^'"^"^ '' ^P' 9p^iacety,.7a-chloro-cis. 
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Crystal data of II : C13H19CIO2, M = 242.7, monoclinic, space 
group P2,/C , a = 10.867 (1), b = 10.334 (2), C = 11.869 (1) A°, Z = 4, F 
(000) = 520, Rigaku AFC6S, Mo - Ka radiation, X = 0.71073 A°, \i (MO 
- Ka) = 0.278 mm"', Dc = 1.326 g/cm\ 3789 independent reflections, 
1894 with 1Z4(I) used direct method, SHELXTL PLUS^ R = 0.047, R^ 
= 0.048. Non - hydrogen atoms refined anisotropic ally, all hydrogen 
atoms refined isotropically, 203 parameters refined. A view of the crystal 
structure of ip, 9p - diacetyl - 7a - chloro - cis - hydrindane was shown 
in fig. 2. 
Vederas et at.'' reported the synthesis and X - ray crystallographic 
study of chiral binaphthyl azodicarboxamide (III a) and 
hydrazodicarboxamide (III b). The crystal structures were shown in Fig. 
3 & 4 respectively. 
(HI a) (Illb) 
Fig-3 X-ray crystal structure of 
binapththyl azodicarboxamide 
Fig-4 X-ray crystal structure of 
hydrazodicarboxamide 
Crystal data of III a : 
Data were acquired on a Siemens P4/RA diffracto meter with a 
rotating anode generator (18 KW). All intensity measurements were 
performed using graphite monochromated Mo-Ka radiation (k = 
0.71073 A°). Azodicarboxamide (III a) (C26H22N4O2) was obtained as 
colourless tetragonal crystals, P432|2 (No. 96), a = 11.490 (2), c = 
16.782 (3) A°, V = 2215.6 (5) A°, Z = 4, T = 295 K, Dc = 1.267 g/cm•^  \i 
= 0.082 mm" . A total of 2886 reflections were collected (1953 unique, 
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R,r.t = 0.036). The data were corrected for Lorentz and polarization 
effects. The structure was solved by direct methods^ and refined by full 
matrix least squares methods on F . 
Crystal data of III b : 
Hydrazodicarboxamide (III b) C65H64Cl2NioO,o [2(C32H3iN505). 
CH2CI2] was obtained as colourless monoclinic crystals, P2i (No.4), a = 
10.3883 (9), b = 15.1512 (9), C = 18.7469 (12) A°, p = 93.020 (9), V = 
2946.6 (4) A°, Z = 2, T = 213 K, D = 1.371 g/cm•^ [i = 1.570 mm"'. A 
total of 8732 reflections were collected (7882 unique, R,nt = 0.028). The 
structure was solved by direct methods - fragment search approach^. 
Mascal et al.^  established conformational study of the higher [n.n] 
paracyclophanes by X - ray crystallography. 
IV 
V 
VI 
CH2 
n 
7 
8 
9 
VII, n = 2 
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Fig-5 X-ray crystal structure of IV 
Fig-6 X-ray crystal structure of V 
Fig-7 X-ray crystal structure of VI 
Fig-8 X-ray crystal structure of VII 
208 
X - ray single crystal diffraction experiments were carried out at 
room temperature on an Enraf - Nonius CAD4 diffractometer (Ni -
filtered C^  - Ka radiation, X= 1.54184 A°). The structures were solved 
by direct methods using MULTAN - 80* and refined by full - matrix 
least squares against F . The crystal structures of IV, V, VI & VII were 
given in figures 5, 6, 7 and 8. 
Table - 1 . X - Ray crystallographic data of compounds IV, V, 
VI & VII. 
Compound 
Formula 
M 
Crystal system 
Space group 
a/A° 
b/A° 
c/A° 
IV 
C26H36 
38.57 
Orthorhombic 
Pbca 
10.897 (2) 
10.371(1) 
19.704 (2) 
V 
C28H40 
376.62 
Triclinic 
PI 
8.549 (2) 
11.232(3) 
12.634 (3) 
VI 
C30H44 
404.68 
Orthorhombic 
Pbca 
11.112(1) 
10.405 (2) 
23.186(2) 
VII 
C36H56 
488.84 
Monoclinic 
P2,/c 
10.500 (2) 
12.194(3) 
12.697 (2) 
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a/° 
p/° 
v/° 
V/A°^ 
Reflections 
used 
Obs. data 
l>2a(l) 
No. of 
variables 
90 
90 
90 
2226.8 (5) 
25 
796 
119 
91.97(2) 
103.84(2) 
93.57 (2) 
1174.1(5) 
25 
822 
174 
90 
90 
90 
2680.8 (6) 
25 
1032 
137 
90 
98.87 
90 
1606.2 (6) 
25 
800 
163 
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Kin - Fai Cheng and Man - Ki Cheung' reported the synthesis 
and X - ray studies of (4aRS, lOaRS) - 1, 1 ,3- trimethyl - 1 , 2 , 4a, 5, 
10, 10a - hexahydro indene [1, 2 - b] indol - 10 - one (VIII). The crystal 
structure of (VIII) was shown in fig. 9. 
H (VIII) 
c(ii)0 
Fig-9 X-ray crystal structure of (4aRS, 10aRS)-l,13-trimethyl -1, 2, 
4a, 5,10,10a- hexahydro indane[l, 2-b] indol-10-one 
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Crystal Data of VIII: 
Molecular composition CisHigNO, pale yellow rectangular 
crystals from methylene dichloride - diethyl ether, M = 265.36, 
monoclinic, space group P2i/C (No. 14), a = 10.800 (1), b = 13.73 (2), C 
9.887 (1) A°, [3 = 98.36 (2)°, V = 1451.2 (8) A°^ Z = 4, Dc = 1.214 
g/cm'^  |i (Mo - Ka = 0.697 cm'', F (000) = 568, T = 297 K. Crystal Size 
: 0.15x0.1 X 0.25 mm. 
10 Abell et al. reported the X - ray crystal structure of (2R, 4S, 
rS)-3-benzoyl-4-[benzoylamino(phenyl)methyl]-4-benzyl-2-phenyl-
1, 3-oxazolidin-5-one (IX), (2R, 4S, I'S) and (2R, 4S, l'R)-3-benzoyl-
4-[benzoylamino(phenyl)methyl]-4-isopropyl-2-phenyl-l, 3 oxazoli-
din-5-one (X) and (XI). Figures 10, Hand 12 displayed the crystal 
structures of compound IX, X and XI. 
Ph 0 . 
PhCON,, / 
Ph 
Ph 
NHCOPh 
ax) 
Ph 0 . 
PhCON,, / 
N = 0 
Ph 
NHCOPh 
(X) 
Ph 0 . 
PhCON,, / 
v=o 
Ph 
NHCOPh 
(XI) 
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Fig-10 X-ray crystal structure of (2R, 4S,rs )-3-benzoy I -4[ben2oyl 
amino(phenyI)niethyl]-4-benzyl-2-phenyl-l,3-oxazoIidin-5-one 
-lC2S 
Fig-11 X-ray crystal structure of 
(2R, 4S, l'S)-3-benzoyl-4-lbenzoyl- Fig-12 X-ray crystal structure of 
amino(phenyl)methyl]-4-isopropyl (2R, 4S, i:R)-3-benzoyl-4-[benzoyl-
-2-phenyl-l, 3-oxazolidin-5-one amino(phenyl)methyl]-4-isopropyl 
-2-phenyl-l, 3-oxazolidin-5-one 
Data for compound (IX) : Molecular composition C37H30N2O4, 
molecular weight = 566.63 crystal dimensions 0.30 x 0.65 x 0.17 mm, 
orthorhombic, a = 11.078 (2), b = 12.609 (3), c = 20.681 (4) A°, a = 90, 
P = 90, y = 90°, V = 2888.8 (10) A'\ space group P2,2,2,, Z = 4, F(OOO) 
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= 1192. Cell parameters were determined by least squares refinement of 
accurately centred reflections in the range 5 < 20 < 12.5°. Using 2.1°co 
scans at a scan rate of 4.00° min"', 2589 unique reflections were 
collected and 2589 of these having I > 3 a (I) were used in structural 
analysis, R = 0.0294, R^ = 0.0548. 
Data for compound (X) : Molecular composition C33H30N2O4, 
molecular weight = 518.9, crystal dimensions 0.62 x 0.28 x 0.28 mm, 
orthorhombic, a = 11.718 (5), b = 13.008 (2), c = 18.063 (5) A°, a = 
90, p = 90, Y = 90°, V = 2753.3 (15) A°\ space group P2|2,2i, Z = 4, 
F(OOO) = 1096. Cell parameters were determined by least squares 
refinement of 11 accurately centred reflections in the range 9.6 < 26 < 
20.7°, Using 1.2°(0 - scans at a scan rate of 5.00° min'', 2454 unique 
reflections were collected in the range 4 < 29 < 48° and 1259 of these 
having I > 4 a (I) were used in structural analysis, R = 0.0383, R^ = 
0.0721. 
Data for compound (XI) : Molecular composition C33H30N2O4, 
molecular weight = 518.59, crystal dimensions 0.80 x 0.15 x 0.13 mm, 
monocUnic, a = 8.290 (2), b = 16.033 (5), c = 10.467 (5) A°, a = 90, [3 = 
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104.65 (3), y= 90°, V = 1346.0 (10) K°\ space group P2,, Z = 2, F(OOO) 
= 548. Cell parameters were determined by least - squares refinement of 
29 accurately centred reflections in the range 5.7 < 29 < 25.6°. Using 
1.8°03 - scans at a scan rate of 9.00° min"', 1834 unique reflections were 
collected in the range 4 < 20 < 45° and 1049 of these having I > 4 a (I) 
were used in structural analysis, R = 0.0605, Rw = 0.1264. 
Chitoshi Kitamura and Yoshiro Yamashita^^ reported the X - ray 
crystallographic studies of dihydrodi pyrrin - dibutyl tin complex (XII). 
The general view of the molecule was shown in fig. 13. 
MeO—C, Bif B^u 0 OMe 
(XII) 
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C(l?) 
Fig-13 X-ray c 
rystal structure of dihydropyrrin-dibutyl-tin-complex 
Crystal Data of (XII) : Molecular composition C21H28N2O4 Bra Sn, 
molecular weight = 650.96, Monoclinic, a = 9.853 (5), b = 18.322 (4), c 
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= 13.948 (4) A°, P = 97.40 (3)°, V = 2497 (1) A°^ (by least - squares 
refinement on diffractometer angles for 16 automatically centred 
reflections X = 0.71069 A°, space group P2i/C (# 14), Z = 4, Dx = 1.731 
g cm'^ , colourless prismatic crystals. Crystal Dimensions : 0.30 x 0.25 x 
0.20 mm, |Li (Mo - Ka) 42.60 cm''. 6235 reflections measured (0 < 20 < 
55°, +h, K, ± 1); 5907 unique; 2928 with I > 3 a (I) which were retained 
in all calculations. 
Dyker et al.^ ^ have given synthesis and X - ray crystallographic 
studies of annelated barrelene (XIII) and its phenylated derivative (XIV). 
The general view of the molecules were shown in Fig. 14 & 15. 
(XIV) 
(XIII) 
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Fig-14 X-ray crystal structure of 7, 12-dihydro-7, 12-benzenobenzo [k] 
fluoranthene 
Fig-15 X-ray crystal structure of l-phenyIdibenzo|j, I] fluoranthene 
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Crystal data of 7, 12-dihvdro-7, 12-benzenobenzo fk] 
fluoranthene (XIII): Molecular composition C26H16, Orthorhombic, 
Pbca, a = 831.22 (8), b = 1611.2 (2), c = 2508.5 (3) pm, V = 3.3596 nm^ 
Z = 8, }i (Mo - Ka) = 71.073 pm, T = - 130 °C. Orange prism ca 0.6 x 
0.5 X 0.3 mm, 2Q^^^ = 50°, 2966 reflections 2961 unique. 
Crystal data of l-phenyldibenzo Ti 11 fluoranthene (XIV) : 
Molecular composition C30H18, monoclinic, P2i/C, a = 1083.87 (10), b = 
1586.1 (2), c = 1123.7 (2) pm, (3 = 102.813 (10), V = 1.8836 nm^ Z = 4, 
X{Mo - Ka) = 71.073 pm, T = - 100 °C, pale orange prism ca. 0.9 x 0.5 
X 0.25 mm, Siemens P4 diffractometer, 26n,ax = 50°, 3482 reflections, 
3301 unique. 
1 '^  
Previtera et al. reported the photodimerization of 16-De-
hydroprogesterone whose structure was estabUshed by using X - ray 
crystallography. The general view of the molecule was shown in fig. 16. 
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Fig-16 X-ray crystal structure of 16-dehydroprogesterone dimer 
.14 Singh et al. reported the structural analysis of sp , 20-diacetoxy-
16a-methyl-aIlopregn-17(20)-ene(XVI) by using X-ray crystallographic 
technique. 
AcO. 
AcO 
,„>>'CH3 
(XVI) 
220 
Flg-17 X-ray crystal structure of 3p, 2Miacetoxy-16a-methyl. 
allopregn-17(20)-ene 
Crystal data of (XVI): 
C26H40O4, orthorhombic, space group P2,2i2,, a = 10.745 (2), b = 11.190 
(3), c = 20.208 (I) A°. The structure was solved by direct method*^ The 
final residual index (R) converges to 0.042, weighted residual index 
(coR) being 0.044. Rings A and B adopted normal chair conformation 
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where as ring C was found to be very close to chair and ring D existed in 
14a-envelop conformation. 
Table - 2, Bond distance (A°) with e.s.d's in parenthesis 
0 1 - C 2 2 
03 - C25 
C l - C l O 
C 3 - 0 1 
C4-C5 
C13-C 14 
C13-C18 
C15-C16 
C16-C24 
C20 - 03 
C22 - C23 
1.307(7) 
1.348(5) 
1.544(6) 
1.464(5) 
1.523(6) 
1.544(5) 
1.535(6) 
1.544(6) 
1.535(7) 
1.422(5) 
1.494(9) 
02 - C22 
C1-C2 
C2-C3 
C3-C4 
C12-C13 
C13-C17 
C14-C15 
C16-C17 
C17-C20 
C20-C21 
C25 - 04 
1.206(9) 
1.522(6) 
1.502(6) 
1.499(6) 
1.544(5) 
1.516(6) 
1.522(6) 
1.521 (6) 
1.329(6) 
1.489(7) 
1.185(6) 
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C25 - C26 
C6-C7 
C8-C9 
C9-C10 
Cl()-C19 
1.491 (7) 
1.512(6) 
1.555(5) 
1.547(6) 
1.537(6) 
C5-C10 
C7-C8 
C8-C14 
C9-C11 
C11-C12 
1.542(5) 
1.520(6) 
1.519(6) 
1.536(5) 
1.526(6) 
16 Gupta et al. analyzed the crystal structure of 20a-propyl amino-
3P-hydroxy-pregn-5-ene (XVII) with water molecule by X-ray analysis. 
The crystal structure was shown in fig. 18. 
(XVII) 
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Fig-18 X-ray crystal structure of 20a.propylamino-3,g hydroxy-pregn-
The compound 20a-propylamino-3P-hydroxy pregn-5-ene 
(C24H41NO . H2O) crystallized in the monoclinic space group P2i with 
cell parameters a = 11.901 (5), b = 8.098 (2), c = 12.398 (6) A°, (3 = 
107.40 (2). The structure was solved by direct method and refined to R 
= 0.067. Ring A and C existed in chair conformation, ring B was 
intermediate between half chair and so far conformation and ring D was 
a 13|3-envelop. The A/B ring junction is quasi-trans, whilst ring system 
B/C and C/D were trans fused about bonds Qg) - C(9) and Qn) - C(i4). 
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Table - 3, Bond distance (A°) with e.s.d's in parenthesis 
C1-C2 
C2-C3 
C 3 - 0 ( l ) 
C5-C6 
C15-C16 
C17-C20 
N22 - C23 
C23 - C25 
C7-C8 
C8-C14 
C9-C11 
C11-C12 
C13-C14 
1.488(6) 
1.551 (6) 
1.390(5) 
1.342(6) 
1.512(6) 
1.544(6) 
1.494(5) 
1.540(7) 
1.552(6) 
1.446(4) 
1.545(5) 
1.488(5) 
1.560(4) 
CI -CIO 
C3-C4 
C4-C5 
C5-C10 
C16-C17 
C20-C21 
C23 - C24 
C6-C7 
C8-C9 
C9-C10 
C10-C19 
C12-C13 
C13-C17 
1.570(6) 
1.544(6) 
1.490(5) 
1.548(5) 
1.570(6) 
1.469 
1.491 (6) 
1.482(6) 
1.562(6) 
1.478(4) 
1.512(4) 
1.520(4) 
1.498(5) 
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C13-C18 1.508(4) C14-C15 1.578(4) 
Table - 4, Endocvclic torsion angle (°) with e.s.d's in 
parenthesis and puckering parameters 
C 2 - C 1 - C 1 0 - C 5 
C 1 - C 2 - C 3 - C 4 
C 3 - C 4 - C 5 - C 1 0 
C 6 - C 5 - C 1 0 - C 9 
C5 - C6 - C7 - C8 
C 7 - C 8 - C 9 - C 1 0 
C 9 - C 8 - C 1 4 - C 1 3 
C 8 - C 9 - C 1 1 - C 1 2 
C n - C 1 2 - C 1 3 - C 1 4 
C 1 4 - C 1 3 - C 1 7 - C 1 6 
C 1 3 - C 1 4 - C 1 5 - C 1 6 
- 44.4 (4) 
- 56.4 (4) 
- 48.9 (4) 
-18.9(5) 
- 9.8 (6) 
- 60.8 (4) 
-55.3(3) 
- 46.3 (4) 
- 56.2 (3) 
44.9 (3) 
29.5 (3) 
C 1 0 - C 1 1 - C 2 - C 3 
C2 - C3 - C4 - C5 
C 4 - C 5 - C 1 0 - C 1 1 
C 1 0 - C 5 - C 6 - C 7 
C6 - C7 - C8 - C9 
C 8 - C 9 - C 1 0 - C 5 
C 1 4 - C 8 - C 9 - C 1 1 
C 9 - C 1 1 - C 1 2 - C 1 3 
C 1 2 - C 1 3 - C 1 4 - C 8 
C17-C13-C14-C15 
C14-C15-C16-C17 
53.6 (4) 
54.4 (4) 
41.5(4) 
-1.0(6) 
38.0 (4) 
49.5 (4) 
46.4 (4) 
54.1 (4) 
58.7 (3) 
- 46.2 (3) 
-1.9(4) 
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18 Rajnikant et al. determined the crystal structure of 4-pregnen-
1 la-ol-3, 20 dione (XVIII) by X - ray crystallographic technique. 
(XVIII) 
Fig-19 X-ray crystal structure of 4-pregnen-l la*l-3,20-dione 
Crystal data of (XVIII): 
The compound crystallized in orthorhombic space group P2i2i2i 
with cell parameters a = 8.4415 (4), b = 10.6884 (3), c = 20.1273 (5) A°. 
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The structure was solved by direct methods and refined to R = 0.050. 
Ring A existed in half chair conformation. Ring B and C adopted a chair 
conformation and ring D was a 13a - envelop. The A/B ring function is 
quasi trans, whilst ring systems B/C and C/D were trans fused about the 
bonds Cg - C9 and C13 - C14. The crystal structure was shown in fig. 19. 
Table - 5, Bond distance (A°) with e.s.d's in parenthesis 
C1-C2 
C 2 - C 3 
C3-C4 
C5-C6 
C6-C7 
C8-C9 
C9-C10 
C10-C19 
CI 1-0(2) 
1.525(4) 
1.498(4) 
1.450(4) 
1.487(3) 
1.518(4) 
1.557(3) 
1.574(3) 
1.552(3) 
1.424(3) 
C l - C l O 
C 3 - 0 ( l ) 
C4 - C5 (5) 
C5-C10 
C7-C8 
C8-C14 
C9-C11 
C11-C12 
C12-C13 
1.541 (3) 
1.216(3) 
1.348(3) 
1.529(3) 
1.530(3) 
1.517(3) 
1.547(3) 
1.519(3) 
1.520(3) 
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C13-C14 
C13-C18 
C15-C16 
C17-C20 
C20 - 0(3) 
1.531 (3) 
1.542(3) 
1.536(4) 
1.505(3) 
1.202(3) 
C13-C17 
C14-C15 
C16-C17 
C20-C21 
1.560(3) 
1.541 (4) 
1.540(4) 
1.501 (4) 
.19 Lubell and Gosselin established the structure of N-(BOC) 
amino quinolizidin-2-one tert-butyl ester (3S, 6R, lOS) (XIX). The 
general view of the molecule was shown in fig. 20. 
BOCHN 
O C02t-Bu 
(XIX) 
Fig-20 X-ray crystal structure of N-(BOC)-amlno quinoUzidiii-2-one 
tert butyl Ester (3S,6R,10S) 
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Crystal data of (XIX) : Molecular composition C19H32N2O5, 
molecular weight = 368.46, monoclinic, colourless crystal, space group 
P2i, unit cell dimensions (A°) a = 9.773 (3), b = 10.201 (9), c = 11.064 
(3), p = 105.01 (2)°, Volume of unit cell (A°^) 1065.4 (10), Z = 2, R, = 
0.04 for I > 2 a (I), C0R2 = 0.12 for all data, GOF = 1.065. The structure 
was solved by using direct methods (SHELXS 96) and refined with 
NRCVAX and SHELXL 96. 
'70 
Middel et al. established the stereochemical and structural 
analysis of Calix [4] arene (XX) by using X - ray crystallographic 
technique. The general view of the molecule was given in fig. 21. 
Am 
Fig-21 X-ray crystal structure of Calix [4] arene 
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Crystal data for Calix [41 arene (XX) : Molecular composition 
C40H46N2O6, Molecular weight = 650.82, colourless prism, monoclinic, 
space group P2,/C with a = 19.260 (2) A°, b = 14.565 (2) A°, c = 12.970 
(2) A°, (3 = 107.939 (7)°, V = 3461.3 A°\ Z = 4, D, = 1.248 g cm '^, 
F(OOO) = 1392, |i (Mo - Ka) = 0.84 cm'', 6281 reflections measured, 
6090 independent (R.m = 3.39 %) (4.0° < 29 < 50.0°, co scan, T = 200 K, 
Mo - Ka radiation, highly oriented graphite monochromator, X = 
0.71073 A°) on a Siemens P4 diffractometer. The structure was solved 
by automated direct methods (SHELXTLIR IS). 
Gonzalez et al.^' reported the X - ray crystallographic studies of 
(±)-trans-1 l-(phenylsulfonyl)-5-methoxy-6-phenyl-5, 6-dihydro-llH-be-
nzo [a] carbazole (XXI) and 5-Methoxycarbonyl-12-methyl-12H-[3] 
benzoxepino [1, 2 - b]-indole (XXII). The crystal structures were 
displayed in fig. 22 and 23. 
Ph H 
H„.\ /,OMe 
C02Me 
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C(22) C(21) 
C(14) 
C(15) 
C(27) 
Fig-22 X-ray crystal structure of 
(+ ).trans-ll-(phenylsulf <»nyl)-5-
methoxy-6.phenyl-5,6-(llhydro-
llH-benzofa] carbazok 
Fig-23 X-ray crystal structure of 5-methoxy 
carbonyl .12-inethyM2H-l31 benzoxeplno [1,2-bl 
indole 
Crystal data for the compound (XXI) : Molecular composition 
C29H23NO3S, molecular weight = 465.57, monoclinic, a = 11.9483 (4), b 
= 10.2506 (2), c = 14.1356(3) A°, p = 94.668 (2)°, V = 2335.90 (10)A°^ 
(by least squares refinement on diffractometer angles for 75 centred 
reflections (65 < 6 < 75°), X = 1.5418 (A°), space group P2i/n, Z = 4, 
Dx = 1.324 g cm•^  colourless rectangular blocks. Crystal dimensions 
0.38 X 0.51 X 0.58 mm, \i (Cu - Ka) = 1.49 mm''. 4804 reflections 
measured (1.5 < 9 < 75.0°, h, K, ± 1), 4804 unique reflections giving 
3781 withI>2o(I). 
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Crystal data for the compound (XXII) : Molecular composition 
CigHisNOs, molecular weight = 305.32, monoclinic, a = 12.3710 (3), 
b = 14.7561 (5), c = 8.6102 (2) A°, (3 = 109.572 (2)°, V = 1480.95 
(7)A° (by least squares refinement on diffractometer angles for 25 
centred reflections (65 < 0 < 70°), X= 1.5418 (A°), space group P2i/c, 
Z = 4, Dx = 1.369 g cm'^  colourless rectangular blocks. Crystal 
dimensions 0.14 x 0.16 x 0.29 mm, i^ (Cu - Ka) = 0.76 mm"'. 2931 
reflections measured (1.5 < G < 70.0°, h, K, ± 1), 2806 unique reflections 
giving 2465 with I > 2 a (I). 
Kibayashi et al. established the structure of cis-decahydroquino-
line (XXIII) by X - ray studies. The crystal structure was shown in 
fig.24. 
(XXIII) 
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Flg-24 X-ray crystal structure of c Is decahydroquinoline 
Crystal data for the compound (XXIII) : Molecular 
composition C20H27NO2, molecular weight = 314.45, orthorhombic, 
space group P2,2,2,, a = 7.998 (3), b = 8.444 (8), c = 26.589 (2) A°, 
o3 7. _ -3 V = 1796 (1) A°-', Z = 4, Dc 1.16 g cm"', F(OOO) = 680, [i (Mo - Ka) = 
0.66 4 cm' , crystal size 0.30 x 0.35 x 0.20 mm. The intensity data were 
collected on a Mac Science DIP 2000 diffractometer with graphite -
monochromated Mo - Ka X - radiations, X = 0.70713 A°. The data were 
corrected for Lorentz and polarization effects to yield 1211 results with I 
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> 3.0 a (I). The structure was solved by direct method using the SIR 
program^^. 
Oliver Mogck et al. '^' have given X - ray crystallographic studies 
of 11, 23-di-tert-butyl-26, 28-dihydroxy-5, 17-dinitro-25, 27-dipentyl-
oxycalix [4] arene (XXIV) and cyclohexadienone derivative (XXV). The 
general view of the molecules (XXIV) and (XXV) were shown fig. 25 & 
26. 
N 0 2 ^ 
f-
r ^ 
0C5H,, 
0 0 = / 
OCsH,, 
N02 
VY 
^ s 
(XXIV) (XXV) 
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C41Q, C49 
Flg-25 X-ray crystal structure of 11,23-dl-tert-butyl-26, 28-dihydroxy-
5,17-diiiitro-25,27-dipeiityloxy Calix[41 arene 
C4U C211 
C210 
Fig-26 X-ray crystal structure of cyclohexadienone derivative of XXIV 
236 
Table - 6. Crystal data of compound XXIV and XXV 
Crystal data 
Empirical formula 
Molar mass 
Colour, habit 
Crystal size (mm) 
Crystal system 
a/A° 
b/A° 
C/A° 
0(/° 
p/° 
v/° 
V/A°^ 
Temp (k) 
Unit-cell reflections (0-range) 
Reflections measured 
(XXIV) 
C46H58N208 
766.9 
Colourless, block 
0.42 X 0.29 X 0.28 
Triclinic 
12.208 (2) 
12.424 (2) 
15.175(2) 
92.528 (10) 
90.816(10) 
101.789(12) 
2250.2 (5) 
294(1) 
15(8.214.9) 
7871 
(XXV) 
C54H74N2O8 
879.2 
Pale yellow, block 
0.41x0.27x0.22 
Monoclinic 
11.5677(15) 
18.0871 (15) 
24.201 (2) 
90 
90.544 (12) 
90 
5063.3 (8) 
294(1) 
25(8.517.3) 
11274 
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Unique reflections 
Reflections with I > 2 a (I) 
7871 
2214 
11025 
3496 
25 Nakayama et al. established the structure of 8-methoxy-4-
methylthiophenetriptycene (XXVI) by X - ray crystellographic studies. 
The general view of the molecule was shown in fig. 27. 
(XXVI) 
Fig-27 X-ray crystal structure of 8-methoxy-4-methyIthiophene 
triptycene 
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Crystal data of (XXVI) : Molecular composition CigHigOSa, 
molecular weight = 358.50, monocyclic, a = 13.752 (3), b = 14.367 (2), 
C =• 9.394 (2) A°, (3 = 93.14 (2)°, V = 1853.1 (6) A°^ (by least squares 
refinement on diffractometer angles for 20 automatically centered 
reflections, X = 1.54178 (A°), space group P2,/n, Z = 4, Dc = 1.28 g cm"^ 
F(OOO) = 752. Pale yellow plates. Crystal dimensions : 0.50 x 0.30 x 
0.10 mm, [i (Cu - Ka) = 3.601 mm''. 
Selected bond lengths (A°): 
S(l)-C(10) 
C(19)-C(10) 
S(2)-C(15) 
C(14)-C(15) 
S(3) - C(20) 
C(19)-C(20) 
C(6)-C(12) 
C(6)-C(17) 
C(6) - C(22) 
C(8)-C(13) 
C(8)-C(18) 
C(8)-C(23) 
1.737(6) 
1.505(8) 
1.727(5) 
1.494(9) 
1.731 (4) 
1.502(7) 
1.534(6) 
1.541 (6) 
1.543(6) 
1.532(6) 
1.521 (6) 
1.536(5) 
Selected Bond angles (°): 
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C(6)-C(12)-C(13) 
C(6)-C(17)-C(18) V 
C(6) - C(22) - C(23) 
C(12)-C(6)-C(17) 
C(17)-C(6)-C(22) 
C(13)-C(8)-C(23) 
C(8)-C(13)-C(12) 
C(8)-C(18)-C(17) 
C(8)-C(23)-C(22) 
C(12)-C(6)-C(22) 
C(13)-C(8)-C(18) 
C(18)-C(8)-C(23) 
115.0(4) 
113.6(4) 
114.5(4) 
103.7 (3) 
102.8 (3) 
103.0(3) 
115.6(4) 
116.4(4) 
115.5(4) 
1041.(3) 
102.9 (3) 
103.4(3). 
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Identification of molecular structure and thereby the isomeric 
relationship between molecules, may be estabUshed by using a number 
of advanced techniques in particular X - ray crystallography, which 
determines the precise three dimensional arrangement of atoms is the 
most powerful method available, as described "There can be no doubt 
that when a compound has to be identified, there is nothing to beat a 
crystal structure determination. After all, the final out come - a drawing 
of the molecule with all the atoms nicely shaded and labeled is 
convincing and will silence all but the most stubborn critics." X - Ray 
crystallography and its ability to measure accurate bond lengths within 
molecules are central to the new type of isomerism "Bond Stretch 
Isomerism." The unusual phenomenon whereby molecules differ only in 
the length of one or more bonds. Thus wide spread utility of this 
technique with only limitation that it requires compound in crystalUne 
form, though powder diffractometer have also been introduced, 
prompted us to undertake the X-ray crystallographic studies of steroidal 
compounds of cholestane series.5 Previous work from our laboratory 
regarding the X-ray crystallographic studies of steroidal compounds 
include the crystallographic studies of 3[3-chloro-6|3-formyloxy-5a-
cholestan-5-ol (XXVII)^^ 2a-7a-dibromo cholest-4-ene-3, 6-dione 
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(XXVIII), 5a-cholestane-3, 6-dione (XXIX), 3P-chloro-5, 6a epoxy-5a-
28 
cholestan (XXX) and 6-oxo-B-homo-5a-cholestan-7-one (XXXI) . 
(XXVII) o-c=o I 
H CgHn 
(XXVIII) (XXIX) 
C«H s^-n 
(XXXI) 
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So in continuation to our work on application of X - ray 
crystallographic technique in the structure elucidation of steroidal 
compounds, we have selected steroidal compounds such as 5a-
cholestan-6-one (XXXII), 6-nitrocholest-5-ene (XXXIII) 3p-chloro-6-
nitrocholest-5-ene (XXXIV) 3(3-acetoxy-cholest-5-en-7-one (XXXV) 
and cholest-3, 5-dien-7-one (XXXVI). 
C«H 8^17 
NO2 
(XXXIV) 
N02 
CsHn (XXXIII) 
AcO 
CgHn 
CgHiy 
(XXXV) 
(XXXVI) 
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X - Ray structure analysis of 5a-cholestan-6-one (XXXII): 
The crystal structure of 5a-cholestan-6-one C27H46O has been 
studied by X - ray crystallographic analysis. It crystallizes in the 
monoclinic form and space group is ?2\. The unit cell parameters with 
estimated standard deviations (as given in parentheses) are a = 10.575 
(1), b = 7.698 (1), c = 15.284 (2) A°, a = 90°, p = 99.34 (I), V= 90°. The 
molecular weight is 386. 64 am|^  and volume (V) of the unit cell having 
2 molecules per unit cell is 1227.7 (3) A°. The structure was determined 
by direct methods. A stylized representation of the compound was 
shown in Fig. 28. Bond distances and bond angles were given in Table 7 
and 8 respectively. 
Table-7. 
Bond distances (A°) for non hydrogen atoms (e.s.d's are 
giyen in 
CI -C2 
CI -CIO 
C2 - C3 
C3-C4 
parentheses) of 5a-cholestan-6-one (XXXII). 
1.530(7) 
1.536(7) 
1.516(10) 
1.503(10) 
C12-C13 
C13-C18 
C13-C14 
C13-C17 
1.532(5) 
1.536(4) 
1.548(5) 
1.547(4) 
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C4 - C5 
C5 - C6 
C5-C10 
C6 - 06 
C6-C7 
C7-C8 
C8~C9 
C8-C14 
C9-C10 
C9-C11 
C10-C19 
Cll -C12 
1.528(7) 
1.499(7) 
1.556(7) 
1.197(6) 
1.487(7) 
1.548(5) 
1.546(5) 
1.505(4) 
1.552(5) 
1.530(5) 
1.530(5) 
1.526(7) 
C14-C15 
C15-C16 
C16-C17 
C17-C20 
C20-C21 
C20 - C22 
C22 - C23 
C23 - C24 
C24 - C25 
C25 - C26 
C25 - C27 
1.527 (6) 
1.529(7) 
1.569(6) 
1.550(5) 
1.535(6) 
1.524(5) 
1.506(6) 
1.503(7) 
1.533 (9) 
1.500(13) 
1.516(13) 
Table - 8. 
Bond angles (°) for non - hydrogen atoms (e.s.d's are given 
in parentheses) of 5a-cholestan-6-one (XXXII). 
C 2 - C 1 - C 1 0 
C 1 - C 2 - C 3 
C2-C3 -C4 
C3 - C4 - C5 
113.6(4) 
110.0(4) 
111.0(6) 
110.5(4) 
C11-C12-C13 
C12-C13-C17 
C12-C13-C14 
C12-C13-C18 
112.7(3) 
116.9(3) 
106.0 (3) 
110.8(3) 
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C 4 - C 5 - C 1 0 
C4 - C5 - C6 
C 6 - C 5 - C 1 0 
C5 - C6 - C7 
C5 - C6 - 06 
06 - C6 - C7 
C6 - C7 - C8 
C7~C8-C14 
C7 - C8 - C9 
C 9 - C 8 - C 1 4 
C8--C9-C11 
C 8 - C 9 - C 1 0 
C10-C9-C11 
C 5 - C 1 0 - C 9 
CI - C 1 0 - C 9 
CI - C 1 0 - C 5 
C9-C10-C19 
C5-C10-C19 
C1-C10-C19 
C 9 - C 1 1 - C 1 2 
113.5(4) 
114.0(4) 
110.3(4) 
114.5(4) 
123.3 (4) 
122.2 (4) 
113.4(3) 
112.0(3) 
111.0(3) 
108.8(3) 
109.8 (3) 
112.7(3) 
114.9(3) 
107.3 (3) 
110.3(3) 
107.8(4) 
111.3(3) 
110.4(3) 
109.7 (3) 
114.2(3) 
C14-C13-C17 
C18-C13-C17 
C18-C13-C14 
C8-C14-C13 
C13-C14-C15 
C8-C14-C15 
C14-C15-C16 
C15-C16-C17 
C13-C17-C16 
C16-C17-C20 
C13-C17-C20 
C17-C20-C22 
C17-C20-C21 
C21-C20-C22 
C20 - C22 - C23 
C22 - C23 - C24 
C23 - C24 - C25 
C24 - C25 - C27 
C24 - C25 - C26 
C26 - C25 - C27 
100.1 (2) 
110.4(2) 
112.0(3) 
114.1 (3) 
104.2 (3) 
119.3(3) 
104.4 (3) 
106.9 (3) 
103.4 (3) 
111.5(3) 
120.0(3) 
110.4(2) 
112.8(3) 
110.6(3) 
116.5(3) 
113.1 (4) 
116.3(4) 
109.8 (5) 
110.6(6) 
111.9(8) 
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X-Ray structure analysis of 6-nitrocholest-5-ene (XXXIII): 
The crystal structure of 6-nitrocholest-5-ene (C27H45NO2) has 
been determined by X-ray structure analysis. It crystallizes in the 
monoclinic form and space group is P2i. The cell parameters with 
estimated standard deviations (as given in parentheses) are a = 12.143 
(2), b = 10.835 (2), c = 19.747 (4) A°. The structure has been elucidated 
by using direct methods. A stylized representation of the molecule 
shown in Fig. - 29 Inter atomic distances and bond angles are given in 
Table-9 and 10. 
Table - 9: Bond distances (A°) for non-hydrogen atoms 
(e.s.d.s are giyen 
C1~C2 
C 2 - C 3 
C4-C5 
C5-C10 
C6 - CI 
N l - 0 2 
C8-C9 
C9-C10 
in parentheses) for compound (XXXIII). 
1.510(9) 
1.527(9) 
1.511(7) 
1.535(6) 
1.481 (6) 
1.208(7) 
1.549(5) 
1.544(6) 
C l - C l O 
C3-C4 
C5-C6 
C6-N1 
N l - 0 1 
C7-C8 
C8-C14 
C9-C11 
1.552(7) 
1.509(8) 
1.347(6) 
1.461 (5) 
1.209(6) 
1.523(6) 
1.517(6) 
1.536(7) 
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C]C)-C19 
C12-C13 
C13-C14 
C 14-C15 
C16-C17 
C20-C21 
C22 - C23 
C24 - C25 
C25 - C27 
1.541 (7) 
1.523(7) 
1.542(6) 
1.520(6) 
1.552(7) 
1.529(9) 
1.503(8) 
1.546(10) 
1.516(14) 
C11-C12 
C13-C18 
C13-C17 
C15-C16 
C17-C20 
C20 - C22 
C23 - C24 
C25 - C26 
1.525(7) 
1.531 (7) 
1.554(6) 
1.542(7) 
1.551 (6) 
1.547(8) 
1.486(10) 
1.452(12) 
Table -10 Bond angles (°) for non - hydrogen atoms 
(e.s.d.'s are given in parentheses) for compound (XXXIII). 
C 2 - C 1 - C 1 0 
C2 - C3 - C4 
C 4 - C 5 - C 1 0 
C 6 - C 5 - C 1 0 
C 5 - C 6 - N 1 
C 6 - N 1 - 0 2 
O l - N l - 0 2 
115.3(4) 
110.6(5) 
116.6(4) 
119.0(4) 
119.5(4) 
117.6(4) 
120.9 (5) 
C 1 - C 2 - C 3 
C3 - C4 - C5 
C4 - C5 - C6 
C5 - C6 - C7 
N 1 - C 6 - C 7 
C 6 - N 1 - 0 1 
C6 - C7 - C8 
109.8 (5) 
114.3(4) 
124.4(4) 
128.1 (4) 
112.4(3) 
121.4(4) 
113.1(3) 
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C 7 - C 8 - C 1 4 
C 9 - C 8 - C 1 4 
C 8 - C 9 - C 1 0 
C5~C10-C9 
C 1 - C 1 0 - C 5 
C 5 - C 1 0 - C 1 9 
C 9 - C 1 1 - C 1 2 
C12-C13-C17 
C12-C13-C18 
C18-C13-C17 
C 8 - C 1 4 - C 1 3 
C8-C14-C15 
C15-C16-C17 
C16-C17-C20 
C17-C20-C22 
C21-C20-C22 
C22 - C23 - C24 
C24 - C25 - C27 
C26 - C25 - C27 
111.0(3) 
110.4(3) 
113.1(3) 
110.8(3) 
109.3 (4) 
105.9 (4) 
115.3(4) 
116.9(4) 
111.2(4) 
110.0(4) 
115.1(3) 
118.5(3) 
106.9 (4) 
113.3(4) 
110.1(4) 
109.9 (5) 
114.1(5) 
109.2(5) 
112.8(8) 
C7 - C8 - C9 
C 8 - C 9 - C 1 1 
C10-C9-C11 
C 1 - C 1 0 - C 9 
C9-C10-C19 
C1-C10-C19 
C11-C12-C13 
C12-C13-C14 
C14-C13-C17 
C18-C13-C14 
C13-C14-C15 
C14-C15-C16 
C13-C17-C16 
C13-C17-C20 
C17-C20-C21 
C20 - C22 - C23 
C23 - C24 - C25 
C24 - C25 - C26 
109.0 (3) 
110.8(4) 
114.2(4) 
109.0 (4) 
112.5(4) 
109.3 (4) 
112.4(4) 
106.1 (4) 
99.5 (3) 
112.5(4) 
104.9 (3) 
103.8 (3) 
103.4 (4) 
119.4(3) 
112.1(4) 
115.3(5) 
114.9(5) 
115.2(6) 
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X - Ray structure analysis of 33-chloro-6-nitro cholest-5-
ene(XXX^IV); 
The vinyl nitro compound C27H44NO2CI crystallizes into 
orthorhombic form and space group is P2i2i2i with cell parameters 
a = 7.207 (1), b = 11.292 (1), c = 32.373 (5) A°, a = p = y = 90°. The 
molecular weight is 450.10 am )i and volume (v) of the unit cell having 4 
molecules per unit cell (Z) is 2634.56 A°. The structure was determined 
by direct methods. A stylized representation of the molecule was shown 
in fig - 30. Interatomic distances and bond angles are given in Table 11 
and 12 respectively. 
Table -11 ; Bond distances (A°) with e.s.d's in parentheses 
for compound (XXXIV). 
CL 1 - C 3 
C 1 - C 2 
C I - C I O 
C 2 - C 3 
1.811(8) 
1.536(12) 
1.534(9) 
1.498(11) 
C 1 0 - C 1 9 
C l l - C 12 
C 1 2 - C 1 3 
C 1 3 - C 1 8 
1.545(10) 
1.507(10) 
1.538(9) 
1.526(10) 
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C 3 - C 4 
C 4 - C 5 
C 5 - C 6 
C 5 - C 1 0 
C 6 - N 1 
C 6 - C 7 
N l - 0 1 
N 1 - 0 2 
C 7 - C 8 
C 8 - C 9 
C 8 - C 14 
C 9 - C 10 
C 9 - C 11 
1.535(12) 
1.485(11) 
1.298(8) 
1.553(8) 
1.455(10) 
1.513(12) 
1.168(11) 
1.167(13) 
1.520(10) 
1.542(2) 
1.514(9) 
1.532(9) 
1.543(9) 
C 1 3 - C 1 4 
C 1 3 - C 1 7 
C 1 4 - C 1 5 
C 1 5 - C 16 
C 1 6 - C 1 7 
C 1 7 - C 2 0 
C 2 0 - C 2 1 
C 20 - C 22 
C 2 2 - C 23 
C 23 - C 24 
C 24 - C 25 
C 25 - C 26 
C 25 - C 27 
1.558(8) 
1.525(9) 
1.536(9) 
1.511(11) 
1.560(10) 
1.538(9) 
1.517(12) 
1.539(11) 
1.505(14) 
1.488(14) 
1.508(12) 
1.477(16) 
1.510(16) 
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Table ~ 12 ; Bond angles (°) with e.s.d's in parentheses for 
compound (XXXIV). 
C 2 - C 1 - C 1 0 
C 1 - C 2 - C 3 
C L 1 - C 3 - C 2 
C2 - C3 - C4 
C L 1 - C 3 - C 4 
C3 - C4 - C5 
C 4 - C 5 - C 1 0 
C4 - C5 - C6 
C 6 - C 5 - C 1 0 
C5 - C6 - C7 
C 5 - C 6 - N 1 
N 1 - C 6 - C 7 
C 6 - N 1 - 0 2 
114.9(6) 
109.1(7) 
109.6 (6) 
111.0(6) 
109.1 (5) 
111.3(7) 
116.8(6) 
123.6 (6) 
119.8(5) 
128.6(6) 
119.7(5) 
111.6(6) 
119.8(8) 
C17-C20-C21 
C 9 - C 8 - C 1 4 
C 8 - C 9 - C 1 4 
C 8 - C 9 - C 1 0 
C10-C9-C11 
C 5 - C 1 0 - C 9 
C 1 - C 1 0 - C 9 
C 1 - C 1 0 - C 5 
C9-C10-C19 
C5-C10-C19 
C1-C10-C19 
C9-C11-C12 
C11-C12-C13 
113.2(6) 
110.4(5) 
112.7(5) 
112.2(5) 
113.2(5) 
110.7(5) 
109.5 (5) 
108.1 (4) 
111.5(5) 
107.1 (5) 
109.7 (6) 
115.0(6) 
113.4(5) 
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C 6 - N 1 - 0 1 
O l - N l - 0 2 
C6 - C7 - C8 
C 7 - C 8 - C 1 4 
C7 - C8 - C9 
C 8 - C 1 4 - C 1 3 
C13-C14-C15 
C8-C14-C15 
C14-C15-C16 
C15-C16-C17 
C13-C17-C16 
C16-C17-C20 
C13-C17-C20 
C17-C20-C22 
120.3 (7) 
119.8(9) 
109.0 (7) 
109.8 (6) 
108.8 (5) 
114.8(5) 
103.4 (5) 
118.8(5) 
105.0 (5) 
107.1(6) 
103.7 (5) 
112.2(5) 
118.9(5) 
111.9(6) 
C12-C13-C17 
C12-C13-C14 
C12-C13-C18 
C 1 4 - C 1 3 - C 1 7 
C18-C13-C17 
C18-C13-C14 
C21-C20-C22 
C20 - C22 - C23 
C22 - C23 - C24 
C23 - C24 - C25 
C24-C25-C27 
C24 - C25 - C26 
C26 - C25 - C27 
118.4(5) 
105.0 (4) 
109.8 (6) 
100.7 (5) 
110.9(5) 
111.5(5) 
111.1(6) 
115.7(8) 
115.4(8) 
114.3(8) 
110.0(7) 
113.8(8) 
110.2(8) 
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X - Ray structure analysis of 33-acetoxv cholest-5-en-7-one 
(XXXY); 
The crystal structure of 3[3-acetoxy cholest-5-en-7-one has been 
determined by X - ray structure analysis. The compound, C29H40O3 
crystallizes in monoclinic form, space group is P2i. The unit cell 
parameters with estimated standard deviations (as given in parentheses) 
are a = 9.623 (1), b = 12.280 (1), c = 23.099 (2) A°, Z = 4 (number of 
atoms in unit cell = 4). The structure has been elucidated by direct 
methods. A stylized representation of the molecule was shown in 
fig - 31. Bond lengths and bond angles were given in table 13 and 14 
Table -13 : Bond lengths (A°) of 3(3-acetoxy-cholest-5-en-
7-one (XXXV). 
0 1 - C 7 
02 - C28 
0 2 - C 3 
03 - C28 
1.228(6) 
1.340(7) 
1.449(5) 
1.202(7) 
C11-C12 
C12-C13 
C13-C18 
C13-C14 
1.540(7) 
1.540(7) 
1.538(7) 
1.541 (6) 
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C1-C2 
C l - C l O 
C 2 - C 3 
C3-C4 
C4-C5 
C 5 - C 6 
C5-C10 
C6-C7 
C7-C8 
C8-C14 
C8-C9 
C9-C11 
C9-C10 
C10-C19 
1.520(6) 
1.553(6) 
1.505(7) 
1.522(6) 
1.519(6) 
1.334(6) 
1.519(6) 
1.461 (6) 
1.514(6) 
1.528(6) 
1.552(6) 
1.520(6) 
1.567(6) 
1.537(5) 
C13-C17 
C14-C15 
C15-C16 
C16-C17 
C17-C20 
C20-C21 
C20 - C22 
C22 - C23 
C23 - C24 
C24 - C25 
C25 - C27 
C25 - C26 
C28 - C29 
1.545(7) 
1.534(6) 
1.549(7) 
1.566(7) 
1.534(7) 
1.515(11) 
1.519(8) 
1.503 (8) 
1.532(10) 
1.487(10) 
1.477(16) 
1.518(16) 
1.474(8) 
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Table - 14 : Bond angles Tdegl of 33-acetoxv-cholest-5-en-7-
one (XXXV). 
C28 - 02 - C3 
C 2 - C 1 - C 1 0 
C 3 - C 2 - C 1 
02 - C3 - C2 
02 - C3 - C4 
C2 - C3 - C4 
C5 - C4 - C3 
C6 - C5 - C4 
C 6 - C 5 - C 1 0 
C 4 - C 5 - C 1 0 
C5 - C6 - C7 
0 1 - C 7 - C 6 
0 1 - C 7 - C 8 
116.9(4) 
115.4(4) 
109.1(4) 
107.6 (3) 
110.3(3) 
110.7(4) 
110.7(3) 
119.3(4) 
124.0 (4) 
116.7(4) 
122.7 (4) 
119.3(4) 
123.3 (4) 
C11-C12-C13 
C18-C12-C13 
C18-C13-C14 
C12-C13-C14 
C18-C13-C17 
C12-C13-C17 
C14-C13-C17 
C8-C14-C15 
C8-C14-C13 
C15-C14-C13 
C14-C15-C16 
C15-C16-C17 
C20-C17-C13 
111.0(4) 
110.9(5) 
112.5(4) 
106.6 (3) 
110.6(4) 
115.8(4) 
99.9 (4) 
119.1(4) 
114.4(4) 
104.2 (4) 
103.2 (4) 
106.7 (4) 
121.6(4) 
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C6 - C7 - C8 
C 7 - C 8 - C 1 4 
C7 - C8 - C9 
C 1 4 - C 8 - C 9 
C 1 1 - C 9 - C 8 
C 1 1 - C 9 - C 8 
C 8 - C 9 - C 1 0 
C5-C10-C19 
C 5 - C 1 0 - C 1 
C 1 9 - C 1 0 - C 1 
C 5 - C 1 0 - C 9 
C19-C10-C9 
C 1 - C 1 0 - C 9 
C 9 - C 1 1 - C 1 2 
117.3(4) 
112.3(4) 
108.4(3) 
110.0(3) 
111.8(3) 
113.3(3) 
112.2(3) 
108.6 (4) 
108.7 (3) 
109.6 (4) 
109.6 (3) 
112.4(3) 
107.9 (3) 
113.0(4) 
C20-C17-C16 
C13-C17-C16 
C21-C20-C22 
C21-C20-C17 
C22 - C20 - C17 
C23 - C22 - C20 
C22 - C23 - C24 
C25 - C24 - C23 
C27 - C25 - C24 
C27 - C25 - C26 
C24 - C25 - C26 
03 - C28 - 02 
03 - C28 - C29 
02 - C28 - C29 
112.2(4) 
103.2 (4) 
109.5 (6) 
112.6(6) 
110.8(5) 
117.4(6) 
111.7(6) 
115.5(8) 
114.9(10) 
105.6(8) 
108.9(10) 
122.8 (5) 
124.4 (6) 
112.8(6) 
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X - Ray structure analysis of choIest-3,5-diene-7-one 
(XXXVI): 
The crystal structure of the compound cholest-3, 5-diene-7-one, 
C27H42O has been determined by X - ray structural analysis, using direct 
methods. It crystallizes in the orthorhombic form, space group is 
P2i2i2i. The unit cell parameters with estimated standard deviations (as 
given in parentheses) are a = 11.275 (2), b = 11.320 (3), c = 18.528 (4) 
A°, a = 90°, (3 = 90° and V = 90°. The molecular weight in 378.57 am|i 
and volume (V) of the unit cell having 4 molecules per unit cell is 
2364.8 (9) A°. A stylized representation of the compound was shown in 
Fig - 32 and bond lengths (A°) and bond angles (°) were given in Table 
15 and 16 respectively. 
Table - 15 : Bond Lengths (A°) for Compound (XXXVI). 
0 1 - C 7 
C1-C2 
CI -CIO 
C 2 - C 3 
1.317(1) 
1.549(2) 
1.592(1) 
1.543(2) 
C12-C13 
C13-C17 
C13-C18 
C13-C14 
1.496(1) 
1.566(1) 
1.585 (2) 
1.586(1) 
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8C3 - C4 
C4-C5 
C5-C6 
C5-C10 
C6-C7 
C7-C8 
C8-C14 
C8-C9 
C9-C10 
C9-C11 
C10-C19 
C11-C12 
1.354(2) 
1.461 (2) 
1.353(1) 
1.494(1) 
1.322(1) 
1.485(1) 
1.540(1) 
1.549(1) 
1.539(1) 
1.522(2) 
1.537(1) 
1.566(1) 
C14-C15 
C15-C16 
C16-C17 
C17-C20 
C20-C21 
C20 - C22 
C22 - C23 
C23 - C24 
C24 - C25 
C25 - C26 
C25 - C27 
1.470(2) 
1.584(2) 
1.544(2) 
1.453(2) 
1.505(2) 
1.510(3) 
1.471 (3) 
1.573(3) 
1.528(3) 
1.461 (3) 
1.561 (2) 
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Table - 16 : Bond 
C 2 - C 1 - C 1 0 
C 3 - C 2 - C 1 
C 4 - C 3 - C 2 
C 3 - C 4 - C 5 
C 6 - C 5 - C 4 
C 6 - C 5 - C 1 0 
C 4 - C 5 - C 1 0 
C 7 - C 6 - C 5 
0 1 - C 7 - C 6 
0 1 - C 7 - C 8 
C 6 - C 7 - C 8 
C 7 - C 8 - C 1 4 
C 7 - C 8 - C 9 
angles fdegl for comnound (XXXVI). 
112.7(9) 
108.6(11) 
122.3(11) 
123.5(11) 
123.3 (9) 
118.2(8) 
118.5(9) 
127.0(10) 
122.7(10) 
116.6(9) 
120.7(10) 
114.9(8) 
108.8 (7) 
C 1 3 - C 1 2 - C 1 1 
C 1 2 - C 13 -C17 
C 1 2 - C 1 3 - C 18 
C 1 7 - C 1 3 - C 18 
C 1 2 - C 1 3 - C 14 
C 1 7 - C 1 3 - C 14 
C 1 8 - C 1 3 - C 14 
C 1 5 - C 1 4 - C 8 
C 1 5 - C 1 4 - C 1 3 
C 8 - C 1 4 - C 1 3 
C 14 -C 15 -C 16 
C 1 5 - C 1 6 - C 17 
C 2 0 - C 1 7 - C 1 3 
110.6(8) 
116.1(8) 
112.8(9) 
109.4 (8) 
109.7 (7) 
101.1(7) 
106.7 (8) 
123.7 (8) 
102.9 (7) 
112.2(7) 
111.5(9) 
100.4 (9) 
120.6 (9) 
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C 1 4 - C 8 - C 9 
C 1 0 - C 9 - C 1 1 
C 1 0 - C 9 - C 8 
C 1 1 - C 9 - C 8 
C 5 - C 1 0 - C 9 
C 5 - C 10 -C 19 
C 9 - C 10 -C19 
C 5 - C 1 0 - C l 
C 9 - C 1 0 - C 1 
C 1 9 - C 1 0 - C 1 
C 9 - C 1 1 - C 1 2 
111.3(7) 
115.1(8) 
111.3(7) 
110.7(7) 
110.0(8) 
110.8(8) 
112.5(8) 
107.5 (7) 
107.4 (8) 
108.3(8) 
115.1(9) 
C 2 0 - C 1 7 - C 1 6 
C 1 3 - C 1 7 - C 16 
C 1 7 - C 2 0 - C 2 1 
C 1 7 - C 2 0 - C 2 2 
C 2 1 - C 2 0 - C 2 2 
C 23 - C 22 - C 20 
C 22 - C 23 - C24 
C 25 - C 24 - C 23 
C 24 - C 25 - C 26 
C 24 - C 25 - C 27 
C 26 - C 25 - C 27 
108.5 (9) 
103.9 (7) 
116.9(11) 
118.1(13) 
107.1(12) 
105.3 (2) 
101.0(2) 
119.0(2) 
126.2(2) 
109.3 (2) 
101.5(17) 
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The structures have been determined by direct methods using 
SHELXS 86 (SHELDRICK, 1986)'^ The structures were subjected to 
full - matrix least - squares refinement. All the calculations were made 
on VAX and Magnum computers. 
33-Chlorocholest-5-ene (XXXVII); 
Freshly purified thionyl chloride (75 ml) was added gradually to 
cholesterol (100 gm) at room temperature. A vigorous reaction ensued 
with the evolution of gaseous products. When the reaction slackened, the 
mixture was gently heated at a temperature of 50 - 60° on a water bath 
for 1 hr and then poured onto crushed ice - water mixture with stirring. 
The yellow solid thus obtained was washed several times with water and 
air dried. Recrystallization of crude product from acetone gave 3^-
chlorocholest-5-ene (95.5), m.p. 95-96 (reported^° 96-97°) 
Cholest-5-ene (XXXVIII): 
3(3-Chlorocholest-5-ene (15.0 gm) was dissolved in warm amyl 
alcohol (300 ml) and sodium metal (35 gm) was added in small portions 
to the solution with stirring over a period of 8 hr. The reaction mixture 
was heated now and then during the course of reaction in order to keep 
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the sodium metal dissolved. The reaction mixture was poured into water, 
acidified with HCl and allowed to stand overnight. A white crystalline 
solid was obtained which was filtered under suction and washed with 
water and air dried. Recrystallization of the crude product from acetone 
gave cholest-5-ene (XXXVIII), m.p. 93° (reported^' m.p.90 - 91°). 
6-Nitrocholest-5-ene (XXXIX); 
Cholest-5-ene (6.0 gm) in glacial acetic acid (50 ml) was stirred at 
room temperature for 5 min. Fuming nitric acid (20 ml) was rapidly 
added and the stirring was continued for 2 hrs. The temperature of the 
reaction mixture was maintained between 20 - 25° by external cooling. 
The reaction mixture was poured into ice cooled water. A yellow 
precipitate thus obtained was filtered washed thoroughly with water and 
air dried. Recrystallization from ethanol furnished (XXXIX) (3.5 gm) 
m.p. 117-118 (reported^^ m.p. 117-118). 
5a-Cholestan-6-one (XXXII): 
6-Nitrocholest-5-ene (XXXIX) (6.0 gm) was dissolved in glacial 
acetic acid (200 ml) by heated and to this solution zinc dust (12.0 gm) 
was added in small portions. The suspension was then heated under 
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reflux for 3 hrs and water (12ml) was added now and then during the 
course of reaction. The solution was then filtered and washed with two 
(10 ml) portions of warm acetic acid. To the filterate a few ml of water 
was added till the turbidity developed and it was allowed to stand 
overnight at room temperature. The crystalline material thus seperated 
was filtered and washed thoroughly with water. The organic solid was 
air dried and then recrystallized from methanol (3.6 g), m.p. 96 - 98° 
(reported^^ m.p. 95 - 96°). 
Colourless crystals of 5a-cholestan-6-one were grown from 
methanol by slow evaporation. The three dimensional intensity data were 
collected on Enraf - Nonius CAD - 4 diffractometer. co/26 scan mode 
was employed. Full - matrix least - square method was used for 
refinement. A total 1968 reflections were recorded with 1863 
independent reflections. Index ranges 0 <= h <= 11, 6 <=K < 8, - 17 < 1 
<=16. The absorption coefficient was 0.450 mm'' and theta range for 
data collection was 2.93 to 59.94 degree. The data were collected for 
Lorentz and Polarization. 
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Table-17 
Crystal data and other experimental details. 
Empirical Formula 
Formula weight 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
C27H46O 
386.64 
1.5418 A° 
Monoclinic 
P2, 
a = 10.575 (l),b = 7.698(1) 
c=15.284(2)A°, a=90 
Volume 
Density (calculated) 
Absorption coefficient 
Crystal size 
Theta range 
Index ranges 
Reflections collected 
P = 99.34(1) and V= 90 
1227.7(3) A° 
2(two molecule per unit) 
1.046 MgW 
0.450 
0.3x0.3x1.5 
2.93 to 59.94 deg. 
e<=h<= 11, 
e <= K <= 8, 
17 <= 1 <= 16 
1968 
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Independent reflections 1863 
Refinement method Full - matrix least - squares on F 
Data/restraints/parameters 1863/1/254. 
Goodness-of-fit on F 1.013 
6-Nitrocholest-5-ene (XXXIII); 
Colourless crystals of 6-nitrocholest-5-ene were grown from 
methanol by slow evaporation. The three dimensional intensity data were 
collected on Enraf - Nonius CAD - 4 diffractometer. co/26 Scan mode 
was employed. Full - matrix least - square method was used for 
refinement. A total of 4020 reflections were recorded with 3832 
independent reflections. Index range 0< -h< 13, 9<= K = 11, -22< 1< 22. 
The absorption coefficient was 0.066 mm"' and theta range for data 
collection was 1.05 to 23.52 degree. The data were corrected for Lorentz 
and Polarization factors. The crystallographic data were presented in 
Table-18. 
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Table - 1 8 
Crystal data and other < 
nitrocholest-5 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Density (calculated) 
Absorption coefficient 
Crystal size 
Theta range for data collection 
3XDerimental details of 6-
-ene (XXXIII): 
C27H45NO2 
415.64 
293 (2) K 
0.71069 A° 
MonocUnic 
P2, 
a =12.143 (2) A° 
b= 10.835 (2) A° 
c = 19.747 (4) A° 
2547.8 (8) A° 
1.084 MgW 
0.066 mm"' 
0.4 X 0.3 X 1.5 mm 
1.05 to 23.52 deg. 
Index ranges e<=h<=13, e<=:K<ll, -22<1<22 
Reflections collection 4020 
Independent reflections 3832 
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Refinement method Full - matrix Least - square 
Data / Restraints / Parameters 3832/1/542 
Final R indices [I >2 sigma (I)] RI=0.0661, (oR2=0.204 
Largest diff. peak and hole 0.688 and - 0.243e.A°"^ 
3(3-Chloro-6-nitrocholest-5-ene (XL): 
To a well stirred mixture of 3(3-chlorocholest-5-ene (XXXVII) 
(12 g) glacial acetic acid (80 ml) and nitric acid (25 ml, d, 1.52) at 
temperature below 20°, was added sodium nitrite (3.0 g) gradually over a 
period of 3 hrs. After complete addition of sodium nitrite, the mixture 
was further stirred for about 1 hr, ice cooled water (200 ml) was added 
and the yellowish solid seperated was filtered and air dried. The desired 
product (XL) was recrystallized from methanol as needles (8.3 g) m.p. 
151 - 152° (reported "^* m.p. 153°). 
Transparent rectangular plate shaped crystals 3[3-chloro-6-
nitrocholest-5-ene were grown from methanol by slow evaporation. The 
three dimensional intensity data were collected on Enraf - Nonius CAD 
4 diffractometer with CuKa radiation (A, = 1.5418 A°). co/20 scan mode 
was employed for data collection. 2247 Reflections were measured of 
which 1789 were treated observed with [Fo > 40 (FQ)]. The structure has 
274 
been solved by direct methods and refined to R = 0.065. The data were 
corrected for Lorentz and Polarization factors. The crystal data and other 
experimental details are given in Table - 19. 
Table -19 
Crystal data and other experimental details of 3(3-chloro-6-
nitro-cholest-5-ene (XXXIV): 
Crystal description 
Chemical formula 
Molecular weight 
Cell oarameters 
Unit Cell Volume 
Crystal system (space group) 
Density (Calculated) [DC] 
Wavelength (k) 
Transparent rectangular plate 
C27H44NO2CI 
450.10 
A=7.207(1)A° 
B =11.292 (1)A° 
C =32.373 (2) A° 
a = p=v = 90° 
2634.56 A° 
Orthorhombic (P2i2i2i) 
1.135 g/cm^ 
4(four molecules per unit cell). 
1.5418 A° 
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Absorption coefficient [\i (CuKa)] 1.44 mm' 
Crystal size 0.34x0.12x0.10 mm 
No. of measured reflections 2247 
No. of Unique reflections 2231 
No. of observed reflections 1789[Fo>40(Fo)] 
Structure solution Direct methods (SHELXS 86) 
Refinement SHELXL 93 (SHELDRICK, 1993) 
R 0.065 
33-Acetoxvcholest-5-ene (XLI): 
A mixture of cholesterol (50 gm), pyridine (75 ml) and freshly 
distilled acetic anhydride (50 ml) was heated on a water bath for 2 hrs. 
The resulting brown solution was poured into crushed ice - water 
mixture with stirring. A light brown solid was obtained which was 
filtered under suction, washed with water and air dried. The crude 
product on recrystallization from acetone gave pure 3P-acetoxy-cholest-
35. 5-ene (45.0 g) m.p. 112° (reported'" m.p. 113°). 
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33-Acetoxvcholest-5-en-7-one (XXXV): 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), CrOa (20 
g), acetic acid (84 ml) and acetic anhydride (10 ml)] was added at 0° to a 
solution of 3[3-acetoxycholest-5-ene (8.0 g) in carbontetrachloride (150 
ml), acetic acid (30 ml) and acetic anhydride (10 ml). The content was 
refluxed for 3 hrs and then it was diluted with water. The organic layer 
was washed successively with water, sodium bicarbonate solution (5 %) 
and water and dried over sodium sulphate (anhydrous). Evaporation of 
the solvent furnished an oil which was crystallized from methanol to 
give (XXXV) (4 g),m.p. 155°. (reported^^ m.p. 156 - 158°). 
Colourless rectangular plate shaped crystals of 3(3-acetoxy 
cholest-5-en-7-one were grown from methanol by slow evaporation. The 
three dimensional intensity data were collected on Enraf-Nonius CAD-4 
diffractometer co/26 Scan mode was employed. Full - matrix Least 
square method was used for refinement. The data were corrected for 
Lorentz and Polarization factors. The crystallographic data were 
presented in Table - 20. 
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Table - 20 
Crystal data and other experimental details for the 
compound 33-acetoxy cholest 5-en-7-one (XXXV): 
Crystal description 
Empirical formula 
Molecular weight 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Rectangular Platey 
C29H46O3 
442.66 
1.5418 A° 
Monoclinic 
P2, 
a=9.632(l)A° 
b =12.280 (1)A° 
c =23.099 (2) A° 
p =99.52 (1)A° 
2694.4 (4) A° 
4 (four molecules per unit cell). 
Cholest-3,5>dien>7-one (XXXVI); 
To a solution of SP-acetoxy cholest-5-en-7-one (XXXV) (4.0 g) 
in ethanol (100 ml) was added hydrochloric acid (5 ml, 12N) and 
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reaction mixture was heated under reflux for 2 hrs. On allowing the 
reaction mixture to cool, the compound (XXXVI) seperated as pellets 
which was filtered and crystaUized from methanol (3.5 gm) m.p. 114° 
(reported^^ m.p. 113-114°). 
Transparent crystals of cholest-3,5-diene-7-one were grown from 
methanol by slow evaporation. The three dimensional intensity data were 
collected on Enraf-Nonius CAD-4 diffractometer with CuKa radiation 
(X = 1.5418 A°) co/29 scan was employed for data collection. The 
structure has been solved by direct methods and refined to R = 0.065. 
The data were corrected for Lorentz and Polarization factor. The crystal 
data and other experimental details are given in Table - 21. 
Table - 21 
Crystal data and other experimental details of cholest-3,5-
dien-7-one (XXXVI): 
Empirical formula • C27 H42 O 
Molecular weight 378.57 
Temperature 293 (2) K 
Wavelength 0.71073 A° 
Crystal system Orthorhombic 
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Space group 
Unit cell dimensions 
P2,2,2i 
a = 
b = 
c = 
a : 
(3 = 
Y = 
= 11.275 (2) A° 
= 11.320 (3) A° 
: 18.528 (4) A° 
= 90° 
 90° 
:90° 
2364.8 (9) A° Volume 
Z 4 (four molecules per unit cell). 
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